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Ischemia and reperfusion (I/R) injury occurs when a transient reduction in blood flow is followed 
by restoration of blood flow. In humans, brain I/R injury occurs during the common conditions stroke and 
cardiac arrest. At present, understanding of the cellular pathology of brain I/R injury is insufficient to 
provide a foundation on which to develop effective clinical therapies. 
When circulation is interrupted prior to entering the brain, a global brain I/R injury affects all 
neurons. Global brain I/R differentiates neurons into selectively vulnerable and selectively resistance 
groups. After global brain I/R, both selectively vulnerable and selectively resistant neurons recover from 
initial disturbances in energy imbalance and ion gradients, and both groups retain the ability to transcribe 
mRNA. Resistant neurons are differentiated from vulnerable neurons by their ability to translate stress 
response mRNAs into protein early in reperfusion. It is not understood how resistant neurons translate 





This thesis work investigates mechanisms of posttranscriptional and translational control in 
pyramidal cell neurons of the ischemia resistant cornu ammonis 3 (CA3) and ischemia vulnerable CA1 
subregions of the rat hippocampus. This work builds on the previous discovery in the DeGracia laboratory 
of the mRNA granule, a stress-induced messenger ribonucleoprotein complex (mRNP) in reperfused 
neurons. This work is also based on an extensive literature describing translation control and cellular 




investigate the posttranscriptional regulation of stress response transcripts following global brain I/R 
 






1.2 Specific Aims 
 
 
1.2.1 Specific Aim 1: mRNA Granule Dependence on Polysome- 
associated mRNA 
Upon reperfusion after brain ischemia, cytoplasmic mRNA forms into distinct structures called 
mRNA granules. mRNA granules form in all injured neurons, but only resolve in neurons which recover 
from  brain  I/R  injury
1
.  While  intact  during  ischemia,  polysomes  disassemble  immediately  upon 
reperfusion, breaking into ribosomal subunits which slowly reassemble as protein synthesis gradually 
returns during reperfusion
2
. Dissociation of neuronal polysomes is expected to liberate free mRNA into 
the cytoplasm and therefore may be necessary for mRNA granule formation. In this aim, mRNA was 
locked onto polysomes with cycloheximide (CHX) to determine if polysome-associated mRNA was 
required  for  mRNA  granule  formation.  Because  mRNA  granules  are  complex  structures  under 
microscopy, texture analysis was used to detect and quantify mRNA granule formation. To further study 
the relationship between polysomes and mRNA granules, polysome dissociation was induced in uninjured 











Ischemia  resistant  neurons  such  as  the  pyramidal  cell  neurons  of  the  CA3  region  of  the 
hippocampus effectively translate stress-response transcripts into protein early in reperfusion after an 
ischemic insult
3,4
. Ischemia vulnerable populations such as CA1 pyramidal cell neurons transcribe stress 
response mRNAs, but they do not translate mRNAs into protein in early reperfusion
3,4
. The mRNA- 
binding protein (mRBP) Hu antigen R (HuR, also called embryonic lethal, abnormal vision, Drosophila- 
like 1) localizes to mRNA granules early in reperfusion only in ischemia resistant neurons, but the 
implications  of  this  finding are  unknown.  HuR  is  known  to  stabilize  the  mRNA  of  stress  response 
proteins such as HSP70 by several mechanisms including facilitated nuclear export
5,6
, but HuR’s effects 
on hsp70 mRNA have not been studied in a brain I/R model. To establish a direct interaction between 
HuR protein and hsp70 mRNA, RNA immunoprecipitation (RIP) with HuR protein was performed from 
reperfused neurons. To investigate facilitated nuclear export of hsp70 mRNA by HuR, relative amounts of 
HuR protein and hsp70 mRNA were quantified in nuclear and cytoplasmic fractions from reperfused 




1.2.3 Specific Aim 3: Polysome Characterization and Association 
with HuR in Reperfused Neurons 
Hu proteins can increase translation of their target mRNAs by associating with polysomes
7
. This 
mechanism may explain why CA3 neurons translate hsp70 mRNA into protein when CA1 neurons do 
not. To study the association of HuR and polysomes, polysomes were isolated in linear sucrose gradients 











Previous microarray studies after global brain I/R have had significant limitations. All microarray 
studies of global brain I/R have use steady-state levels of mRNA which poorly reflect the amount of each 
transcript being translated on polysomes. Choice of input tissue has also been a limitation. Prior to this 
study,  no  expression  profiling  had  compared  ischemia  resistant  CA3  and  ischemia  vulnerable  CA1 
neurons after global brain I/R. Here, polysome profiles were used to isolate translating mRNA which was 
compared to cytoplasmic, non-polysome-bound mRNA. Tissue used in the polysome profiles was 





















Ischemia, a restriction of blood flow, causes injury to the brain. Cerebral ischemia can be either 
global, resulting from reduction of blood flow in vessels entering the brain, or focal, resulting from 
blockage of blood flow to a specific region within the brain. Clinically, global cerebral ischemia occurs in 
the context of cardiac arrest. Focal ischemic manifests as ischemic stroke. Blockage of an artery within 
the brain by an embolus or thrombus in stroke generates a focal ischemic insult with central necrosis and 
peripheral injury radiating from a point of restricted circulation. Cardiac arrest causes a global ischemia 
affecting all CNS neurons. Ischemic stroke and cardiac arrest are by far the most common cardiovascular 
causes of death in the United States. Considered together, cardiovascular disease causes about one-third 
of all deaths in the United States, more than 2200 deaths per day
8
. Estimated national direct and indirect 













In 2005, the last year for which data were available, stroke was the fourth leading cause of death in the 
United States and the leading cause of long-term disability
9
. Annual cost for treatment of stroke in the 
United States was estimated to be over $18 billion for 2005
9  
and lost productivity estimated to cost an 
additional $15 billion
8
. Although significant advancements have been made in prevention of stroke and in 




palliative. While other thrombolytics and surgical approaches may become alternatives, the only approved 
treatment to directly reverse arterial blockage in stroke is tissue plasminogen activator (tPA). The NINDS 
recombinant tPA stroke study showed a clear benefit from thrombolysis with tPA given within 3 hours of 
onset of stroke
10
. tPA also commonly causes hemorrhagic transformation in patients with longer durations 
of occlusion
4
. The three hour therapeutic window of tPA, along with other common contraindications, 
 
limits its use to just 3% of ischemic stroke patients
11
. Most patients will also receive supportive therapy 
such as oxygen and aspirin and treatment for comorbidities. Despite longstanding intensive research, no 






2.1.1 Cardiac Arrest and Resuscitation 
 
 
Advances   in   the   emergency   medical   system   and   widespread   public   education   about 
cardiopulmonary resuscitation currently allow for the return of spontaneous circulation (ROSC) in about 
5 to 15% of out-of-hospital cardiac arrest victims
13
. Inpatient cardiac arrest victims fair much better with 
 
nearly half having ROSC
14
. Unfortunately, most victims in both the community and inpatient populations 
do not survive to hospital discharge. In-hospital mortality after cardiac arrest is between 55% and 71%
15 
and mortality has not improved since the statistic were first recorded in the 1950s
16
. I/R injury affects the 
whole body after ROSC, but death is due primarily to brain damage
17 
manifesting as seizures, coma, and 














Given the immense clinical impact of brain damage after stroke and cardiac arrest, protection of 
central nervous system (CNS) neurons from I/R injury is an area of intensive research. The short time 
frame from onset of ischemia to neuron damage makes revascularization therapies unlikely to prevent 
neuronal injury. However, final death of CNS neurons occurs slowly, often days after the initial ischemia, 
providing a  therapeutic  window to  protect  damaged  neurons  and  promote  their  recovery.  Protracted 
injury, occurring over days after even a brief ischemic insult, culminates in cell death called delayed 
neuronal death (DND)
19
. Therapies aimed at salvaging neuron which die by DND are classified as 
neuroprotection. Unfortunately, all large-scale clinical trials of neuroprotective therapies have failed 
(reviewed in O’Collins et al., 2006)20. Neuroprotectants which have failed in clinical trials have targeted a 
variety of damage mechanisms and shown efficacy in multiple animal models, and their failure in large 
clinical  trials  has  been  a  major  concern  in  the  field  of  stroke  research
21,22
.  Acute  treatment  with 
hypothermia may prove to be the exception
23
, but robust clinical data measuring long term outcomes after 
 
hypothermia are still sparse, and the track record of other all other previous therapies signals caution. 
Overall, clinical research into neuroprotective therapies indicates a lack of basic understanding of damage 










There are numerous biological models of stroke and brain injury from cardiac arrest ranging from 
cell culture systems to full animal primate models. Cellular models either deprive cultured neurons of 
essential nutrients such as the oxygen and glucose, or expose cells to a specific insult such as hydrogen 
peroxide. Although cellular models benefit from simplicity and reproducibility, they cannot recreate the 
multifaceted injury seen in whole brains
24
. Whole animal models incorporate the variables of 
hemodynamics, CNS architecture, support from glial cells, and systemic immune and inflammatory 




Focal  I/R  injuries  are  most  often  modeled  with  an occluding filament  placed  in  the  middle 
cerebral artery, the most common site of occlusion in ischemic stroke
25
. Cardiac arrest is modeled by 
occluding the carotid arteries, usually accompanied in rats and mice by either occlusion of the vertebral 
arteries (4VO) or hypovolemic hypotension (2VO/HT). Transient global ischemia by 2VO/HT can 
reproducibly generate a delayed cell death in selectively vulnerable populations of neurons such as the 
CA1 region of the hippocampus. The adjacent CA3 region of the hippocampus survives the same insult. 
Because these two groups of cells, both pyramidal neurons in the same structure and receiving the same 
injury, have dichotomous outcomes, the transient global ischemia model is ideal for the study of the 
intrinsic ability of neurons to respond to the I/R injury. In this thesis, the 2VO/HT model of Smith et al.
26 
was used because of its specific relevance to cardiac arrest, and because it allowed for the comparison of 
vulnerable CA1 and resistant CA3 regions of the hippocampus. Behavioral, histological, biochemical, and 
electrophysiological studies of this model are all consistent with pathology seen in human brains after 
cardiac arrest and resuscitation
26
. In the DeGracia laboratory, the 2VO/HT model induces selective cell 
death of CA1 but not CA3 hippocampal neurons at 3 days reperfusion after 10 minutes of ischemia in 
adult, male Long Evans rats.   More information about the specific methods of the 2VO/HT model and 











I/R is a complex, protracted injury process. Many damage mechanisms have been shown to be 
active during brain I/R, but a systematic description of their contribution to DND is lacking. The 
progression of events in brain I/R begins with loss of glucose and oxygen supplied by the blood. After 
cardiac arrest, partial pressure of oxygen in the ischemic brain reaches zero after only 2 minutes of 
ischemia
24




and concentrations of sodium, potassium, and calcium ions rapidly equilibrate across the membrane. 
Subsequently, excitatory amino acid neurotransmitters are released from neurons, and mechanisms of 
lipolysis, proteolysis, and free radical damage are activated. After stroke and in focal ischemia models, 
inflammatory responses are also important in damage and recovery of injured neurons
27
. Transient global 
I/R lacks a necrotic focus, so inflammation is less important
28
. The ostensible sequence of damaging 
 







Figure 1: The ischemic cascade. Loss of blood flow rapidly depletes neurons of ATP. NaKATPase fails and 
sodium and potassium equilibrate across the plasma membrane. Depolarization opens inwardly directed, 
voltage gated calcium channels, increasing intracellular calcium. Depolarized neurons also release glutamate 




lipolytic  and  proteolytic  enzymes  which,  in  turn,  generate  free  radicals.  A  confluence  of  upstream 





2.2.2 Loss of Blood Glucose and Excitotoxicity 
 
 
In the rat model of global brain ischemia, levels of cellular ATP in the cortex fall rapidly until 
ATP is undetectable after 30 minutes of ischemia
30,31
. Concurrently lactate produced by anaerobic 
respiration increases 11-fold
31
. Without blood glucose and resultant ATP, neuronal NaKATPase cannot 
maintain ion gradients across the cell membrane. Sodium and potassium rapidly equilibrate during 
ischemia
32
. Ionic imbalances across the plasma membrane have unique consequences for neurons, causing 
calcium influx and neurotransmitter release. Voltage gated calcium channels open upon depolarization. 
Influx of calcium drops extracellular calcium concentration from 1.2 mM to less than 100 µM after just 
one  minute  of  global  brain  ischemia  in  rats
33
.  Intracellular  calcium activates  a  variety  of  catabolic 
enzymes and the downstream effects are discussed below. Depolarization also releases the excitatory 
neurotransmitter glutamate into the extracellular space, and extracellular glutamate concentration remains 
elevated for at least 3 hours after global ischemia
34
. Glutamate release in I/R injury opens the 2-amino-3- 
(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid (AMPA) and N-methyl-D-aspartic acid (NMDA) 
ionotropic glutamate receptors on neurons, depolarizing them
35
. Depolarization causes further calcium 
influx and then glutamate efflux, a feed forward phenomenon known as excitotoxicity. However, blood 
glucose and cellular ATP are both rapidly restored upon reperfusion even in regions of the brain which 





















damage by calcium-activated enzymes such as calpains
38
. Calpains are a family of cysteine proteases 
activated by micromolar (µ-calpain) or millimolar (m-calpain) concentrations of intracellular calcium
39
. 
Calpain activity is increased in neurons after both focal and global ischemia in rat models
38
. In transient 
global I/R, calpain activity was greatest in CA1 hippocampal neurons at 1 hour reperfusion. Eukaryotic 




are substrates for calpain, and calpain may damage these 
complexes during global ischemia as discussed below. 
Increased intracellular calcium also triggers lipolysis through activation of phospholipase A2 
(PLA2)
42
. PLA2 are a family of esterases that release free fatty acid chains from the second carbon of 
glycerol
43
. PLA2   can liberate arachidonic acid from triglycerides, and arachidonic acid is converted by 
cyclooxygenase-2 (COX-2) and downstream enzymes into pro-inflammatory prostaglandins and 
leukotrienes
44
. Inducible COX-2 is increased after focal ischemia in humans and localized to necrotic 
cells  near  the  ischemic  focus
45
.  Activation  of  PLA2   can  also  generate  damaging  free  radicals  and 
membrane permeability changes as discussed below. 
Other calcium-activated enzymes induced by brain I/R include protein kinase C (PKC) and 
calcium/calmodulin-dependent kinase II-alpha (CaMKII)
46
. PKC is a family of serine/threonine protein 
kinases with complex signaling functions in eukaryotes. CaMKII is also a family of serine/threonine 
protein kinases which have been implicated in long term potentiation and mediate glutamate signaling
47
. 
Both kinases act at the cell membrane, and PKC and CaMKII translocated to cell membranes in neurons 
near the ischemic focus in a rat focal model I/R model
46
. CaMKII inhibitors have been shown to be 
protective in a cell culture I/R model
48
, but the role of both enzymes remains unclear in brain I/R
49
. 
Finally, the neuronal nitric oxide synthase (nNOS) is induced by intracellular calcium and generates the 
highly reactive peroxynitrite free radical
50
. There are many sources of free radicals in brain I/R injury, 








While necessary for survival, restoring blood flow provides a high oxidative potential to brain 
tissue which is primed by ischemia to produce free radicals. Mitochondria are an important source of free 
radicals during reperfusion. The mitochondrial inner membrane, which allows the hydrogen ion gradient 
of  the  electron  transport  chain,  is  permeabilized  by  mitochondrial  calcium  accumulation  during 
ischemia
51
. When mitochondrial function is restored upon reperfusion, leakage of the inner mitochondrial 
generates superoxide. Other sources of free radicals during brain I/R include nNOS (mentioned above), 
arachidonic  acid  production  by  COX-2
52





At fours hours reperfusion after 30 minutes of global ischemia in the rat, nitric oxide, superoxide, 
and peroxynitrite are all elevated in injured neurons
54
. Superoxide production, prominent in all injured 
neurons in early reperfusion, was observed only in CA1 pyramidal neurons past 24 hours of reperfusion
55
. 




in reperfused neurons and cross-link DNA
58
. 
Free radical scavengers such Cu/Zn superoxide dismutase and xanthine oxidase inhibitor reduce cell 
death in models of focal and global brain ischemia (reviewed by Lipton, 1999)
28
. However radical 




All of these damage mechanisms interact in complex pathways. For example, lipid peroxidation 
by PLA2  can further inhibit NaKATPase, promoting depolarization
59
. The mitochondrial permeability 
transition caused by high mitochondrial calcium releases cytochrome c which can trigger apoptosis
60
. 
These  complex  interactions  make  it  difficult  to  quantify  the  relative  contributions  of  each  damage 





2.2.3 Selective Vulnerability and Delayed Neuronal Death 
 
 
After brain I/R injury, neurons will have one of three outcomes: survival, necrotic cell death, or 
the protracted DND
19




extent of necrosis in global I/R depends on the duration of ischemia. Because necrotic cells are not 
salvageable and because the clinical focus of post-cardiac arrest care is preservation of injured neurons, 
this dissertation focuses rather on neurons which die by DND in a predictable manner days after ischemia. 
It has long been known that progressive brain injury follows even brief ischemic insults. Kirino, 
et al. first showed this phenomenon in the gerbil global I/R model, where 48 hours after a five minute 
ischemic insult, CA1 pyramidal neurons began to show swelling of organelles followed by plasma 
membrane clefts and nuclear perikarya
19
. When observed next at 4 days reperfusion, the CA1 neurons 
were lysed and dead. DND was subsequently observed in the rat global model, also restricted to CA1 
pyramidal cells after a ten minute ischemic insult
61
.  Isolated hippocampal damage is also consistent with 
common memory deficits following cardiac arrest
18
, and this pattern of cell death was found in humans 
 




. DND restricted to CA1 pyramidal 









Figure 2: Delayed neuronal death of CA1 hippocampal pyramidal cell neurons. Rat 50 micron dorsal 
hippocampal sections from non-ischemic controls (NIC), and animals after 15 minutes I/R and reperfusion 
for 48 hours (48hR) or 72 (72hR) hours. Staining is for A) toluidine blue and B) fluoro-jade. Toluidine blue, a 
structural stain, shows that CA1 pyramidal cells have died and lysed at 72hR while CA3 cells remain intact. 
Fluoro-jade labels degenerating neurons and strongly reacts only in the CA1 region at 72hR. Scale bar 






In human patients and animal models, irreversible brain damage begins after only 4 minutes of 
cardiac arrest
67
. After 30 minutes of cardiac arrest, the resulting CNS damage is usually too extensive to 
allow  long-term  survival
68
.  Ischemic  durations  between  4  and  30  minutes  cause  DND  to  neurons 
depending on the neuron’s selective vulnerability to I/R injury. CNS neurons as a whole can be thought of 
as a selectively vulnerable population relative to surrounding glia. Neurons have a high metabolic demand 




Considering only neurons, specific brain regions are known to be relatively vulnerable or resistant 
 
to  I/R  injury.  As  described  above,  CA1  pyramidal  neurons  are  especially  vulnerable  to  even  mild 
ischemic insults. Consistent with ischemic duration determining magnitude of injury, longer durations of 
ischemia extended DND into areas of the cortex
70
. With increasing ischemia, DND was found in parts of 
the hippocampal CA4 region and cortex layers II and V
71 




Because shorter durations of ischemia, 5 minutes in the gerbil and 10 minutes in the rat, cause 
DND only in CA1, these durations have been used to study intrinsic differences in neurons selectively- 
vulnerable or selectively-resistant to I/R. At present, there is no coherent explanation of why DND occurs. 
Classical morphological markers of DND are late-stage changes such as organelle swelling and DNA 
damage, not visible until at least 24 hours and usually 48 hours after ischemia
72
. These late changes are 
not merely a delayed necrosis, as selectively-vulnerable neurons show recovery of acute derangements to 
energy consumption, electrophysiological activity, ion gradients, and physiological pH during early 
reperfusion. After a CA1-lethal  insult, these acute derangements are indistinguishable between CA1 and 
CA3 in the time preceding DND
73,74 




). Cerebral blood 
flow measurements indicate the metabolic state of human brains is normalized by two hours after ROSC, 
making acute necrosis an unlikely cause of brain damage after cardiac arrest
76
. Neither are adjacent CA3 
neurons simply dying more slowly. Studies out to one year after I/R injury show CA3 neurons are 
preserved with normal morphology after a CA1-lethal insult
77
. As outlined above, secondary changes in 






but  clinical  trials  of  calcium  channel  blockers  and  free  radical  scavengers  to  treat  brain  I/R  have 
universally failed
20
. Likewise, while proapoptotic markers are upregulated in reperfusion
66
, antiapoptotic 
treatments fail to reduce injury from brain I/R
20
, suggesting DND is not apoptotic cell death. 
An important development in the field of brain I/R was the recognition, first made by Kleihues, et 
al., that protein synthesis remained impaired in selectively vulnerable neurons but recovered in resistant 
neurons
2
.  During reperfusion  after  brief  transient  ischema,  protein  synthesis  returns  slowly  over  the 
course of hours in resistant neurons. In ischemia vulnerable neurons, protein synthesis never returns to 
normal pre-ischemic levels. This variable protein synthesis differentiates CA3 from CA1 much earlier 
than classic morphological markers. Recovery of protein synthesis is both an absolute requirement for 
long term survival of the cell and also an immediate requirement for expression stress response proteins 
which allow the neuron to recover
75,79
. Below, the mechanisms of protein synthesis inhibition and 
expression of stress response transcripts are reviewed. 
 
 






Expression of protein-coding genes is a complex process regulated by environmental cues. 
Regulation of gene expression is combinatorial, incorporating multiple levels of control. Typically control 
of gene expression is divided into transcriptional regulation, posttranscriptional regulation, and regulation 
of translation. Posttranscriptional regulation of gene expression can be further divided into 
posttranscriptional modifications, nuclear export, cytoplasmic localization, and mRNA degradation. 
Posttranscriptional and translational control are particularly important under conditions of acute stress 
such as brain I/R where cells do not have the time or resources to control gene expression through 
transcription factors
80
. In reperfused neurons, gene expression is altered in a well-characterized sequence 
of events: complete translation arrest, upregulation of stress response gene transcription, selective 













2.3.2.1 Normal Translation Initiation 
 
 
Initiation of normal protein translation requires the formation of the ternary complex composed of 
initiator tRNA (Met-tRNAi) and eukaryotic initiation factor 2 (eIF2) bound to GTP (Figure 3). eIF2 is a 
heterotrimer with two catalytic subunits, beta and gamma, and a regulatory subunit, alpha. Formation of 
the ternary complex is rate-limiting in translation, and therefore a key regulatory point in protein 
expression
81,82
. After the ternary complex  forms,  it joins  the 40S small ribosomal  subunit  and other 
initiation factors to form a 43S preinitiation complex. The 43S preinitation complex is recruited to the 5’ 
untranslated region (UTR) of the mRNA, a process promoted by eIF4F. eIF4F is a heterotrimer of eIF4E, 
eIF4G, and eIF4A. eIF4E binds the 5’ cap structure of the mRNA, eIF4G is a scaffolding protein the links 
eIF4E to other initiation factors, and eIF4A is a RNA helicase that melts mRNA secondary structure. 
Together, the subunits of eIF4F facilitate scanning of the 5’UTR for an AUG start codon. Loading of the 
start codon into the A site of the ribosome causes a conformational change in eIF2 resulting in hydrolysis 
of eIF2-associated GTP
83
. The small and large ribosomal subunits then join and elongation of the nascent 






Figure 3: Initiation of protein synthesis. 1) Initiator tRNA (Met-tRNAi) and eukaryotic initiation factor 2 
(eIF2) bound to GTP form the ternary complex. Addition of other initiation factors forms a 43S preinitiation 
complex. 2) The 43S preinitiation complex begins scanning the 5’UTR of the mRNA which is associated with 
the eIF4F complex. 3) When the preinitiation complex arrives at the start codon, GTP asso ciated with eIF2 is 
hydrolyzed and the 60S large ribosomal subunit joins the small ribosomal subunit to begin chain elongation. 









GTP must be restored to eIF2 before a new ternary complex can form and a new round of 
initiation can begin, a process catalyzed by the eIF2B subunit. Recycling of GTP by eIF2B is  blocked by 
phosphorylation of the regulatory alpha subunit of eIF2 at serine 51
84
. Alpha-phosphorylated eIF2 binds 
eIF2B  with  high  affinity,  sequestering  eIF2B  and  acting  as  a  competitive  inhibitor
85
.  Inhibition  of 
translation initiation through eIF2(αP) is a common mechanism to regulate many forms of cell stress, a 
process collectively referred to as the integrated stress response
86
. 
eIF2 activity is rapidly inhibited upon reperfusion after global brain ischemia. After 15 minutes of 
 
transient global brain ischemia and 30 minutes of reperfusion in the rat, the ability of eIF2 to form ternary 
complexes decreased 50% in both CA1 and CA3
87
. Again in the global rat model, decrease in eIF2 
activity was shown to correlate to eIF2(αP) and inhibition of the guanidyl transferase activity of eIF2B88. 




In  all  regions  of the brain  after  transient  global  I/R,  eIF2(αP)  gradually remits,  returning to 
 
control levels by about 4 to 6 hours reperfusion
90,91
. Immunohistochemical mapping and assay of 
hippocampal subregion microdissections has established that eIF2α phosphorylation persists for the same 
duration in both ischemia vulnerable CA1 and ischemia resistant neurons CA3
92
. This initial inhibition of 
protein synthesis is generally considered protective
93
, conserving energy and amino acid pools and 
preventing damage from the failed synthesis of misfolded proteins
94  
or the successful synthesis of pro- 
apoptotic proteins
93
. Identical patterns of eIF2(αP) between CA1 and CA3 suggest that, like energy and 




2.3.2.3 eIF2(αP)-induced Translation Arrest Causes Polysome Dissociation 
 
 
Observations from a variety of whole-animal brain I/R models and post-mortem human tissue 
show that CNS neuron polysomes remain intact during brain ischemia, a phenomenon Kleihues and 




Kleihues et al. first showed this phenomenon in cats subjected to global ischemia for 30 minutes
95
. They 
made three important observations that would later hold for all animal models investigated: 1) Polysome 
profiles of ischemic animals which were not reperfused prior to sacrifice resembled those of controls, 
while animals reperfused after I/R injury lost almost all polysomes. 2) During reperfusion, absence of 
polysomes correlated to reductions in protein synthesis as measured by in vivo radioactive incorporation 
of amino acids into proteins. 3) Electron microscopy showed well-defined polysome rosettes in CNS 
neurons of ischemic animals, but not in animals studied during early reperfusion after ischemia. 
Kleihues and Hossmann went on to show the same phenomenon in monkeys after 1 hour of 
global brain ischemia
2,96
. Based on well-defined peaks in absorbance correlating to rRNA concentration at 
specific densities, this work also showed that rather than separating into individual ribosomes, the 
polysomes of reperfused neurons dissociated into individual 40S and 60S ribosomal subunits. The same 
observations were later noted by Cooper et al. in a rat model of cerebral compression
97
. The Cooper study 
also isolated the ―frozen‖  polysomes from ischemic, non-reperfused rat brain and found that they were 
functional in an in vitro reticulocyte lysate system as measured by incorporation of radioactive 
phenylalanine.  The  observation  that  ischemic  polysomes  remain  functional  indicates  that  nonlethal 
ischemia does not damage the ribosome. The return of polysomes and protein synthesis depends on the 
duration of the ischemia. In vivo radioactive amino acid studies in the rat 4VO global model showed 
protein synthesis returned to normal 4 hours after ten minutes of ischemia, but protein synthesis was 





2.3.2.4 Persistent Translation Arrest in CA1 
 
 
Although eIF2α phosphorylation remits in all brain regions after about 4 hours in the global brain 
I/R model, translation arrest persists in CA1 neurons (reviewed in Hossmann, 1993)
75
. This persistent 
translation arrest differentiates CA1 and CA3 neurons and is the earliest known marker of ischemia 




There is evidence that in addition to phosphorylation of the α subunit of eIF2, other initiation 
factors are altered by ischemia. As mentioned above, eIF4G, a subunit of the mRNA-binding eIF4F 
complex, is partially degraded in reperfused neurons
38
, which may be mediated by µ-calpain activated by 
increased intracellular calcium
40
. Another eIF4F subunit, eIF4E, was degraded specifically in rat CA1 at 4 
hours reperfusion after a 30 minute global ischemia, but eIF4G levels were unchanged
91
. Additional 
changes  in  eIF4E-binding  proteins  and  small  ribosomal  protein  subunit  S6 have  been  noted  but,  in 
general, changes in protein translational machinery have been poorly characterized relative to other injury 
mechanisms in I/R
82
. Moreover, damage to initiation factors is not insurmountable, even in CA1 neurons. 
In the rat, the vulnerable CA1 neurons express stress-response proteins such as HSP70 in amounts 
comparable to CA3, but only after 30 hours of reperfusion, presumably too late to allow for recovery
65
. 
Conversely, CA3 makes HSP70 protein as early as 8 hours after ischemia. This time delay is believed to 
be critical to the difference in outcome between the two regions
79
. 
The general hypothesis of this thesis is that the exclusive ability of ischemia resistant neurons to 
 
effectively  translate  inducible  stress  response  mRNAs  early  in  reperfusion  allows  these  neurons  to 






2.3.3 Selective Translation of Stress Response Transcripts 
 
 
As discussed above, an important focus of brain I/R research has been the development of 
neuroprotective agents which block damage mechanisms in injured neurons. However neurons, like all 
stressed cells, exert their own neuroprotection through intrinsic stress responses, some of which require 
new transcription and translation. Stress responses allow neurons to recover after I/R injury and prevent 
DND.  Understanding  neuronal  stress  responses  also  offers  the  potential  to  manipulate  them  for 








Kleihues, et al. first noted in 1975 that specific proteins were preferentially translated in early 
 
reperfusion while global protein synthesis was still suppressed
2
. Later Kiessling et al. isolated polysomes 
from reperfused brain and used them for in vitro protein synthesis in a reticulocyte lysate system
99
. 
Proteins synthesized by the isolated polysomes were systematically studied by 2-D electrophoresis. At 3 
hours reperfusion after 30 minutes of 4VO ischemia they found an increase in proteins with molecular 
weights of 70 kDa, 90 kDa, and 110 kDa. These were later identified as heat shock proteins from the 
HSP70, HSP90, and HSP110 families
100
, respectively, previously known by immunohistochemistry to be 
expressed in gerbil neurons after global brain I/R
101,102
. HSP70 protein expression localized exclusively to 
CA3 neurons in the gerbil; gerbil CA1 neurons did not make HSP70 protein after global brain I/R. It is 
important to note that, in this model of I/R, global  protein synthesis was still inhibited at 3 hours 
reperfusion, and heat shock proteins were preferentially translated in spite of global translation arrest. 
 
Heat shock proteins are a highly conserved superfamily of molecular chaperones that assist in 
protein folding and prevent damaging protein aggregation
103
. HSP70, the cytoplasmic member of the 
HSP70 family, is induced in all manner of cellular stress including heavy metal poisoning, hypoxia, 
glucose deprivation, and many others (reviewed in Lindquist, 1986)
103
. There is strong evidence that 
HSP70 is neuroprotective in brain I/R. Overexpression of hsp70 using a herpes simplex vector  improved 
neuron survival after both focal
104  
and global ischemia in the rat
105
. Functionally, induction of HSP70 
caused reduced aggregation of ubiquitin, a marker for protein misfolding in a focal ischemia model
106
. 
Other proteins are expressed during the translation inhibition of early reperfusion. c-Fos and c- 
Jun are immediate early genes (IEGs), a class of genes which are transiently and rapidly upregulated in 
response to stress. c-fos mRNA was present throughout the gerbil hippocampus just fifteen minutes after 
a five minute global ischemia
107
, and c-Fos protein was expressed as early as one hour  after transient 
ischemia
108
.  c-jun  mRNA  were  found  30  minutes  after  a  10  minute  ischemia  in  the  rat
109
.  In  the 
 




remitted by 8 hours reperfusion
110
. Other proteins expressed while global translation is inhibited in early 
reperfusion  include  a  caspase-3-like  protein
111
,  brain-derived  neurotrophic  factor  (BDNF)
112




How polysomes in ischemia resistant cells re-assemble and translate specific classes of mRNAs 
during early reperfusion is not known. After prolonged ischemia, polysomes in both CA1 and CA3 
remain intact and able to translate mRNAs in an in vitro system
97
. Detailed studies of hsp70 transcription 
suggest  that  transcriptional  regulation  alone  does  not  allow  for  increased  HSP70  protein  expression 
during  early  reperfusion.  In  the  DeGracia  laboratory,  hsp70  mRNA  and  HSP70  protein  have  been 
measured directly from microdissected, reperfused hippocampal subregions at various time points after 10 
minutes of 2VO/HT
65 
(Figure 4). Both CA1 and CA3 regions show strong expression of hsp70 mRNA at 
8 hours reperfusion. In fact, hsp70 mRNA expression in CA1 is four to five-fold greater than in CA3. 
 
hsp70 mRNA expression remains elevated in CA1 until at least 30 hours reperfusion, long after CA3 
hsp70 mRNA expression has returned to baseline. Conversely, HSP70 protein is expressed at 8 hours 
reperfusion  in  CA3  but  not  until  30  hours  reperfusion  in  CA1.  Using  in  situ  hybridization,  other 












Figure 4: Expression of HSP70 protein correlates to recovery from brain I/R. All data are from rats after 10 
minutes 2VO/HT and reperfusion as indicated. A) hsp70 mRNA is expressed at 8hR in both CA1 and CA3, 
returns to baseline in CA3, but remains elevated to 30hR in CA1. B) Unlike mRNA expression, HSP70 
protein is expressed at 8hR only in CA3 as shown by western blotting and densitometry. C) 
Immunohistochemistry staining for HSP70 protein confirms expression is early in CA3 and late in CA1. A) 
and B) adapted from Roberts, et al. 2007
65








2.3.3.2 Regulation by 5’ UTR elements 
 
 
Selected stress  response  transcripts  can translated without  the  formation  of  a regular  5’  cap 
structure or eIF4E association, called cap-independent translation
113
. Internal ribosome entry sites (IRES) 
is a cap-independent mechanism present in an estimated 3-5% of all translated mRNAs
114
. A consensus 
5’UTR regulatory sequence for IRES has not been found and likely depends on complex secondary or 
tertiary structure
115
. All eukaryotic instances of IRES regulation have been determined experimentally
116
. 







118   
5’UTRs  have  been  reported  to  contain  an  IRES117.  However,  the  IRES  sequence  is  not 
necessarily conserved and has not been reported in corresponding rodent transcripts. Transcriptional 
profiling of mRNA from isolated polysomes after focal ischemia showed that IRES-containing transcripts 
were not enriched in reperfusion
119
. 
Another 5’UTR mechanism that may allow translation in early reperfusion is multiple upstream 
 
open reading frames (uORFs)
120
. Ribosomes initiate on the first open reading frame encountered in the 
 
5’UTR of a transcript. In unstressed cells, ribosomes will initiate on the uORF and release the transcript 
before reading the authentic coding region. Under conditions of cell stress, when eIF2(αP) increases, 
ribosome scanning is prolonged and the likelihood of initiating at the downstream,  authentic coding 
domain increases
41,94
. The best characterized uORF-containing transcripts in brain I/R are CCAAT/- 
enhancer-binding protein homologous protein (CHOP) and activating transcription factor 4 (ATF), both 
transcription factors induced by the unfolded protein response (UPR), a stress response pathway in the 
endoplasmic reticulum. Although the UPR and specifically CHOP are both induced by brain I/R, the 
resulting amount of CHOP is orders of magnitude less than the amount of HSP70 produced in the heat 
shock response
65,79
. The low level of CHOP induction relative to HSP70 suggests the UPR and CHOP 




2.3.3.3 mRBPs and mRNA Operons in Brain I/R 
 
 
Rapid  changes  in  posttranscriptional  and  translational  regulation  of  gene  expression  are  a 
hallmark of the cellular stress response. RNA is regulated by cis-acting sequences, usually in the 5’ and 3’ 
UTRs and the trans-acting mRNA binding proteins (mRBPs) which bind to these regulatory sequences. 
mRBPs are associated with mRNAs from transcription through degradation, regulating splicing, nuclear 
export, localization, translation, and degradation
121
. 
Ribonucleoproteins  (mRNPs),  groups  of  mRNAs  and  associated  mRBPs,  such  as  the  stress 
 




cytoplasmic mRNPs which are sites of mRNA ―triage,‖ directing mRNAs in stressed cells to storage, 
degradation, or translation
122
. The number of stress granules increases in cultured cells stressed with 
arsenate
123 
or the protein synthesis inhibitor puromycin
124
. Stress granules also increase with eIF2(αP) in 
brain ischemia
66









Previous work by Drs. Jamison and DeGracia has shown that cytoplasmic polyadenylated mRNA 
undergoes a major rearrangement in reperfused neurons forming mRNA granules
1,125  
(Figure 5). mRNA 
granules are distinct cytoplasmic structures that form rapidly upon reperfusion after brain ischemia and 
contain mRNA and poly-A binding protein (PABP). mRNA granules form no later than 1 hour into 
reperfusion in all injured neurons after global brain ischemia. In focal ischemia, mRNA granules do not 
form neurons of the necrotic lesion core   but are abundant in the damaged tissue surround the core 
(penumbra) (M. Lewis and D. J. DeGracia, unpublished observation). mRNA granules do colocalize with 




ribosomal subunit and therefore do not sequester ribosomal subunits 




mRNA granules were present in all neurons known to have repressed protein translation. mRNA 
granules were present in CA1 neurons from one hour reperfusion out to 48 hours reperfusion, the last time 






Figure 5: Changes in mRNA granules correlate to survival after brain I/R. A) In situ hybridization to 
polyadenylated RNA in hippocampal pyramidal cells from non-ischemic control animals (NIC) and after 10 
minutes I/R for 16 (16hR) or 36 hours (36hR). Arrowheads indicate mRNA granules. B) FISH/ 
Immunofluorescent microscopy for polyadenylated RNA (green) and HuR protein (red). mRNA granules 
form in all injured neurons, but only remit in CA3 neurons. HuR is present in CA3 neurons at 16hR, but only 











The binding sites in the 5’ and 3’ untranslated regions (UTRs) of eukaryotic mRNAs allow for 
the coordinated posttranscriptional regulation of mRNAs through mRBPs. Common UTR binding sites 
interacting with a mRBP have been called mRNA operons, in reference to prokaryotic operons which 
allow  coordinated  expression  of  genes  with  a  common  function  behind  a  single  promoter
127,128
. 
Eukaryotic genomes are not functionally organized like prokaryote genomes, but groups of mRNAs with 
common UTR binding sites (mRNA operons) can be coordinately regulated by the same mRBPs, 
generating the same functional effect
128
. 
The adenylate uridylate-rich element (ARE) is a cis-regulatory sequence found in the 3’UTR of 
 
5%-8% of all mRNAs
129




immediate early genes, transcription factors, and cytokines; proteins that typically exert powerful effects 
in  the  cell  relative  to  their  steady-state  concentrations
130
.  hsp70  mRNA  also  has  a  3’UTR  ARE 
sequence
131  
and binds HuR in mammalian cells
132
. In unstressed cells, the ARE identifies transcripts for 
rapid degradation. Cytoplasmic ARE-containing mRNAs are bound by tristetraprolin (TTP), an mRBP 
which activates decapping and degradation of these mRNAs at the processing body
133
. 
HuR is another mRBP which specifically interacts with the ARE. In mammals, HuR is the only 
ubiquitous  member  of  the embryonic  lethal  abnormal  vision  (ELAV)/Hu  protein  family,  which  also 
includes  the  neuron-specific  members  HuB,  HuC,  and  HuD
134
.  All  Hu  proteins  have  three  RNA 
recognition motifs (RRMs) and a hinge region (called the HNS) between RRMs 2 and 3
135
. RRMs 1 and 2 




Under conditions of cell stress, when it is advantageous to increase the steady state levels of 
 
stress response transcripts, HuR can stabilize ARE-containing mRNAs
137
. HuR staining can differentiate 
ischemia resistant CA3 neurons from ischemia vulnerable CA1 neurons after transient global brain 
ischemia. HuR was present in mRNA granules in CA3 neurons at one hour reperfusion and remains 
colocalized until the granules dissipate before 36 hours reperfusion (Figure 5B)
1
. In CA1 neurons, HuR 
was not found in mRNA granules until 36 hours reperfusion
1
. 
The mechanisms by which HuR influences gene expression are not well characterized and vary 
 
between cell types and cellular stresses
138
. Three distinct mechanisms have been shown to independently 
increase translation of HuR-target transcripts: reduced target degradation
139
, facilitated nuclear export of 
targets
140
, and increased association of target mRNAs with polysomes
7
. The most commonly studied 
mechanism of regulation by HuR is reduced degradation. In stressed cells, cytoplasmic HuR is associated 
with ARE-containing mRNAs, blocking their transport by TTP to PBs
141
. By preventing the degradation 
of  ARE-containing  mRNAs,  HuR  increases  the  steady-state  concentration  of  these  mRNAs  and, 
therefore, their translation into protein
142
. However, prevention of mRNA degradation is not likely to 




mRNA is more abundant in CA1 neurons than CA3 neurons during reperfusion, but is not translated. 
Even  if  hsp70  mRNA  is  preferentially  degraded  in  reperfusion,  this  mechanism cannot  account  for 




2.3.3.3.3 Facilitated Nuclear Export of ARE-containing mRNAs by HuR 
 
HuR can also increase the translation of its target mRNAs by facilitating their nuclear export. In 
unstressed cells, HuR is a predominantly nuclear protein, actively shuttled into the nucleus by association 
with importin B
143
. Under conditions of cell stress, a variety of poorly characterized phosphorylation 
events cause the HNS region of HuR to associate with the shuttling proteins pp32 and APRIL
144
. pp32 
and APRIL both contain nuclear export signals (NES) recognized by nuclear export factor chromosomal 
region maintenance protein 1 (CRM1). CRM1 actively exports HuR bound to pp32 and APRIL out of the 
nucleus in response to cell stress. While all proteins exit the nucleus in a GTP-dependent fashion by 
association with shuttling proteins such as CRM1, most mRNAs use a GTP-independent mechanism 
associating the TAP/p15 transport receptor. However, there is a subpopulation of mRNAs which shuttle 
in a CRM1-dependent fashion
145
. 
In Hela cells stressed with heat shock, HuR specifically colocalized with pp32 and APRIL, and 
 
CRM1 immunoprecipitated in complexes with HuR
146
. Inhibition of the CRM1 pathway by leptomycin B 
blocked nuclear export of HuR after heat shock. Leptomycin B also blocked the export of hsp70 mRNA, 
leading  Gallouzi  et  al.  to  speculate  that  HuR  may  regulate  the  nuclear  export  of  hsp70  mRNA. 
Subcellular  localization  of  HuR  also  had  functional  significance  in  breast  cancer  cell  lines,  where 
decreased HuR specifically in the cytoplasm increased JNK activity and responsiveness to tamoxifen
6
. 
HuR regulation of target mRNA nuclear export was later shown in Jurkat T cell culture where APRIL and 










Recently,  a  third  mechanism  by  which  Hu  proteins  may  regulate  target  mRNAs  has  been 
proposed.  HuD  is  a  Hu  protein  family  member,  highly  homologous  to  HuR,  involved  in  neuronal 
differentiation
147
.  Fukao,  et  al.  showed  that  the  HuD  directly  interacted  with  eIF4A  and  that  this 
interaction was necessary for enhanced translation of target mRNAs
7
. The authors hypothesize that 
because HuD-enhanced translation required target transcripts to have both a 5’ m7G cap and 3’ poly(A) 
tail, that HuD may be promoting circularization of mRNAs. As discussed above, the 5’ cap structure of 
translating mRNAs is bound by eIF4E, and the 3’ poly(A) tail is bound by PABP. mRNA circularization 
on a ribosome occurs when both PABP and eIF4E associate with eIF4G in what is called the closed loop 
model
148
. Circularization promotes reinitiation of ribosomes on the translating mRNA
148
. 
Like HuR, HuD binds to both ARE sequences and poly(A). Association of HuD with eIF4A 
 
could promote initiation by bringing the polyadenylated 3’ tail of ARE-containing mRNAs adjacent to 
eIF4E. This provides a novel mechanism of selective initiation of ARE-containing mRNAs and may 




2.3.3.4 Measuring Gene Expression in the Reperfused Neuron 
 
 
Neurons change their transcriptional program after brain I/R injury and express new transcripts 
which are necessary for recovery
109,149
, making reperfused neurons an ideal target for expression profiling 
studies such as microarray. Reperfused brain tissue has been studied by microarray since the method 
entered mainstream molecular biology in the early 2000s
150
. Since then nearly 40 microarray studies of 
brain I/R have published
151
. Most of these studies used the rat focal ischemia model, but global ischemia 
has also been studied
152
. 
Despite the large amount of expression profiling work done in brain I/R, present studies have 
major limitations. Earlier studies were limited by array technology and knowledge of the rat genome. The 
first global ischemia microarray only contained probes for 750 genes, just 3% of the rat genome. Beyond 




microarray do not  correlate well to levels of protein expression
153
. This problem has  been  carefully 
studied in yeast
154
, and recently appreciated in mammals. A recent study in mouse hematopoietic cell 
lines found that only 40% of protein expression levels could be explained by mRNA abundance
155
. 
This issue was addressed in the focal brain I/R model in 2004 by MacManus et al. who performed 
microarray analysis on mRNAs extracted from polysome peaks after sucrose density gradient 
centrifugation, a technique called translation state analysis. Translation state analysis showed only 36% of 
transcripts upregulated by focal ischemia were bound to polysomes. This finding indicated that previous 







mRNA granules form in all reperfused neurons after I/R injury. Dissociation of mRNA granules 
correlates with recovery of neurons from I/R injury and differentiates the ischemia vulnerable CA1 
neurons from ischemia resistant CA3 neurons. The presence of HuR in mRNA granules correlates to 
synthesis of HSP70 protein, occurring early reperfusion in CA3 and late in CA1. How HuR may regulate 
the expression of HSP70 in brain I/R is not known, but several mechanisms of posttranscriptional 
regulation by HuR have been described in other systems. To investigate the potential mechanisms of HuR 




1.   mRNA granule formation is dependent on polysome-associated mRNA. (Chapter 3) 
 
2.   HuR binds hsp70 mRNA and facilitates its export from the nucleus. (Chapter 4) 
 
3.   hsp70 translation in reperfused neurons is regulated by HuR. (Chapter 5) 
 

















Previous work by Drs. Jamison and DeGracia has identified the mRNA granule as a distinct 
cytoplasmic structure which forms in all injured neurons during early reperfusion after transient global 
brain ischemia
1
. The mRNA granule does not colocalize with other mRNPs such as the SG, PB, or 
polysome
1
. mRNA granules do not contain markers of the small or large ribosomal subunits, but they do 
contain densities of cytoplasmic polyadenylated mRNA, PABP, and eIF4G. Roughly 2/3 of cytoplasmic 
mRNA is associated with polysomes in unstressed cells
156
. If translating mRNA on polysomes is required 
to form mRNA granules, then persistence of mRNA granules could explain the prolonged translation 
arrest seen in vulnerable neuron populations during reperfusion after brain ischemia. Prior to the present 
study, the relationship between the polysome and the mRNA granule was not characterized. Here, 
pharmacological agents that alter polysome function were used to study the relationship between mRNA 
granules and polysomes. 
CHX is a glutarimide antibiotic that prevents the release of tRNA during translation elongation, 
inhibiting translation in eukaryotes
157
. There is limited evidence that CHX is neuroprotective against brain 
I/R injury. In a rat 30-minute four-vessel occlusion model of global brain ischemia, 1.5 mg/kg CHX 
reduced hippocampal DND when given 1 hour prior to ischemia by not 1 hour after ischemia
158
. Another 
study also found that 2 mg/kg subcutaneous CHX given just prior to reperfusion reduced DND in CA1 
neurons after 10 minutes of four-vessel occlusion
159
. However, in a 2-vessel gerbil model, 2 mg/kg CHX 
given after 10 minutes reperfusion slightly increased DND
160




injury speculate that the translation arrest induced by CHX conserves cell resources and prevents aberrant 
protein synthesis, protecting neurons in the same manner as transient eIF2(αP) phosphorylation158. 
Authors finding CHX detrimental in global ischemia models speculate that prolonged protein synthesis 
inhibition is detrimental and any positive effects likely arise from CHX’s ability to lower body 
temperature
161
. Although the potential of CHX as a neuroprotectant is certainly interesting, here the drug 
is used because of its proven ability to functionally alter polysomes. 
 
As CHX prevents the release of tRNA, it locks intact polysomes together with translating 
mRNAs
157
.  In cell culture models of cell stress, the formation  of PBs
161   
and SGs
124   
is inhibited by 
freezing  mRNA  onto  polysomes  with  CHX.  Puromycin  is  a  protein  synthesis  inhibitor  acting by a 
different mechanism- a nucleoside analog that inhibits translation by causing premature termination, thus 
destabilizing polysomes and causing their dissociation
162
. By increasing available mRNAs, puromycin 
increases the number of processing bodies and stress granules formed after stress in cell culture
124
. 
A robust literature describes the use of CHX and puromycin in mammalian brain establishing 
 
effective dosage and method of administration. Using radioactive amino acid incorporation, Jonec et al. 
showed that 1.5 mg/kg IP CHX inhibited 74% of forebrain protein synthesis as early as 15 minutes after 
injection and protein synthesis inhibition was maintained for at least two hours
163
. Intra-cerebral injection 
of 90 µg of puromycin per cerebral hemisphere in rat rapidly inhibited 90% of hippocampal protein 
synthesis, an effect that was maintained from a single dose for over four hours
164
. 
mRNA granules have not yet been characterized biochemically, but have only been studied under 
 
the microscope. mRNA granule formation is a complex process with changes in staining intensity and 
pattern. Simple methods of measuring fluorescence or colocalization were inadequate to quantitatively 
measure changes in mRNA granule formation. This problem was addressed with texture analysis. Texture 
analysis is the calculation of a large, diverse set of image features combined with statistical variable 
reduction techniques to quantify image features. Texture analysis is commonly used to classify images in 
the physical sciences
165,166

















mRNA  granules  form  in  all  affected  neurons  after  transient  global  brain  ischemia.  mRNA 
granules abate in the ischemia resistant CA3 region of the hippocampus, but they persist in the ischemia 
vulnerable CA1. Persistence of mRNA granules correlates to persistent protein synthesis inhibition and 
selective cell death in CA1. mRNA granules may require translating mRNA from polysomes to form, like 
other stress-induced mRNPs do. Sequestering mRNA on polysomes with CHX should prevent mRNA 
granules from forming if they require polysome-associated mRNA. Conversely, liberating polysome- 
associated  mRNA  in  unstressed  cells  may  cause  the  formation  of  mRNA  granules  as  it  causes  the 
formation of other stress-induced mRNPs. Since, at present, mRNA granules can only be detected 







1. Preventing polysome dissociation prior to injury will prevent the formation of mRNA granules. 
 










Alexa 488-labeled streptavidin (S32354) was from Invitrogen (Carlsbad, CA). Biotinylated goat 
anti-streptavidin (BA-0500) was from Vector Laboratories (Burlingame, CA). HuR (sc-5261) antiserum 
was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). A 5 -biotinylated 50-mer oligo-dT 
probe was made by Integrated DNA Technologies, Inc. (Coralville, IA). CHX (c1988) and puromycin 










3.2.2 Animal Model 
 
 
All animal  experiments  throughout  the thesis were approved by the Wayne State University 
Animal  Investigation  Committee  and  were  conducted  following the  Guide  for  the  Care  and  Use  of 
Laboratory Animals (National Research Council, revised 2011)
170
. Global forebrain ischemia was induced 
in adult (275-300 g) male Long Evans rats using the bilateral carotid artery (two-vessel) occlusion and 
hypovolemic  hypotension  (2VO/HT)  model  developed  by Smith  et  al.
26   
and used  commonly  in  the 
DeGracia laboratory
65,66,126
. Animals were anesthetized with 5% halothane and anesthesia was maintained 
at 2% halothane in 100% O2  using a facemask throughout the duration of the surgery. Throughout the 
ischemic period and the first hour of reperfusion, body temperature was maintained at 37 ± 0.5 
o
C using a 
homeostatic blanket system and rectal temperature probe. Temperature of the head was also maintained at 
37 ± 1 
o
C and independently monitored with a thermocouple probe placed in the temporalis muscle. Mean 
arterial  pressure  was  monitored  in  real  time  via  tail  artery  access.  Blood  gas  measurements  were 
maintained at pH = 7.4 ± 0.1, pO2 = 80 mmHg and pCO2 = 35 ± 5 mmHg until immediately prior to the 
initiation of ischemia. 
To initiate ischemia, blood was withdrawn from the femoral artery into a 10-mL syringe until a 
mean arterial pressure of 50 mmHg was reached. Following the withdrawal of blood, the common carotid 
arteries were clamped using microaneurysm clips. Additional blood was withdrawn to maintain a mean 
arterial pressure of 40 mmHg for 10 minutes. Following 10 minutes of ischemia, microaneurysm clips 
were released and blood was reinfused at a rate of 5 mL per minute. All wounds were sutured and 
anesthesia and temperature control was maintained for one hour following the surgery. Post-surgical 
animals displaying frank necrosis, weight loss > 15% initial body weight/day, or sustained seizure activity 




processing and brain dissection is further described below. As outlined above in Chapter 2, it is well 
established that transient global brain ischemia can cause DND. DND following 2VO/HT has been shown 
repeatedly in the DeGracia laboratory
1,65 
and independently confirmed in other laboratories
19,70
. In the 
DeGracia laboratory, multiple, independent lines of evidence have established selective cell death of CA1 
pyramidal cell neurons in the 2VO/HT model including fluoro jade staining and morphology of toluidine 




3.2.3 CHX and Puromycin Treatments 
 
 
For the CHX study, animals were subjected to 10 minutes ischemia followed by one hour 
reperfusion. 1.5 mg/kg CHX in saline was administered via intraperitoneal injection at either 15 minutes 
prior to onset of ten-minute ischemia (C-pre; n = 6) or at 15 minutes into reperfusion after ischemia (C- 
post; n = 5). One hour reperfused groups were repeated using saline vehicle alone (v-pre; n = 5) (v-post; n 
= 5), and groups of sham-operated nonischemic animals (NIC; n = 4) and 1 hour reperfused animals 
(1hR; n = 7) without injection served as controls. The CHX dose and delivery method were chosen 
because they have previously been shown to rapidly and inhibit protein synthesis in the rat brain
163
. This 
dose may also be neuroprotective in global ischemia models when given prior to ischemia
158
. 
For the puromycin study, three non-ischemic animals were injected with puromycin (Pur) and 
 
two animals were injected only with saline vehicle (Veh). Sections from two animals previously subjected 
to 10 minutes of ischemia and one hour of reperfusion (1hR) and and two uninjected non-ischemic 
animals (NICs) were also stained as controls. Puromycin dose and administration were based on the 
method of Flexner, et al.
164  
who showed that intra-cerebral injection 90 µg of puromycin at 9 mg/mL in 
each cerebral hemisphere in the rat rapidly inhibited 90% of protein synthesis in the hippocampus, an 
effect that was maintained from a single dose for over four hours. 
To administer intra-cerebral injections of puromycin, rats were anesthetized IP with 100mg/kg 




drilled tangent to the surface of the skull at the angle formed by the caudal parietal suture and origin of 
temporalis muscle. In each hemisphere, 90 µg puromycin in 10 µL saline was injected at depth of 3 mm, 
targeting the hippocampus (Bregma coordinates -2.1 mm caudal, 2.0 mm lateral, and 1.4 mm vertical)
171
. 












One hour after ischemic injury or sham surgery or two hours after puromycin injection, rats were 
transcardially perfused with 250 mL of ice-cold 0.9% NaCl at a rate of 20.8 mL/min. Following the NaCl 
solution, 300 ml of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffered saline (PBS) was perfused 
at a flow rate of 10 mL/min. Once perfusion was complete, brains were excised and post-fixed by 
immersion in 4% PFA, 0.1M PBS. Duration of the post-fix was 24 hours. Following post-fix, the dorsal 
hippocampus was sectioned in 50 μm coronal slices using a vibratome. Sections used for staining below 
were taken near 3.0 mm posterior to Bregma. The tissue was sectioned in 0.1M PBS and resultant 
sections were stored in cryostat solution at -20 
o
C until used for staining. 
 
 
3.2.4.2 Immunofluorescent Microscopy / Fluorescent in situ Hybridization 
 
 
Immunofluorescent microscopy and fluorescent in situ hybridization (IF/FISH) was performed in 
a two stage procedure. FISH was a modification of the procedure of Bessert and Skoff
172
. The combined 
procedure was performed exactly as described in Jamison, et al
1
. All IF procedures were at room 
temperature with gentle agitation on an orbital shaker. Brain sections were washed four times for 10 
minutes in 0.1 M PBS. After the last wash, sections were pre-blocked for 25 minutes in 0.1M PBS 




After three ten-minute washes in PBS, blocked sections were immersed in 1:25 mouse anti-HuR primary 
antibody PBS 0.3% Triton X-100 and 1% donkey serum at room temperature overnight. The following 
day, samples were washed three times for 10 minutes in PBS and incubated with donkey anti-mouse 
secondary antibody in PBS with 0.3% Triton X-100 and 10% donkey serum for 2 hours. HuR staining 
provided a useful signal  for generating nuclear and cytoplasmic image  masks as part of the texture 
analysis described below. 
Primary and secondary antibody concentrations were determined in previous studies in the 
DeGracia laboratory based on dilution series
1
. HuR was tested with a series of dilutions on control and 
experimental animals in order to determine the concentration that limits background and provides the best 
overall  signal.  Validation of  antisera  staining included:  (1)  loss  of  signal  with  omission  of  primary 
antisera, (2) graded loss of signal with antisera dilution, and (3) agreement with published descriptions of 
antisera staining patterns were previously reported
1
. 
The second stage, FISH, was performed under low light illumination or in the dark. At the end of 
 
the IF procedure, slices were mounted on lysine-coated slides. IF-stained sections were fixed in 3.6% 
formaldehyde in PBS for 10 minutes at room temperature and then drained and blotted. Prehybridization 
was in a box humidified with 50% formamide/4X saline-sodium citrate (SSC) at 32 
o
C for 3 hours in 
prehybridization buffer. Slides were then incubated overnight in the same apparatus in a solution of 50 
ng/mL of a 5’- biotinylated 50-mer oligo-dT probe dissolved in hybridization buffer. The next day, all 
subsequent processing was performed at room temperature. Slides were washed three times in 2X SSC for 
10 minutes and then incubated in the dark at 1:500 Alexa 488-labeled streptavidin in 4X SSC/0.1% Triton 
 
X-100 for 60 minutes. Slides were then washed once in 4X SSC for 10 minutes followed by incubation in 
 
2X SSC/0.1% Triton X-100 containing 1:667 of biotinylated goat anti-streptavidin for 60 minutes. Slides 
were again washed once in 4X SSC for 10 minutes and then incubated in 1:667 Alexa 488-labeled 
streptavidin in 2X SSC/0.1% Triton X-100 for 60 minutes. Slides were then washed sequentially in 4X 
SSC for 10 minutes and 2X SSC for 10 minutes, and then coverslipped for viewing. Previous studies 




double-labeled sections and individually stained sections. Negative controls demonstrating the specificity 
of poly(A) FISH staining including pre-incubating NIC brain slices in DNAse-free RNAse or 0.1 M 





3.2.5 Texture Analysis 
 
 
3.2.5.1 Image Acquisition 
 
 
Photomicrographs of the CA3 pyramidal cell layer of the dorsal hippocampus were acquired on 
an Axioplan 2 Imaging System (Carl Zeiss, Oberkochen, Germany) equipped with an ApoTome as 
previously described
66
. This study focused exclusively on the hippocampal CA3 region because of the 
large cytoplasmic area of this population of cells. The DeGracia laboratory has previously shown that 
mRNA granule formation occurs in all post-ischemic neurons
1
. 
Similar to a laser scanning confocal microscope, the apotome focuses on a specific plane in the 
 
tissue  and  can  acquire  optical  sections  moving  up  or  down  from  the  original  plane  of  focus.  The 
microscope is controlled via a computer that is programmed to acquire optical sections of consecutive 
focal planes marked by a defined distance (the software sets this distance to meet Nyquist sampling 
requirements). The set of sequential optical sections are referred to as a z-stack. z-Stacks of ten optical 
sections were acquired under 63× oil immersion lens (1388 × 1040 w × h; pixel spatial dimensions; x = 
0.1 m, y = 0.1 m, and z = 0.35 m). Eight-bit per channel maximum intensity orthographic projections 
were constructed in NIH ImageJ
173  
from the 16-bit acquired z-stacks and used as input images for the 
texture analysis. Excitation at 488 nm and 568 nm, and emission at 518 nm and 600 nm were used for 
Alexa 488 (green, poly(A)) and Alexa 555 (red, HuR) respectively. Orthographic projections were used 
because  they  provided  a  denser  staining  pattern  than  single  z-slices
66,125
,  and  were  thus  more 
representative of the distribution and density of the mRNA granules in the cell cytoplasm. Each image 
contained, on average, 24.1 ± 3.8 cells. The ratio of total cytoplasmic area to total cell area was 73.6% ± 








3.2.5.2 Texture Analysis Computations 
 
 
Texture analysis is a method to quantitatively measure complex changes in images. The data 
processing elements in the texture analysis pipeline were image masking, feature calculation, feature 
selection, feature projection, and significance testing. 
Image masking divides an image into regions of interest onto which downstream methods are 
applied.  Using  distinctive  HuR  nuclear  staining,  images  were  segmented  into  regions  of  nucleus, 
cytoplasm,  and  background.  Semi-automated  image  segmentation  was  performed  in  the  EDISON 
program (Edge Detection and Image Segmentation, v1.1)
174
. 




Features  calculated  by  MaZda  are  quantifiable  pieces  of  information  which  can  be  measured  and 
compared between images. Calculated features were derived from histogram analysis, absolute gradient 
methods, run length matrix, co-occurrence matrix, autoregressive modeling, wavelet analysis, and fractal 
dimension.  A  brief  description  of  each  parameter  follows:  Histogram  analysis  quantifies  statistical 
features of the image histogram such as kurtosis. Absolute gradient features compare each pixel to a five- 
pixel neighborhood matrix. A run length matrix measures how many pixels in any direction maintain the 
same intensity. A co-occurrence matrix measures the probability two pixels will have the same intensity 
at a set distance apart. An autoregressive model assumes a pixel is influenced by a weight sum of 
neighboring pixel intensities. Discrete wavelet transform is a linear transformation of pixel intensity. 
Fractal dimension measures how image patterns change with the scale at which they are measured. In 
total, 155 different image features were calculated in MaZda. 
Ten features were selected to be compared between sample groups (Table 1). These ten features 
were the most discriminant between sample groups by Fisher coefficient, a ratio of between-group to 
within-group variance. The ten most discriminant features were carried forward to feature projection, the 




projection was accomplished by principal component analysis (PCA), a variable reduction technique 
performed within MaZda. PCA generates a first principal component or most expressive factor (MEF1) 
which consolidates as much variance as possible from the ten most discriminant original variables. One- 
way ANOVA was used to test the significance of group differences in MEF1 followed by Tukey post-hoc 
testing of each possible pair with p<0.05 considered significant. 
Table 1: Image features selected from the texture analysis. From 155 image features measured, ten each were 
selected for the pre-treatment and post-treatment experiments by Fisher coefficient (F). For each set, these ten 
features were then used in PCA, and a first principal component or most expressive factor (MEF1) was 









3.3.1 Pre-treatment but not Post-treatment with CHX inhibits 
mRNA granules 
Cytoplasmic staining of polyadenylated mRNA was quantified after one hour of reperfusion. Of 
the six animals pretreated with CHX, only one displayed obvious mRNA granulation (Figure 6A). 
Following  CHX  post-treatment,  four  of  the  ﬁve  animals  displayed  mRNA  granules  (Figure  6A). 









Figure 6: Effect of CHX on mRNA granules at 1 hour reperfusion after global ischemia. (A) Merged images 
of pA (green) and HuR (red) double-labeling of individual samples as indicated. Scale bar applies to all 
images. (B) On the left, CHX pretreated TA: PCA scatter plots for pA cytoplasmic textures in experimental 
groups as indicated with Fisher coefﬁcient in upper right. On the right, average (±standard deviation) of 
MEF1 for groups as indicated in legend. pA ANOVA p = 0.017, *Tukey HSD post hoc p < 0.05 compared to 
v-pre group. (C) CHX post-treatment. On the left, TA: PCA scatter plots for pA cytoplasmic textures in 




indicated in legend. pA ANOVA p = 0.023, # Tukey post hoc p < 0.01 compared to the NIC group. Modified 





Texture analysis was used to quantify these changes and measure the effect of CHX on the C-pre 
and C-post groups. After quantifying 155 unique image features in the cytoplasm of each image, Fisher 
coefficient was used to select the ten features most discriminant for all animal groups (Table 1), and these 
variables were consolidated by principal component analysis. MEF1 consolidated well over half the 
variance in the ten most discriminant image features. The C-pre animals were indistinguishable from 
NICs but significantly different from v-pre on Tukey post hoc testing after one-way ANOVA (Figure 6B). 
Conversely,  C-post  and  v-post  groups  were  indistinguishable,  but  these  groups  were  significantly 
different from NICs. 
Consistent with my original hypothesis, I found that CHX administered before ischemic and 
reperfusion injury, when polysomes are intact, inhibited the formation of mRNA granules. CHX 





3.3.2 Puromycin induces mRNA granules in neurons of uninjured 
animals. 
Consistent with previous observations
1
, NIC animals showed no mRNA granules (Figure 7A), 
while 1hR animals had robust mRNA granule formation in CA3 neurons (Figure 7B).  mRNA granules 
have  never  previously been  observed outside the context  of  global  brain I/R.  Two of three animals 
injected with puromycin showed mRNA granule formation near the puromycin injection site (Figures 7B 
and 7C). mRNA granules were not observed over 1 mm away from the injection site. Vehicle-injected 
animals showed no mRNA granules throughout the entire section, showing that mechanical trauma from 
the injection did not generate mRNA granules. Thus mRNA granules could be pharmacologically induced 









Figure 7: Puromycin induced mRNA granule formation in uninjured neurons. Representative images of pA 
staining in CA3 hippocampal neurons. A) Vehicle-injected non-ischemic animal without mRNA granules. B) 
and C) Images from two separate, nonischemic, puromycin-treated animals showing partial mRNA 
granulation near injection site. D) Animal without puromycin injection after 10 minutes ischemia and 1hR 









Chapter 4 – HuR Binds hsp70 mRNA but does not 
 
 








After transcription, stress-induced mRNAs such as hsp70 may exit through the CRM1 pathway. 
Through binding partners APRIL and pp32, HuR exits the nucleus with CRM1 in stressed cells. HuR has 
been shown to facilitate nuclear export of some target mRNA, increasing their translation
146
. To study the 
nuclear export of HuR and hsp70 mRNA, neurons from microdissected CA1 and CA3 hippocampal 
regions were separated into nuclear and cytoplasmic fractions by differential centrifugation after gentle 
mechanical homogenization. RNA  immunoprecipitation (RIP) detects transcripts specifically bound to a 







1. If hsp70 mRNA is associated with HuR in reperfused neurons, RIP will precipitate hsp70 
 
mRNA with HuR. 
 
2. Facilitated nuclear export of hsp70 mRNA by HuR will allow translation of hsp70 mRNA in 
ischemia resistant CA3 while lack of nuclear export of hsp70 mRNA in ischemia vulnerable CA1 will 







4.2.1 Animal Model 
 
 
Animal model was used as described in Chapter 2.  RIP used whole cortex tissue, and subcellular 
localization used microdissection hippocampal subregions as described below. Animal groups were: For 
RIP- 10 minutes ischemia followed by 8 hours reperfusion (8hR), n=3); for HuR in subcellular fractions- 









RIP was based on the method Keene, et al
177,178
. All efforts were made to prevent RNase 
degradation of samples. Consumables were RNase-free and other containers and surfaces were treated 
with Zap (Ambion). Where possible, procedures were performed under a laminar flow hood and all 
solutions were prepared with DEPC-treated water. 
8hR or NIC animals were sacrificed and brains rapidly removed. Whole forebrain was dissected 
at 4 
o
C and homogenized on ice in 1:5 (w/v) of 50 mM HEPES pH 7.5, 150 mM NaCl, 1% (v/v) Triton 
X-100, 10% (v/v) glycerol, 1 mM MgCl2, 1 mM EGTA, 80 U/mL RNase inhibitor (Ambion, Austin, TX, 
USA), 0.2% ribonucleoside vanadyl complexes (Sigma, St. Loius, MO, USA), and 1:85 protease inhibitor 
cocktail  (Sigma).  Centrifugation  of  the  2500  g  post-nuclear  supernatant  at  25,000  g  generated  a 
cytoplasmic supernatant, and 600 µg of supernatant protein was precleared with 1 µL of an unrelated 
antibody (Lamin AlC, Santa Cruz Biotech, Santa Cruz, CA, USA) plus 20 µL Protein A-Sepharose beads 
(Invitrogen, Carlsbad, CA, USA). Precleared supernatants were rotated 16 hr, 4°C in 15 µL Protein A- 
Sepharose prebound with 16 µg HuR antiserum (Santa Cruz) or 10 µg PABP antiserum (Abcam). Beads 
were  washed  three times  in  sterile  phosphate  buffered  saline.  RNA was  extracted  from precipitated 
protein  using  TRIzol  reagent  (Invitrogen).  2  µg  total  RNA  was  measured  by  A260  and  reverse 
transcriptase PCR was performed according to vendor instructions (Roche, Boulder, CO, USA). Primers 




TTGTCATTGAGAGCAATGCCAGCC-3'; 1.0 kb product) and hsp70 (5'- 
TCTTGGTTGCCAACACCCAAATCC-3’,  5’-AAAGGTCACTGCTAGCTCCGTGTT-3’;  0.5  kb 
product). Amplification products were run on Tris-acetic acid- EDTA-1% agarose gels and visualized by 
SYBR gold (Invitrogen). For some IP reactions, RNA was not extracted but rather beads were boiled in 
Laemmli buffer, run on SDS-PAGE gels, and western blotted for HuR or PABP using methods previously 




4.2.3 Quantification of HuR Protein and hsp70 mRNA in Nuclear 
and Cytoplasmic Fractions 
4.2.3.1 Hippocampal Subregion Microdissection 
 
 
Microdissection of dorsal hippocampus CA1 and CA3 subregions was according to the method of 
Roberts et al
65
. Briefly, animals were anesthetized with 5% halothane and quickly decapitated after the 
appropriate reperfusion duration. For each animal, whole brain  was rapidly removed and snap-frozen in a 
dry ice-ethanol  bath for 15 seconds. A semi-frozen coronal section was  cut from 2.30 to 3.80 mm 
posterior to Bregma in a brain blocker. This section, containing the dorsal hippocampus, was further 
subdivided on an ice-cooled stage under a dissecting microscope (Figure 9A). A vertical cut was made 
slightly medial to CA3 and surrounding cortex was removed to isolate CA3. CA1 was separated from the 
dentate gyrus by a horizontal cut through the hippocampal fissure. Corpus callosum and other superior 
tissues were separated to isolate CA1. Bilateral sections were rapidly weighed and then stored at -80 
o
C. 
Bilateral wet weight for each subregion averaged 25 mg per rat. Microdissection of CA1 and CA3 
hippocampal  subregions  allowed  for  the  comparison  of  ischemia  vulnerable  and  ischemia  resistant 
neurons  in  a  global  ischemic  model.  Additionally,  these  regions  consist  primarily  of  hippocampal 










4.2.3.2 Subcellular Fractionating 
 
 
Microdissected tissue samples were homogenized at 1:15 (w/v) in a homogenization buffer of 
 
320 mM sucrose, 1 mM MgCl2, 1 mM NaH2PO4, pH 6.6. 2.39, 1 mM DTT, 80 units/mL RNase inhibitor 
 
(Ambion), 0.5% protease inhibitor cocktail (Sigma). Homogenization used a glass Kontes dounce with 
 
150 µM clearance to preserve the nuclear membrane. Nuclei were pelleted by 850 g centrifugation for 10 
minutes followed by three washes of the nuclear pellet. Nuclei were then resuspended in 1 mL 
homogenization buffer and mixed with 5 mL of nuclear purification buffer (2.39 M sucrose, 1 mM 
MgCl2, 1 mM NaH2PO4, 10% (v/v) triton X-100, pH 6.6, 1 mM DTT, 80 units/mL RNase inhibitor, 0.5% 
protease inhibitor cocktail). Resuspended nuclei were centrifuged 48,000 g for 1 hour at 4 
o
C in a 
 
Beckman SW50.1 rotor. Pellet of intact nuclei was washed 3 times in homogenization buffer and then 









Western blotting was performed exactly according to vendor instructions (Amersham). 2 µL 
aliquots of each sample were taken in triplicate for Lowry assay to determine protein concentration. All 
antibody conditions were identical to previous western blotting used in the DeGracia laboratory
1,65
. Prior 
to loading, all protein samples were boiled for 2 minutes in equal volume of 2x Laemmli buffer. SDS- 
PAGE gels were 10% total, 0.8% bis acrylamide. Pilot studies determined the total protein from each 
subcellular fraction necessary to generate good signal in western blotting, and all western blots compared 
only samples from the same subcellular fractions. After SDS-PAGE, proteins were transferred to 




HuR 5261 (Santa Cruz Biotechnology) 1:200 without blocking for 2 hours at room temperature; mouse 
anti-lamin B1 16048 (Abcam) 1:5000 overnight 4 at 
o
C without blocking; and rabbit anti-glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) 25778 (Abcam) 1:1000 for one hour at room temperature without 
 
blocking. The base buffer for all primary antisera incubations was tris buffered saline with 0.1% tween 
 
20. All peroxidase-linked secondary antibodies were at a concentration of 1:6700 and blocked in 4% 
serum of the secondary host. Films were scanned at 300 dpi on a Scanmaker 9800XL flatbed scanner 




4.2.3.4 RNA Isolation and Real Time PCR 
 
 
RNA was extracted from hippocampal subregions by guanidinium-acid-phenol using the TRIzol 
reagent exactly according to vendor instructions. As described in the method of RIP above, all efforts 
were made to prevent RNase degradation of samples. Final isolated RNA had an A260:A280 ratio >1.7, and 
RNA integrity was confirmed with denaturing agarose gel electrophoresis. cDNA was generated using the 
Transcriptor First Strand cDNA Synthesis kit (4896866001) from Roche. cDNA was transcribed using 
poly-T primers so that only full length transcripts were amplified. This step was taken to ensure that only 
mature and not nascent transcripts were amplified from the nuclear fraction. The resultant cDNA was 
input to quantitative PCR reactions using SYBR Green quantitative PCR (qPCR) Master Mix (600548) 
from Stratagene, on the Mx3000P real time PCR thermocycler. Primers for qPCR were the same as for 
the RIP method, above measuring differences in hsp70 and using gapdh as a normalizer. After an initial 
10 minutes at 95 
o




seconds elongation at 72 
o
C, and   30 seconds dissociation at 95 
o
C followed by a dissociation curve. 
Amplification data were analyzed in MxPro v.3.00 from Stratagene using 2
-∆∆CT 
method for relative 
quantification
180
. Threshold fluorescence was determined using a minimum cycle threshold (Ct) spread 
algorithm in MxPro which minimizes the overall spread of Ct standard deviation for all replicates in a 










RIP of HuR or PABP was performed on cytoplasmic fractions from forebrain homogenates of 
NIC and 8hR samples (Figure 8). HuR RIPs selectively brought down hsp70 mRNA but not gapdh. 









Figure 8: Figure: hsp70 mRNA co-precipitates specifically with HuR after transient global brain ischemia. 
Results from PABP (left) and HuR (right) RNA co-immunoprecipitation (RIP) reactions from 8hR forebrain. 
Left panels for each RIP show enrichment of precipitated protein by western blot. HC and LC are antibody 
heavy and light chains from the immunoprecipitation. Right panels for each RIP are reverse transcriptase 
PCR products after 35 cycles. Both gapdh mRNA and hsp70 mRNA co-precipitate with PABP, but only hsp70 




4.3.2 Nuclear and Cytoplasmic Fractionation 
 
 
To study whether HuR facilitates the nuclear export of hsp70 mRNA, nuclear and cytoplasmic 
fractions of CA1 and CA3 were generated for NIC and 8hR animals. Microdissected regions are shown in 
Figure 9A. Cortex HSP70 expression was used to validate brain I/R injury for all 8hR samples; NICs did 
not show appreciable HSP70 expression on western blot. 
Subcellular fractionation was validated with GAPDH and Lamin B1, markers for the cytoplasmic 
and nuclear fractions respectively (Figure 9B). Both markers were present in samples of homogenate 
prior to fractionation. Nuclear fractions contained only Lamin B1 and cytoplasmic fractions contained 






Figure 9: Nucleocytoplasmic fractioning method and controls. A) Example of CA1 and CA3 microdissection 
from the dorsal hippocampus showing hippocampal subregions and cuts made in the tissue. B)  Western blot s 









4.3.2 HuR Does Not Exit the Nucleus During Global Brain I/R 
 
 
HuR was quantified in cytoplasmic and nuclear fractions and unfractionated homogenate from 
microdissected CA1 and CA3 regions. Consistent with previous microscopy work in the DeGracia lab 
and published reports of other laboratories
144,146
, HuR was predominantly nuclear in both NIC and 8hR 






However, the amount cytoplasmic  HuR did not change in response to 1/R injury in any region or fraction, 
 















































































































Figure 10: HuR  in subcellular fractions. A) Western blot  measuring HuR  in cytoplasmic fractions from  CAl 
of 6 NIC and  6 8hR  animals. NIC unfractionated  homogenate and  nuclear fmctions were  loaded  as controls. 
Similar blots were gene1·ated for  unfractionated homogenate and  nuclear fractions and  for the CA3 region. B) 




cytoplasmic fractions or silver staining for nuclear fractions. Each column represents 6 samples; error bars 






4.3.3 8hR CA1 and CA3 have the same Distribution of Nuclear and 
 
 
Cytoplasmic hsp70 mRNA 
 
 
Levels of hsp70 mRNA were also assessed in each region and fraction by qPCR (Figure 11). 
hsp70 in unfractionated homogenate was increased roughly 26-fold in both regions at 8hR with no 
significant differences between CA1 and CA3. In the cytoplasm, hsp70 was increased between 200 and 








Figure 11: Real time quantitative PCR for hsp70 in unfractionated homogenate (Unfract. Hom.) and 
cytoplasmic fractions of CA1 and CA3. Fold change of hsp70 mRNA from NIC to 8hR in unfractionated 
homogenate (left) and cytoplasmic (right) fractions from CA1 and CA3. Both unfractionated homogenate and 




Calculation of relative differences by 2
-∆∆CT 
assumes that the increase in amplicon per cycle, the 
PCR efficiency, is the same for each PCR target. Values for efficiency range from 1 (no efficiency) to 2 
(perfect efficiency). Efficiency was quantified using the slope of the log-fold dilutions of each primer 









Figure 12: Example of efficiency experiments for hsp70 and gapdh. Amplification curves show linear changes 
in Ct at logarithmic dilutions (left). Dilution of cDNA (logarithmic) versus CT (right) shows efficiencies of 
1.81 (SD 0.08) for hsp70 and 1.79 (SD 0.07) for gapdh. 
 
These studies show that there is no significant difference in the nuclear export of either HuR 
 











The work described in Chapter 4 shows that HuR interacts specifically with hsp70 mRNA in 
reperfused neurons, but does not export hsp70 mRNA out of the nucleus. A second mechanism by which 
HuR could regulate hsp70 is by directly enhancing translation through association with eIF4A
7
. Polysome 
profiles present a method to assess whether HuR increases its association with polysomes during 
reperfusion. Eight hours reperfusion was again selected as the time point for these studies because rats are 














5.2.1 Experimental Groups 
 
 
Animal model was identical to previous chapter. Experimental groups were NIC, n=4 and 8hR, 
n=4. All tissue was homogenized as whole cortex. 
5.2.2 Tissue Processing 
 
 
Whole cortex from either 8hR animals expressing HSP70 or NICs was homogenized at 1:2 (w/v) 
in a 7-mL dounce homogenizer in cold lysis buffer (340 mM sucrose, 50 mM tris pH 7.4, 25 mM NaCl, 5 
mM MgCl2, 100 µg/mL CHX, 5.2 µL/mL protease inhibitor cocktail, 1 mM DTT, 80 U/mL RNase 





After 20 strokes with the dounce homogenizer, homogenates were centrifuged 1000 g for ten 
minutes at 4 
o
C to pellet nuclei and membranes. Supernatants were then centrifuged 10,000 g for 30 
minutes at 4 
o





5.2.3 Polysome Profiles 
 
 
Polysome profiles were generated based on the methods of MacManus, et al.
119 
and DeGracia, et 
al
181
. Gradient and homogenate preparation and polysome profile centrifugation were performed on ice or 
at 4 
o
C. Sucrose gradients were prepared by layering sucrose concentrations of 15%, 20%, 25%, 30%, 
35%, 40%, and 45% (w/v) sucrose dissolved in gradient buffer (50 mM tris pH 7.4, 25 mM NaCl, 5 mM 
MgCl2, 100 µg/mL CHX, 5.2 µL/mL protease inhibitor cocktail, 1 mM DTT, 80 U/mL RNase inhibitor) 
and allowing layers to equilibrate overnight. 
Spectrophotometry of PMS was taken at 254 nm and 75 A254  units were layered on top of each 
 
11.5-mL sucrose gradient. Sucrose gradient was centrifuged at 240,000 g (37500 rpm) for three hours in a 
 




After centrifugation, each gradient was placed in a Beckman fraction recovery stand and tube 
bottom was pierced. 66% (w/w) sucrose was pumped via peristaltic pump at 1-mL per minute into the 
bottom of the tube to displace the gradient. Eluent was run through a spectrophotometer photocell 
measuring A254  and then into a fraction collector. Gradients were fractionated into 15 equal volumes of 
800 µL and absorbance at 254 nm was continuously recorded with a strip chart recorder advancing at 0.5 
 
mm per second. 
 
For graded input controls, 25, 50, or 75 A254 units of NIC cortex were loaded onto gradients 
identical to above. For CHX control, tissue was homogenized in the presence of 15 mM EDTA. Gradient 






5.2.4 Western Blotting 
 
 
To  study protein  concentrations  of  proteins  in  each fraction  of  the  polysome  profile,  whole 
fractions were concentrated by ultrafiltration with a 3 kDa cutoff device (Amicon) and all protein from 
each fraction was loaded onto one lane of an SDS-PAGE gel. Western blotting and HuR antibody 
conditions were as described in Chapter 4. Other antibody conditions were: mouse anti-S6 2317S (Cell 
Signaling) 1:250 in 5% dry milk incubated overnight at 4 
o
C, rabbit anti-PABP 21060 (Abcam) 1:500 
without blocking incubated overnight at 4 
o
C, rabbit anit-L7a 2403 (Cell Signaling) 1:1000 in 5% dry 
 




For densitometry, raw band densities for each fraction were scaled by average density across the 
gradient. Scaling allowed comparison of values across gradients. For each fraction, relative density of 







5.3.1 Polysome Profile Controls 
 
 
Traces of A254 along the density gradient had similar forms between NIC and 8hR groups (Figure 
 
13).  8hR animals  showed peaks  similar  in  height  and  area to NICs.  To detect  polysome-containing 
fractions,  all  fractions  were  western  blotted  for  polysome-associated  markers  (Figure  13).  Small 
ribosomal subunit protein S6 and large ribosomal subunit protein L7a both concentrated in fractions 8-11. 








Figure 13: Polysome profile control data from 8hR (left) and NIC (right) cortex. Polysome profile A 254 traces 
are similar between conditions. Polysome profiles were divided into 15 fractions for western blotting. S6 and 
L7a markers of the small and large ribosomal subunit, respectively, concentrate in polysome enriched 
fractions. PABP concentrated in less dense fractions. 
 
 
Other controls for polysome profiles included graded increase in polysome peak with sample 
loaded (Figure 14A), and loss of polysome peak with addition of EDTA (Figure 4B) which chelates Mg
2+ 








Figure 14: NIC input and EDTA controls. A) Gradients with 25, 50, and 75 A254 units showing polysome peak 
increases with input. B) 15 mM EDTA abolishes polysome peak from 75 NIC A254 units. 
 
To  assess  HuR  association  with  polysomes,  densitometry of  8hR  and  NIC  cortex  polysome 
profiles was performed. Densitometry confirmed that HuR distributed evenly across densities relative to 
polysome-associated or free proteins (Figure 15B). At each fraction, NIC and 8hR HuR density was 
compared by two-tailed t-test, and there were no significant differences for any fraction. 









Figure 15: HuR association with polysomes. A) Western blots of HuR (darkest band) in fractions from NIC 
and 8hR cortex polysomes. B) Densitometry for 4 NIC and 4 8hR cortex polysome profiles expressed as 
percent of average density of each gradient. Error bars are standard deviation. No differences between NIC 












In order to recover from I/R injury, neurons need to translate newly-transcribed mRNAs encoding 




microarray studies of reperfused brain, all previous studies suffer from major limitations in measuring the 
post-ischemic transcriptional program. Many well-designed brain I/R microarray studies were conducted 
prior to advancements in array technology and genome mapping, making the number of transcripts 
measured a small fraction of the whole genome. More recently, it has been appreciated that steady-state 
levels of mRNA and protein are only weakly correlated
153,155
, severely limiting the ability of microarrays 
to measure actively translating transcripts. The loose correlation in mRNA and protein steady states is 
due, in part, to posttranscriptional RNA regulatory mechanisms. Through specific mRBP interactions, 
stress response transcript translation can be significantly altered over short time frames in stressed cells
128
. 
In particular during reperfusion after brain ischemia, stress-response transcripts are able to escape the 
global suppression of translation
149
. The functional effects of mRBPs and translation suppression are not 
detectable by microarray of whole-cell RNA. 
Translation state analysis can identify upregulated transcripts which localize to the polysome
197
. 
MacManus, et al. performed the only translation state analysis of brain tissue after I/R injury. This study 
used a mouse focal ischemia model to compare lesioned and unlesioned hemispheres of the brain. While 
MacManus made an important finding that only 36% of upregulated transcripts were bound to polysomes, 
use of a focal model limits the interpretation of this result. I/R damage and induction of stress responses 
are not constant throughout a focal lesion
198
. In fact, genes produced by inflammatory cells in the necrotic 






Selectively vulnerable CA1 dies by DND while adjacent CA3 neurons survive. This dichotomous 
outcome is a useful model to study the intrinsic ability of neurons to recover from I/R injury. By studying 
the CA1 and CA3 regions of the hippocampus in the transient global ischemia model, researchers have 
shown conclusively that persistent suppression of translation correlates to selective vulnerability. Yet no 
study has yet compared the CA1 and CA3 regions in global brain ischemia by microarray. 
This chapter investigated both the differences between polysome-bound and unbound transcripts 







There are quantifiable differences in the mRNA populations bound to polysomes in CA3 and 
 







6.2.1 Animal model 
 
 
The 2VO/HT model was performed exactly as described in Chapter 3. Experimental groups used 
in this chapter were: NIC (n = 15) and 8hR (n=15).  For the purpose of validating the integrity of RNA 
















Homogenates for microdissected CA1 and CA3 were prepared as described in Chapter 5, section 
 
5.2.2. For rats used to assess integrity of polysome-extracted RNA, whole forebrain homogenates were 
prepared. Whole forebrain consisted of bisecting the brain coronally at the level of the superior colliculus 
and taking all structures anterior, including the diencephalon. Whole forebrain was homogenized at 1:2 
(w/v) the same buffer used to homogenize CA1 and CA3. Homogenates of CA1, CA3, and whole 
forebrain were processed exactly as described in Chapter 5, section 5.2.2 to produce PMS fractions that 




6.2.4 Pooling of microdissected regions 
 
 
Polysome profiles required loading 75 A254 units of PMS to isolate RNA. Microdissection of as 
single, bilateral CA1 or CA3, in its entirety, provided 20 A254 units of PMS.  Therefore, to achieve the 
required quantities for polysome profiles, five homogenates per hippocampal region per experimental 
group were randomly pooled to generate a single pooled sample. Thus, the four main experimental 
groups: (1) NIC CA1, (2) NIC CA3, (3) 8hR CA1, and (4) 8hR CA3 each consisted of three pooled 
samples, where each pooled sample contained 5 pooled homogenates from individual animals (Figure 
16A). 
 
Because of the pooling requirements, pilot studies to assess RNA extraction quality were 
performed on whole forebrain homogenates, where each animal provided enough material to run a single 




6.2.5 Polysome profiles 
 
 
Polysome profiles of pooled hippocampal regions and forebrain samples were run exactly as 
described in Chapter 5, section 5.2.3. The data shown in Chapter 5, section 5.3.1 established that gradient 




pooled and constituted the polysome-bound fractions (bound, B). The lower density fractions, 1-6, were 




6.2.6 RNA extraction. 
 
 
RNA was extracted from B and U fractions using the same protocol as described in Chapter 4. 
Ethanol washed RNA pellets, resuspended in sterile water, were shipped overnight on dry ice to Genome 
Explorations (Memphis, Tennessee) who performed microarray hybridization as described below. An 
aliquot of resuspended RNA pellets was used to measure RNA concentration by A260 and estimate RNA 
purity by A260/A280 ratio. 
 
 
6.2.7 Summary of Experimental Design 
 
 
There were a total of 24 samples analyzed by microarray.  The overall design of the microarray 
studies is illustrated in Figure 16.  Five samples from forebrain were used for pilot studies on RNA 






Figure 16: Design of microarray experiments. A) Design of main experiment comparing CA1 and CA3. Each 
polysome (p) contained tissue from 5 animals, pooled randomly. RNA was isolated from polysome bound (B) 
and unbound (U) fractions of each polysome profile. B) Design of pilot study for RNA extraction from 
polysome profiles. Each polysome contained tissue from a single forebrain. 
 
 
6.2.8 Performance of Microarrays 
 
 





A. RNA quality control. 
 
Immediately prior to cDNA synthesis, the purity and concentration of RNA samples were 
determined from OD260/280 readings using a dual beam UV spectrophotometer and RNA integrity was 
determined by capillary electrophoresis using the RNA 6000 Nano Lab-on-a-Chip kit and the Bioanalyzer 









RNA (5-25 ng each sample) was converted to cDNA, amplified, fragmented, and labeled with 
biotin using the Ovation Pico WTA, Ovation Exon Module, and Encore Biotin Module kits according to 




C. Oligonucleotide array hybridization and analysis. 
 
Fragmented, biotin-labeled cDNA was hybridized for 17hr at 45 
o
C to GeneChip® Rat Gene 1.0 
 
ST Arrays (Affymetrix, Santa Clara CA). The Rat Gene 1.0 ST array is a perfect-match-only array 
comprised of 722,254 unique 25-mer oligonucleotide features representing transcripts from roughly 
27,000 rat genes with each gene represented on the array by approximately 27 probes spread across the 
full length of its transcript
200
. Arrays were washed and stained with phycoerythrin -conjugated 
streptavidin (Life Technologies, Carlsbad, CA) in a Fluidics Station 450 (Affymetrix) according to the 
manufacturer’s recommended procedures. Fluorescence intensities were determined using a GCS 3000 
7G high-resolution confocal laser scanner, and analyzed using programs resident in the Affymetrix 
GeneChip Operating Software suite, v.3.2. (GCOS; Affymetrix). GCOS quality control outputs included 
average expression across arrays (ALE) box plots, relative level of expression (RLE) box plots , and 
positive vs. negative area under curve (AUC) values, and were used to identify potential outlier arrays. 
Outlier evaluation was also performed by principal component analysis in GeneMaths XT (Applied 






Genome Explorations provided the resulting data files generated by the Affymetrix software. 
These included raw 16-bit pixel intensity image files (.DAT), and probe intensity files (.CEL). All 








Background correction by the PM-CGBG method and probe set signal summarization using the 
PLIER algorithm
201,202 





filtering, hierarchical clustering, and class comparisons to identify probe sets exhibiting significant 
differential expression were performed using BRB-ArrayTools v.4.2.1 developed by Dr. Richard Simon 
and the BRB-ArrayTools Development Team.  BRB-ArrayTools is a microarray analysis plug-in for 
Microsoft Excel, freely distributed by the National Cancer Institute at the NIH. The filter criteria used for 
class comparisons was log intensity variation > 75
th 
percentile.  Application of this filter reduced the 
 
initial 26,309 genes to a set of 6,578 genes. Hierarchical clustering was by Pearson correlation with 









(1) NIC CA1 bound (N1B) vs. 8hR CA1 bound (R1B), 
(2) NIC CA3 bound (N3B) vs. 8hR CA3 bound (R3B), 
(3) NIC CA1 unbound (N1U) vs. 8hR CA1 unbound (R1U), 











Results were expressed as: (1) Tables of significant hits, including p values, false discovery rates 
 





Gene Ontology Analysis 
 
Gene annotation, gene ontology information, and biochemical pathway information were 




(ww.affymetrix.com), the Gene Ontology Consortium (http://amigo.geneontology.org), and WebGestalt 
(http://bioinfo.vanderbilt.edu/webgestalt). Enrichment of gene ontology (GO) categories in each 
comparison was estimated by hypergeometric distribution using GO TermFinder
205
. A biological process 
term was considered enriched if the number of genes annotated by the GO term in a list was greater than 




ARE database search 
 
Differentially expressed transcripts were tested for the presence of ARE sites using the AU-Rich 
element containing database (ARED) (http://brp.kfshrc.edu.sa/ARED/)
206
. ARED is an assembly of all 
mRNA and 3’ expressed sequence tags (ESTs) in the GenBank and EMBL sequences databases, screened 
for the ARE consensus sequence, WWWU(AUUUA)UUUW, allowing for one mismatch. Gene lists for 




IRES database search 
 
There is no consensus IRES site for eukaryotic transcripts expressed by cap-independent 
translation, so these sites are currently determined experimentally. A database of experimentally 
determined IRES sites (IRESite) is maintained by Charles University in Prague (http://iresite.org/ )
207
. 





Transcription factor database search 
 
Transcription factor binding site enrichment for was tested in MAtInspector (genomatix)
208
. 
MatInspector uses a large library of matrix descriptions for transcription factor binding sites to locate 
matches in DNA sequences. MatInspector assigns a quality rating to matches by aligning them to a 




assigned a score between 0 and 100 for each possible nucleotide. Transcription factor binding is measured 






6.3.1  Polysome  fractions  are  enriched  in  rRNA  and  translating 
mRNAs 
To assess the integrity of polysome profile RNA, rRNA and transcribing mRNAs were measured 
across density gradients generated from whole forebrain (Figure 17). Both 8hR and NIC samples showed 
good RNA integrity for all fractions by rRNA in by denaturing electrophoresis. 18S and 28S rRNA bands 
concentrated in fractions enriched in polysomes while small nucleotides concentrated at low density. 
Polysome-enriched fractions of NIC were able to generate gapdh product in RT-PCR. 8hR samples are 
known  to  be  translating  large  amounts  of  hsp70  mRNA.  The  8hR  polysome-enriched  fractions 






Figure 17: Figure: Polysome profiles for translation state analysis. Representative polysome profile A254 
traces for 8hR (left) and NIC (right) cortex. Whole RNA from each gradient fraction was isolated by TRIzol. 
RNA  from odd  numbered fractions was  separated by  denaturing agarose electrophoresis. (Agarose gel 
images inverted for clear viewing.) Samples of 2 µg RNA from odd numbered fractions were input for reverse 
transcriptase PCR amplifying primers for either hsp70 (8hR) or gapdh (NIC) mRNA. Shown are primer 
products after 25 cycles on 1.2% agarose. 
 
 
6.3.2 Microarray Validation 
 
 
All arrays were normalized by quantile normalization where the values of each array are 
transformed so that all arrays have the same distribution of transformed probe intensities. Normalization 







Figure 18: Box plots of probe set intensity values for each microarray expressed as log2 intensity. A) Probe set 
intensity values before normalization. B) Probe set intensity values after normalization. 
 
Sample groups were first assessed by hierarchical clustering of genes (Figure 19).  Genes with the 
top ¼ of log intensity variation were used in the clustering analysis. Clustering arranges genes according 




of the heat map, the more similar their expression. Expression was different between bound and unbound 
fractions for each treatment group and region. Smaller differences are apparent between NIC and 8hR 
samples from the same fraction. 
 
 
Figure 19: Hierarchical clustering of most differentially expressed 2630 genes. Microarrays in columns are 
grouped by sample sets. Distances were calculated by complete linkage. Scaled gene expression is shown in 
blue (downregulated) or red (upregulated) as indicated by the scale bar below the heat map. 
 
 
Gene clustering in Figure 19 is unsupervised; microarrays were arranged to show the differences between 
polysome bound and unbound groups. Unsupervised clustering of both genes and samples still grouped 
all arrays into their respective sample groups (not shown). 
A PCA plot of the first three principal components was generated for all samples (Figure 20). 




complete arrays were outliers. There is a sharp divide between polysome-bound (lower left, B) and 
unbound (upper right, U) transcripts for all groups. 
 
 
Figure  20:  Principal  component  analysis  of  all  microarrays  and  genes  show  the  top  three  principal 
components as x, y  and z  axes. Polysome-bound transcripts (B) group to  the lower left while unbound 




6.3.5 Polysome-bound Subpopulations at 8hR 
 
 
In each hippocampal region transcripts were then compared between the polysome-bound NIC 
and polysome-bound 8hR groups. Overall, the CA3 region had both more upregulated transcripts at 8hR 






Figure 21: Expression of polysome-bound transcripts. A) Volcano plots of expression changes (Log2  fold 
changes) on the x-axis and significance of two-tailed t-test (y-axis) comparing polysome-bound 8hR to NIC 
samples in CA3 (left) and CA1 (right). Hits above the significance threshold, p<0.01 are in blue. B) 
Distribution of I/R-induced, polysome-bound transcripts between CA1 and CA3 at p<0.01, >2-fold change. 




1005 transcripts in CA3 region and 247 transcripts in the CA1 region cleared thresholds. Overall, 
both regions had more upregulated than downregulated transcripts with 75% (185) of differentially 
expressed CA1 transcripts upregulated and 59% (592) of CA3 transcripts upregulated. Only 95 of the I/R- 
upregulated,  polysome-bound  transcripts  (R/N-bound)  were  identical  between  CA3  and  CA1  groups 
(17% of the CA3 group or 52% of the CA1 group) (Figure 21B). 




Transcripts were then compared between unbound NIC and unbound 8hR groups. As with bound 
transcripts, the CA3 region had more upregulated transcripts at 8hR, but fold-changes were comparable 
between CA1 and CA3 (Figure 22A). 
 
 
Figure 22: Expression of unbound transcripts. A) Volcano plots of expression changes (Log 2 fold changes) on 
the x-axis and significance of two-tailed t-test (y-axis) comparing unbound 8hR to NIC sa mples in CA3 (left) 
and CA1 (right). Hits above the significance threshold, p<0.01 are in blue. B) Distribution of I/R-induced, 
unbound transcripts between CA1 and CA3 at p<0.01, >2-fold change. Values in Venn diagrams are for 
exclusive CA3 hits (left), exclusive CA1 hits (right) and overlapping hits (middle). 
 
1,429 transcripts in CA3 region and 926 transcripts in the CA1 region cleared thresholds. Less 
differentially regulated transcripts were upregulated relative to the bound groups. 51% (185) of 
differentially expressed CA1 transcripts upregulated and 58% (830) of CA3 transcripts upregulated. 272 




(32% of the CA3 group or 57% of the CA1 group) (Figure 22B). The percent of CA3 R/N-unbound 
transcripts shared by CA1 R/N-unbound (32%) is more than double the percent of CA3 R/N-bound 




6.3.7 GO for Biological Processes in R/N-bound Groups 
 
 
Overall, both R/N-bound CA1 and CA3 were enriched in GO groups related to signaling, 
development, and stress response. 
 
 
Figure 23: Biological process GO for R/N-bound groups. GO categories were considered upregulated if 
likelihood if the enrichment of transcripts in the GO category was p<0.01 by chance. 
 
 
6.3.8 ARE Enrichment in R/N-bound and R/N-unbound Groups 
 
 
By the relatively stringent standards of ARED, 1.92% of the rat transcriptome contains an ARE 
sequence. Both R/N-bound CA1 and CA3 were enriched in AREs. In R/N-bound CA1, 16 transcripts 
contained AREs (3 predicted) and in R/N-bound CA3, 39 transcripts contained AREs (9 predicted). These 
values correlate to a 5.3- fold enrichment in R/N-bound CA1 AREs and at 4.3- fold enrichment in R/N- 






Figure 24: Upregulated R/N-bound (A) and R/N-unbound (B) transcripts were searched in the ARED 
database to determine number of upregulated transcripts in each list. Values in Venn diagrams are for 
exclusive CA3 hits (left), exclusive CA1 hits (right) and overlapping hits (middle). 
 
 
R/N-unbound groups were also enriched in AREs. R/N-unbound CA3 had 44 ARE-containing transcripts 
(9 predicted, 5-fold increase) and R/N-unbound CA1 had 19 ARE-containing transcripts (4 predicted, 5- 
fold increase). Both R/N-bound CA1 and CA3 were enriched in AREs. In R/N-bound CA1, 26 transcripts 










Transcription factor binding site enrichment for the R/N-bound transcripts found in both CA3 and 
CA1 (overlap of Figure 24A) were tested in MAtInspector
208
. The ten most-enriched transcription factors 
are shown in Table 2. 
Table 2: Top ten enriched transcription factors in MAtInspector. 





SMTTTTGT motif (uncharacterized) 14 7 e-09 
Heat Shock Factor 1 13 6 e-08 
 
















































(uncharacterized)   
 
 
6.3.10 IRES Enrichment in R/N-bound Transcripts 
 
 
IRESite was screened for the R/N-bound transcripts found in both CA3 and CA1 (overlap of 
Figure 24A). There was specific evidence from rat for one IRES-containing transcript in the R/N-bound 














7.1 Summary of Results and Their Implications 
 
 
In this dissertation, I investigated causal and functional aspects of brain I/R-induced mRNA granule, with 
emphasis on the role of HuR, whose presence in mRNA granules correlates with translation of hsp70 
mRNA. Specifically, I investigated formation of mRNA granules in brain reperfusion (Chapter 3), the 
levels of HuR and hsp70 mRNA in subcellular fractions of control and reperfused samples (Chapter 4), 
and the distribution of HuR on polysome profiles isolated from control and reperfused samples (Chapter 
5), and performed the first microarray studies of (1) the differential transcription between reperfused CA1 







1.   Cycloheximide prevented the formation of mRNA granules when given before, but not after 
global brain ischemia. 





1.   hsp70 mRNA immunoprecipitated with HuR in cortical homogenates after 8 hours reperfusion. 
 
2.   HuR levels in subcellular fractions did not change at 8hR compared to NIC in CA1 and CA3. 
 
3.   Increase in hsp70 mRNA was not different between CA1 and CA3 at 8hR in unfractionated 











1.   Differential gene expression was detected between CA1 and CA3 at 8hR as compared to the 
respective NIC groups. 
2. A different and larger population of mRNAs was isolated on polysomes from 8hR CA3 compared 
to 8hR CA1; there was only fractional overlap in the polysome-bound transcripts between the two 
regions. 
3.   Both CA1 and CA3 R/N-bound groups were enriched for similar biological processes by broad 
categories of gene ontology and express both proliferative and pro-death transcripts. 
4.   ARE-containing transcripts were enriched in all 8hR compared to NIC groups. 
 
5.   Heat shock factor (HSF) binding sites were enriched in the polysome-bound, I/R upregulated 
transcripts common to CA1 and CA3. 
6.   There was no evidence of a concentration of mRNA regulation by IRES in the polysome-bound 
transcripts that increased at 8hR in CA1 and CA3. 
 
Each of these main findings will be discussed in turn.  Interspersed through these discussions will be 
statements of the limitations of each study and suggestions for future directions.  The Discussion will 
conclude with comments about the significance of these findings for the field of brain I/R studies. 
 
7.2 Dependence of mRNA Granules on Polysome State 
Pretreatment with CHX blocked the formation of mRNA granules in CA3 neurons after transient 
global ischemia. The same CHX treatment after ischemia had no effect. These findings are consistent 
with the hypothesis that polysome-associated mRNA is required to form mRNA granules. Other dynamic 
mRNPs such as SGs and PBs also increase in response to cell stress
124
. In the 2VO/HT model, SGs were 
already increased at 10 minutes reperfusion
79
. SGs are known to route mRNAs between other mRNPs, 




together with my finding that polysome mRNA is necessary for mRNA granule formation gives rise to 
the following model: 
 





The present investigation of mRNA granules is limited to the 1hR time point. Therefore, we do 
not know how suppressing mRNA granule formation may affect cell survival. It is tempting to argue that 
these findings may explain the neuroprotective effect of CHX, but previous reports in CHX in brain I/R 
argue against this hypothesis. Some researchers found no effect of CHX of comparable dose and 
administration in global I/R
209
. Also, some researchers have reported neuroprotection from CHX given 
after ischemia
159
, directly contradicting a mechanism of preventing mRNA granule formation. Despite 
 
conflicting reports in the brain I/R field, it is well established that CHX does prevent cell death in cultured 
cells  under  stress
210
,  and  this  is  usually  attributed  to  the  drug’s  ability  to  exert  something  like  an 
integrated  stress  response, suppressing protein  synthesis  during stress
159
. Reperfused  neurons already 
exert a strong integrated stress response during early reperfusion
87
, so it is doubtful that additional protein 
synthesis inhibition would have much of an effect. Mattson and Furukawa have noted that less than 3% of 
CHX studies on cellular stress actually measure protein synthesis, and the dose of CHX in many positive 
studies is known to be too low to block more than a small fraction of protein synthesis
211
. They present 
the  interesting  alternative  hypothesis  that  CHX  may  selectively  increase  the  steady  state  level  or 
translation  of  some  mRNAs.  This  has  already  been  shown  to  be  true  for  several  IEGs
211
,  but  the 
mechanisms are not clear. Given the evidence against CHX neuroprotection through protein synthesis 
inhibition, the drug’s ability to influence behavior of mRNA granules is even more important. More 
investigation of how CHX could regulate steady state levels of mRNA and translation in the transient 
global ischemia model are warranted. 
Future studies should investigate the effect of a single CHX bolus over a reperfusion time course, 




throughout reperfusion, then outcome studies measuring cell death would indicate the role of the mRNA 
granule in damage or recovery from I/R. Also, detailed studies of early reperfusion in non-CHX-treated 
animals should reveal when mRNA granules form relative to SGs. 
The novel use of texture analysis allowed me to quantify the changes in cytoplasmic mRNA seen 
under the microscope. Previously, cellular changes in brain I/R have often been reported descriptively. 
While still useful, descriptive changes can only be compared nominally; either findings are present, or 
they are absent. Descriptive findings are typically reported as ―representative‖ images. These images may 
only be a small fraction of the actual cells visible under the microscope, and they cannot express diverse 









While it is accepted that HuR can regulate ARE-containing mRNAs in stressed cells, the 
mechanisms by which HuR exerts posttranscriptional regulation are not well-studied
138
. HuR’s best 
characterized regulatory mechanism is blocking mRNA degradation at the PB
212
. I have not excluded this 
possibility in reperfused neurons, but there is strong evidence that this mechanism, even if active, is not 
important  in the  differential  regulation  of  stress response transcripts  between CA1  and CA3.  First, 
reperfused neurons are known to be transcriptionally active and expressing IEG transcripts in response to 
I/R, even after just minutes of reperfusion
108
.   Second, radioactive nucleic acid probes
149     
and qPCR
65 
have established that hsp70 mRNA is more abundant in CA1 than CA3 throughout early reperfusion. 
The implausibility of differential regulation by blocking mRNA degradation led me to consider 
alternative mechanisms. In all systems tested, nuclear export of HuR is necessary for the protein to exert 
posttranscriptional control
146
. Additionally, there is more limited evidence that HuR nuclear export itself 
can regulate gene expression by exporting associated mRNAs
140
. However, I found that the levels of both 




Because unfractionated homogenate was also measured for each region and time point, we may also 
assert that new HuR is not synthesized at 8hR in response to I/R injury. Together with the main finding 
that HuR is not exported from the nucleus, this implies that HuR which enters the mRNA granules is 
present in in the cytoplasm prior to ischemia. Because all known regulatory mechanisms of HuR require 
nuclear export, HuR may be regulating reperfused neurons by an unknown mechanism. 
Increases in hsp70 mRNA after brain I/R are the same between CA1 and CA3 in cytoplasm and 
unfractionated homogenate. This is direct evidence that regulation of nuclear export, by HuR or any other 
means, does not affect the differential translation of hsp70 after I/R. 
I found that HuR binds specifically to hsp70 mRNA in reperfused neurons at 8hR. HuR did not 
recognize gapdh mRNA, suggesting that its interaction with hsp70 is not based in the poly(A) tail. 
Conversely, PABP recognized both hsp70 and gapdh mRNAs at 8hR. This was expected, as PABP 
associates  with  all  polyadenylated  mRNAs  as  they  are  being  translated.  My  discovery  that  HuR 
specifically binds hsp70 mRNA in reperfused neurons at 8hR both reinforces previous microscopy work 
from the DeGracia laboratory and provides justification for future studies of regulation by mRNPs. 
An important limitation of this study and of all RIP designs is the possibility of false positives 
from nonspecific binding or in vitro interactions. Despite measures to prevent nonspecific binding, pre- 
blocking protein A beads and pre-clearing samples, some nonspecific interaction of RNA with protein A 
sepharose  is  unavoidable.  While  PCR  is  sensitive  enough  to  detect  trace  amounts  of  transcripts 
precipitated  by  nonspecific  interactions,  the  difference  between  specifically  interacting  and 
nonspecifically bound transcripts should be obvious. Indeed, when limiting PCR to 25 cycles, we found 
that only hsp70 mRNA was detectable from HuR immunoprecipitation. 
In vitro interactions are more difficult to control. While the majority of cellular mass in cortex 
tissue comes from neurons, glia and other cell types are also present in the homogenate
179
. It is possible 
that  HuR  from  other  cells  in  the  cortex  binds  neuronal  hsp70  mRNA  once  the  cells  are  lysed  in 
homogenate. Mili and Steitz showed an in vitro HuR-mRNA interaction in HEK293 cells
213
. They 




of both cell populations showed FLAG-tagged HuR did pull down c-fos. Presently, the only way to 
control for in vitro interactions in RIP is to add a cross-linker to samples prior to homogenization, but this 
method introduces the possibility of forming nonspecific interactions within the cell, depending on the 







7.4  HuR Distribution on Polysomes 
 
 
Hu proteins can increase translation of target mRNAs by associating with polysomes through eIF4A
7
. 
After ruling out the possibility that HuR prevents degradation of hsp70 mRNA and showing that HuR 
does not export hsp70 mRNA out of the nucleus, we decided to investigate the model proposed by Fukao, 
et al. that Hu protein binding to eIF4A could increase translation in the closed loop model. HuR binds 
3’UTR ARE and poly(A) sequences. Association of HuR with eIF4A would bring the 3’ end of the 
mRNA adjacent to cap-binding complex of which eIF4A is a subunit. 
The  distribution of  HuR across the polysome  profile  did not change  in response to  I/R  injury. 
However, lack of differential association in response to I/R does not necessarily imply that HuR is not 
regulating  translation.  Distribution  of  HuR  across  the  gradient  is  unlike  either  polysome-associated 
proteins or non-polysome-associated PABP. While broadly distributed across densities like PABP, HuR 
is most concentrated in high-density fractions like ribosomal proteins (Figure15A). With this distribution, 
HuR is likely constantly associated with the polysomes to some extent.  This distribution also suggests 






indicate that mRNP interactions are complex, and HuR is not 
 
likely to be an exception given its diverse role in posttranscriptional regulation. No drugs exist which can 




regulation will likely require a knockout or knockdown study after which the expression of known HuR 
 








Comparison to Previous Expression Profiling 
 
While translation state analysis was a novel approach to study global brain I/R, our design was 
limited by lack of comparisons to total RNA. We have no way to normalize fold changes between the 
bound and unbound groups (and therefore do not compare them directly). Because we are unable to sum 
bound and unbound transcripts, we cannot directly compare our quantitative results to those of previous 
brain I/R microarray studies of total RNA. However, this does not preclude qualitative and order-of- 
magnitude comparisons with highly-expressed transcripts. 
A literature and database search and review article
151 
indicated that no microarrays have been 
 
performed on brain tissue at 8hR after global ischemia. The most similar study, Büttner, et al., is from a 
rat transient global ischemia model at 6hR
186
. Still, the Büttner study uses cortex from the entire left 
hemisphere of post-ischemic brain while our study was of only polysome-bound samples from 
hippocampus. Differentially regulated transcripts with fold change ≥75th percentile over all arrays were 
used to compare upregulated transcripts at 8hR to reported 6hR values. The top ten most differentially 




Table 3: Most differentially expressed transcripts, 8hR polysome-bound (left) and 6hR whole cell RNA 
(right). Transcripts common to both lists are underlined. 
 
8hR polysome-bound Büttner,09 Cortex at 6hR 
Fold Symbol Name Fold Symbol Name 
change change 
54 Hspb1 heat shock protein 1 250 Hspa1b heat shock 70kD protein 1B (mapped) 
50 Atf3 activating transcription 16 Hspb1 heat shock protein 1 
factor 3 






29 Ptgs2 COX-2 13 Atf3 activating transcription factor 3 
18 Cdkn1a P21 / WAF1 10 Egr2 Early growth response 2 
15 Mt1a metallothionein 1a 9 Ccl2 Chemokine ligand 2 
14 Ttr transthyretin 9 GADD45g Growth arrest and DNA-damage-inducible 45 
gamma 
14 Inhba inhibin beta-A 8 Tnfrsf12a Tumor necrosis factor receptor superfamily, 
12a 
14 Hmox1 heme oxygenase 
(decycling) 1 
8 FosB FBJ murine osteosarcoma viral oncogene 
homolog B 
13 Srxn1 sulfiredoxin 1 homolog 8 Hmox1 heme oxygenase (decycling) 1 
 
Four genes, Hspb1, Atf3, Hspa1b, and Hmox1 are among the top ten most upregulated in both 
groups, suggesting that these groups of arrays are from similar expression profiles. The proteins encoded 
by Hspb1, Atf3, Hspa1b, and Hmox1, are HSP27, activating transcription factor-3, HSP70, and heme 
oxygenase 1, respectively. HSP27, HSP70, and heme oxygenase 1 are all heat shock family member 
proteins,  and  ATF3  is  a  cAMP-responsive  transcription  factor.  All  four  proteins  are  known  to  be 
expressed in early reperfusion
216–219
. Consistent with the idea that polysome-enriched fractions contain 
translating mRNA, there is direct evidence for the upregulation of each of the other proteins encoded by 











, and inhibin beta-A
220
. It is also noteworthy that hsp70 and Cdkn1a mRNA are both 
 




Translation State Analysis of 8hR CA1 and CA3 
 
The primary motivation for this study was to see if the mRNAs on the polysomes were concentrated in 
HuR regulatory sites in their 3’-UTR. That is, this study was the most direct way, without using 
pharmacological or genetic interventions, to test the role of HuR in mediating selective translation. We 
could have performed microarray of HuR-precipitated transcripts , but polysome profiles avoid the false 
positive issues of RIPs discussed above. Whereas it is clearly thermodynamically favorable for mRNA- 
mRBP bindings to occur in vitro after cell disruption
213
, it is thermodynamically highly unfavorable that 
polysomes will spontaneously form in a tissue homogenate that lacks exogenous energy charge.  Thus, we 
had a high degree of confidence of avoiding false positive results and regarding the mRNAs on the 




We observed an increase in ARE-containing mRNAs, suggesting that HuR and other ARE-binding 
mRBPs contribute somehow to getting the mRNAs onto the polysomes when global translation itself is 
suppressed.  Limitations of the ARE result are discussed below. 
Our design had a number of other advantages over previous global brain I/R expression profiling. This 
was the first study to compare CA1 and CA3 regions after global brain I/R, and therefore, the first global 
I/R study of translation state analysis
151
. Previous global brain I/R microarrays necessarily assumed that 
steady-state levels of total RNA correlated to protein expression. Exclusive comparison of polysome- 
associated transcripts removes this assumption. The error associated with total RNA microarrays is 
apparent in our results for unbound transcript comparisons; these changes would be averaged with bound 
transcript changes in a microarray from total RNA. 
Important and unexpected results were 1) R/N-bound CA3 had a more diverse population of mRNAs 
than R/N-bound CA1 and 2) there was relatively little overlap in the R/N-bound CA1 and CA3 
populations. Lack of overlap is due, in part, to differences in steady-state RNA levels between CA1 and 
CA3 as indicated by comparison of the R/N-unbound populations. However, R/N-unbound did share 
more transcripts than R/N-bound (32% of R/N-unbound CA3 transcripts versus 17% of R/N-bound 
transcripts). 
A more diverse induction of transcription at the outset of reperfusion may allow CA3 to recovery 
from I/R injury, while the more limited transcriptional program of CA1 is insufficient to repair the 
neuron. Alternatively, considering recovery from I/R as dynamic process, CA3 may have a faster rate of 
recovery than CA1. The larger diversity of transcripts in CA3 may, therefore, reflect recovery of normal 
translation. 
Our microarray results were necessarily limited by the mixed cell population of microdissections. 
The microdissection procedure minimizes but does not eliminate contamination of other cell types. 
Interneurons are present in the hippocampus at about a 1:20 ratio with principle neurons
179
, as well as 
glial cells at 1:10. Pyramidal cells account for roughly 90% of cell mass in the pyramidal cell layer. Our 
 




expression differences in the microarray data were the result of non-pyramidal cells.  For example, 
HSP27, one of the biggest fold difference hits, has been previously shown to be exclusively transcribed 
and translated in astrocytes
218
. That the level of hsp27 mRNA is greater in CA3 than CA1 suggests a 
functional role for astrocytes in outcome and recovery, and is consistent with work from Rona Giffard 
who has extensively studied astrocytes after brain I/R
226,227
. Alternative approaches which would prevent 
mixed cell populations include laser capture microdissection and high throughput in situ hybridization, 
either of which are technically and financial unfeasible. 
One obvious future direction will be to repeat this experimental design, but sampling over the entire 
time course of reperfusion:  1) in CA3 until it fully recovers the control pattern of polysome-bound 
mRNAs, and 2) in CA1 until the cells die at 72 hr reperfusion. Such a design will reveal the exact time 
course of all transcript changes, their fates in terms of translation, and shed a completely new light on 
how stress responses function in post-ischemic neurons, and open up understanding of the diversity of 
regulatory mechanisms that bear on how individual mRNAs gain access to ribosomes in the reperfusion 
period. 
 
Database Searches for ARE and IRES-containing mRNAs 
 
Ideally, we would like to screen the 5’ and 3’UTRs of all upregulated sequences for enrichment of 
regulatory sites. Unfortunately, global comparison of RNA regulatory sequences has not matured to the 
extent of other sequence comparisons such as transcription factor binding sites. RNA regulatory 
sequences typically depend in secondary if not tertiary structure, making prediction from primary 
sequences difficult. Some regulatory sequences such as IRES are determined entirely experimentally. 
Therefore, our database search results pertaining to AREs and IREs concentration in the mRNA 
populations must be taken only as a first approximation of what is, undoubtedly, a more complex picture. 
Given the limits of current mRNA regulatory site databases, empirical measures are absolutely 
necessary.  This could be accomplished by (1) studying individual mRNAs that are high on our hit lists 




sites. (2) Comparing transcripts upregulated by translational state analysis to transcripts upregulated in 
RIP for an mRBP of interest such as HuR. Parallel translation state analysis and RIP was used, for 
example, to identify transcripts regulated synergistically when associated with both the polysome and the 




7.6 Significance of the Work in this Thesis 
 
 
The discovery of mRNA granules was a significant advancement in the field of brain I/R studies. 
It offered a new model of translation arrest, and pointed to a causal role for the mRNA granule in post- 
ischemic outcome. However, prior to this thesis, our understanding of mRNA granules after brain I/R was 
entirely descriptive, based only on histological and correlative observations. This is the very first study to 
assess the molecular significance of mRNA granules. 
In particular, the studies here have advanced the understanding of how HuR may regulate 
expression of HSP70. The results here suggest that 2 of the 3 known Hu protein regulatory mechanisms, 
prevention of transcript degradation and facilitated nuclear export, are unlikely to play a significant role in 
post-ischemic outcome. 
The work here has not ruled out a role of HuR selective translation of stress induced mRNAs. 
While a change in the binding of HuR to polysomes was not observed during reperfusion, translational 
state analysis showed a concentration of ARE-containing mRNAs on polysomes in both CA1 and CA3 
(the interpretation of which is subject to the constraints listed above). 
Perhaps the most important finding, one not anticipated when the studies were conducted, was the 
greater diversity of transcripts in CA3. This has wide-ranging implications for understanding the response 
of specific neurons to I/R injury, how stress responses are executed via transcription and translational 
coupling, and how regulation of stress responses relates to outcome.  Much new work is expected to 




These findings significantly advance the understanding of HuR function, mRNA granules, and 
the execution of stress responses in post-ischemic neurons beyond the present general understanding in 
the field. 
 




Previous expression profiling studies of the reperfused brain have been almost exclusively focused 
on hypothesis discovery rather than testing concrete hypotheses. The work described here represents the 
application of expression profiling technology to answer well-focused questions pertaining to mRNA 
regulation. To do so, we applied methods commonly used in basic science studies of ribosome and mRNA 
regulation, where assessing entire populations of mRNAs simultaneously is important for understanding 
the biology of the system.  It is hoped that the present work stands as an example for others in the field as 
a way to apply –omics technology to address specific, and biologically meaningful questions. 
 
In conclusion, it is hoped that the studies described here will contribute to the 







APPENDIX A: TRANSCRIPTS DIFFERENTIALLY 





































































3.9E-06 0.0016 12.36 1083129 
8 










S100 calcium binding protein A8 116547 
0.002578 0.0306 11.22 1080612 
2 






0.000529 0.0165 9.6 1085570 
1 















potassium inwardly-rectifying channel, subfamily J, member 13 94341 
4.7E-06 0.0018 8.98 1089918 
7 
glycerol-3-phosphate dehydrogenase 1 (soluble) 60666 
0.00027 0.0118 8.74 1083090 
8 





crystallin, alpha B 25420 
7.5E-06 0.0019 8.6 1071140 
1 




0.000848 0.0192 8.55 1082768 
6 















zinc finger, AN1-type domain 2A 360772 
0.00045 0.0152 8.22 1075976 
2 
Klotho 83504 
7.4E-06 0.0019 8 1079752 
7 





ectonucleotide pyrophosphatase/phosphodiesterase 2 84050 
0.009407 0.0581 7.79 1075411 
6 
zinc finger and BTB domain containing 20 288105 
5.2E-06 0.0018 7.74 1075634 
3 















tribbles homolog 1 (Drosophila) 78969 
7.3E-06 0.0019 7.47 1081755 
2 
thioredoxin interacting protein 117514 
0.001064 0.0212 7.32 1072021 
5 
zinc finger protein 36 79426 
0.007462 0.0514 7.17 1077939 
0 





potassium inwardly-rectifying channel, subfamily J, member 9 116560 
0.001709 0.0254 6.94 1076521 
2 





serum/glucocorticoid regulated kinase 1 29517 
0.003999 0.0388 6.68 1086286 
7 
growth arrest and DNA-damage-inducible, alpha 25112 












fatty acid 2-hydroxylase 307855 
7.5E-06 0.0019 6.22 1073945 
5 





regulator of G-protein signaling 2 84583 
0.004185 0.0393 6.2 1083957 
9 










protocadherin 8 64865 
0.000111 0.0069 5.93 1073820 
9 





VGF nerve growth factor inducible 29461 




   0   
7.1E-06 0.0019 5.83 1090791 
3 





glycosylation dependent cell adhesion molecule 1 25258 
0.0008 0.0185 5.73 1092953 
6 

























claudin 11 84588 
0.004176 0.0393 5.56 1082074 
8 
UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) 310019 
6.5E-06 0.0019 5.53 1080450 
8 





prostaglandin D2 synthase (brain) 25526 
0.000571 0.0169 5.52 1084422 
3 





heat shock protein A8 24468 













7.06E-05 0.0054 5.29 1092097 
7 
NA NA 
0.000112 0.0069 5.27 1077258 
0 
NA NA 
0.000628 0.0177 5.27 1092529 
1 





















0.000451 0.0152 5.09 1084970 
0 





chloride intracellular channel 6 304081 
0.004832 0.0416 5.05 1081668 
8 





solute carrier organic anion transporter family, member 2a1 24546 
0.005854 0.0458 5.01 1076000 
8 









0.000861 0.0192 4.99 1085667 
3 















myelin-associated glycoprotein 29409 
0.000449 0.0152 4.89 1093513 
1 






0.00074 0.0184 4.86 1083882 
3 






























DnaJ (Hsp40) homolog, subfamily A, member 1 65028 







heat shock protein A8 24468 
0.005631 0.0449 4.7 1087893 
8 










solute carrier family 44, member 1 85254 
0.000998 0.0206 4.64 1088427 
4 




















Kruppel-like factor 10 81813 
0.000755 0.0184 4.59 1073669 
7 




















DDB1 and CUL4 associated factor 10 313242 
0.00246 0.03 4.46 1083303 
1 
sphingosine-1-phosphate lyase 1 286896 










0.001277 0.0226 4.35 1082769 
1 










protein phosphatase 1, regulatory (inhibitor) subunit 15A 171071 
0.000538 0.0165 4.25 1073485 
3 
aurora kinase B 114592 







heat shock protein 1 (chaperonin) 63868 
0.000349 0.0134 4.18 1093130 
8 





solute carrier family 16, member 5 (monocarboxylic acid transporter 6) 690212 
0.00222 0.0285 4.17 1088009 
5 





solute carrier family 12 (sodium/potassium/chloride transporters), member 2 83629 
0.000348 0.0134 4.15 1071358 
3 





metallothionein 2A 689415 
0.004485 0.0405 4.13 1071360 
2 
NA NA 
0.000947 0.0198 4.12 1071997 
7 
melanoma inhibitory activity 81510 
0.002525 0.0304 4.12 1088971 
9 
suppression of tumorigenicity 13 81800 
0.000756 0.0184 4.1 1071800 
1 
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) 170919 
0.004008 0.0388 4.09 1089136 
4 
alkB, alkylation repair homolog (E. coli) 362766 
0.008592 0.0556 4.08 1076081 
3 
NA NA 
0.001191 0.0221 4.04 1079918 
7 
DIP2 disco-interacting protein 2 homolog C (Drosophila) 307067 
0.000513 0.0162 4.02 1080932 
8 





DnaJ (Hsp40) homolog, subfamily B, member 5 313811 
0.000328 0.013 4 1078119 
7 
stathmin-like 4 79423 
0.005452 0.0442 4 1072666 
9 
cytochrome c oxidase, subunit VIIIb 25250 
0.000648 0.0178 3.99 1078837 
4 
mitochondrial tumor suppressor 1 306487 
0.000742 0.0184 3.97 1084039 
6 
Sec23 homolog B (S. cerevisiae) 362226 
0.002432 0.0299 3.92 1075353 
3 
myc induced nuclear antigen 266670 
0.000699 0.018 3.91 1083424 
1 
ATP-binding cassette, subfamily A (ABC1), member 2 79248 
0.005957 0.0463 3.91 1084793 
2 




0.001926 0.0267 3.86 1084250 
0 
similar to Docking protein 5 (Downstream of tyrosine kinase 5) (Protein dok-5) 502694 
0.000332 0.013 3.85 1086681 
9 
branched chain aminotransferase 1, cytosolic 29592 
0.000398 0.0143 3.84 1089143 
6 
general transcription factor IIA, 1 83830 
0.000276 0.0118 3.83 1085385 
2 
suppression of tumorigenicity 7 296911 
0.000577 0.017 3.8 1078905 
9 
1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) 290843 
0.002031 0.0274 3.8 1082683 
7 
cytochrome P450, family 2, subfamily u, polypeptide 1 310848 
0.003644 0.0371 3.8 1083180 
2 
NA NA 
0.003595 0.0369 3.79 1079929 
1 
Kruppel-like factor 6 58954 
0.002881 0.0323 3.77 1083752 
0 
suppression of tumorigenicity 13 81800 
0.005492 0.0444 3.77 1093764 
1 
NA NA 
0.000581 0.0171 3.75 1075813 
4 





ATPase, Na+/K+ transporting, alpha 1 polypeptide 24211 
0.001873 0.0265 3.74 1072668 
2 
interferon induced transmembrane protein 3 361673 
7.06E-05 0.0054 3.73 1090660 
8 
solute carrier family 38, member 2 29642 
0.002478 0.03 3.73 1076270 
9 























Cd44 molecule 25406 
0.000479 0.0158 3.67 1088595 
9 
similar to HESB like domain containing 1 500694 








0.000364 0.0138 3.61 1073719 
6 
NA NA 
0.000502 0.016 3.61 1088684 
6 
NA NA 
0.005226 0.0433 3.6 1072997 
0 
retinol binding protein 4, plasma 25703 
0.000252 0.0114 3.58 1092112 
0 
solute carrier family 6 (proline IMINO transporter), member 20 113918 
0.00076 0.0184 3.58 1078136 
1 
leucine-rich repeat LGI family, member 3 306013 
0.000299 0.0122 3.57 1082007 
1 
G protein-coupled receptor 150 499486 














myelin gene regulatory factor 293736 
0.001869 0.0265 3.51 1085060 
8 
NA NA 
0.005496 0.0444 3.5 1091748 
3 





cerebellar degeneration-related 2 308958 
0.003804 0.038 3.46 1089183 
4 
legumain 63865 







actin, gamma 1 287876 
0.004633 0.0412 3.44 1087262 
6 
G protein-coupled receptor 3 266769 
0.001714 0.0254 3.43 1080810 
3 
telomeric repeat binding factor 2, interacting protein 307861 
0.006673 0.0487 3.43 1081339 
2 
FYN binding protein (FYB-120/130) 499537 
0.001263 0.0225 3.42 1091963 
7 
transferrin 24825 
0.001544 0.0244 3.42 1076701 
6 











0.001086 0.0213 3.38 1073801 
5 
zona pellucida binding protein 2 363676 
0.00201 0.0273 3.37 1075048 
9 
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 288161 
0.000549 0.0167 3.35 1093506 
4 
proteolipid protein 1 24943 
0.000734 0.0184 3.35 1093477 
7 
NA NA 
0.002239 0.0286 3.35 1093517 
7 





apolipoprotein L domain containing 1 444983 
0.000334 0.013 3.34 1085896 
7 
tumor necrosis factor receptor superfamily, member 1a 25625 
0.0012 0.0222 3.34 1087147 
9 
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 679532 
0.001477 0.0239 3.34 1075194 
5 
somatostatin 24797 












methionine adenosyltransferase II, alpha 171347 
0.004237 0.0394 3.29 1093810 
1 
protein kinase, X-linked 501563 
0.008187 0.0541 3.29 1085319 
3 








solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 307811 
0.001032 0.021 3.26 1082660 
7 
UDP glycosyltransferase 8 50555 
0.006149 0.0472 3.26 1079781 
1 
CD83 molecule 361226 
0.000222 0.0103 3.24 1071231 
7 
patatin-like phospholipase domain containing 2 361676 
0.008799 0.0564 3.23 1087285 
2 
similar to RIKEN cDNA 4930555I21 500566 
0.000555 0.0167 3.22 1087951 
6 
major facilitator superfamily domain containing 2 298504 
0.000851 0.0192 3.22 1081769 
6 
protein kinase, AMP-activated, beta 2 non-catalytic subunit 64562 
0.00036 0.0137 3.21 1089558 
9 
carboxypeptidase M 314855 
0.000401 0.0143 3.21 1083402 
2 
arrestin domain containing 3 309945 
0.001245 0.0224 3.21 1073920 
4 
survival motor neuron domain containing 1 287768 
0.000361 0.0137 3.19 1082405 
9 
NA NA 
0.001813 0.026 3.19 1083727 
9 
integrin, alpha V 296456 
0.004062 0.0389 3.19 1090348 
2 
solute carrier family 25, member 32 315023 
0.000934 0.0197 3.18 1087151 
1 
L-amino acid oxidase 1 298483 
0.001513 0.0243 3.18 1086983 
9 
NA NA 
0.006605 0.0484 3.18 1089191 
0 
interferon, alpha-inducible protein 27 like 2B 299269 
0.007375 0.0511 3.18 1084022 
6 
similar to Protein C20orf103 precursor 362220 
0.001231 0.0224 3.17 1093710 
3 
synaptophysin 24804 
0.000536 0.0165 3.15 1090732 
4 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 683264 
0.000697 0.018 3.15 1079614 
9 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 117276 
0.001434 0.0236 3.15 1079650 
7 
solute carrier family 39 (zinc transporter), member 12 291328 
0.002094 0.0277 3.15 1076211 
5 










TIMP metallopeptidase inhibitor 3 25358 
0.000283 0.0119 3.13 1077447 
0 
NA NA 
0.000257 0.0115 3.12 1086090 
0 
pyruvate dehydrogenase kinase, isozyme 4 89813 
0.000276 0.0118 3.1 1076760 
5 
contactin 2 (axonal) 25356 
0.000294 0.0121 3.1 1080926 
9 





prostate androgen-regulated mucin-like protein 1 286894 




   1   
0.006351 0.0479 3.08 1072611 
4 
cytochrome c oxidase, subunit VIa, polypeptide 2 25278 
0.002047 0.0275 3.06 1073935 
3 
potassium inwardly-rectifying channel, subfamily J, member 2 29712 
0.002054 0.0275 3.06 1073088 
4 
survival motor neuron domain containing 1 287768 
0.001177 0.0221 3.04 1080126 
0 
NA NA 
0.001372 0.0233 3.04 1077323 
5 
zinc finger protein 509 305428 
0.001756 0.0258 3.03 1072880 
0 
transmembrane protein 132A 338474 
0.002461 0.03 3.03 1073148 
4 





protein tyrosine phosphatase type IVA, member 3 362930 
0.000739 0.0184 3.01 1094038 
0 
ATPase, H+ transporting, lysosomal accessory protein 1 83615 
0.004756 0.0414 3.01 1085214 
4 
prostate transmembrane protein, androgen induced 1 311676 
0.000477 0.0158 3 1086247 
3 
NA NA 
0.002006 0.0273 3 1076967 
2 
regulator of G-protein signaling 4 29480 
0.004433 0.0402 3 1082666 
9 
NA NA 
0.008454 0.0549 3 1075046 
0 
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) 304063 
0.004946 0.0421 2.99 1076347 
7 
Mki67 (FHA domain) interacting nucleolar phosphoprotein 246042 
0.00147 0.0239 2.98 1088650 
9 
NA NA 







sprouty homolog 2 (Drosophila) 306141 
0.000304 0.0123 2.97 1080365 
3 
actin, gamma 1 287876 
0.00042 0.0146 2.97 1079459 
9 
neural precursor cell expressed, developmentally down-regulated 9 291044 
0.001445 0.0237 2.97 1085010 
4 
solute carrier family 23 (nucleobase transporters), member 2 50622 
0.004441 0.0402 2.97 1090451 
1 
activity-regulated cytoskeleton-associated protein 54323 
0.007542 0.0515 2.96 1082350 
8 
cyclin L1 114121 
0.000765 0.0184 2.95 1086156 
5 
zinc finger, C3HC-type containing 1 296957 
0.00142 0.0236 2.95 1087785 
5 
NA NA 
0.002355 0.0295 2.95 1089062 
6 
glycoprotein hormone beta 5 366668 
0.000637 0.0177 2.94 1078298 
6 
orthodenticle homeobox 2 305858 
0.004579 0.041 2.94 1085731 
4 
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 29464 
0.000261 0.0115 2.93 1076574 
4 




0.000586 0.0171 2.93 1083575 
7 
gelsolin 296654 
0.000691 0.018 2.93 1081929 
8 
NA NA 
0.002253 0.0287 2.93 1074599 
4 
LOC360590 360590 
0.000279 0.0118 2.92 1087419 
3 
ERBB receptor feedback inhibitor 1 313729 
0.000475 0.0158 2.92 1084433 
9 
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 246771 
0.00039 0.0143 2.91 1072422 
8 
Bcl2-like 1 24888 
0.000715 0.0183 2.91 1090306 
1 
serine hydroxymethyltransferase 2 (mitochondrial) 299857 
0.005144 0.0429 2.91 1089558 
5 
lysozyme C type 2 688047 
0.003122 0.0339 2.9 1076533 
5 
cellular repressor of E1A-stimulated genes 1 289185 
0.003622 0.0371 2.9 1077641 
9 
transmembrane protein 165 364137 
0.000553 0.0167 2.89 1072388 
4 
serine (or cysteine) peptidase inhibitor, clade H, member 1 29345 
0.000604 0.0173 2.89 1076354 
7 
NA NA 
0.000319 0.0127 2.88 1077088 
8 
actin, gamma 1 287876 
0.002224 0.0285 2.88 1074949 
5 
lectin, galactoside-binding, soluble, 3 binding protein 245955 
0.000796 0.0185 2.87 1088222 
1 
transmembrane protein 88B 680723 
0.00032 0.0127 2.86 1070587 
2 
actin, gamma 1 287876 
0.000488 0.0158 2.86 1083753 
7 
actin, gamma 1 287876 
0.001622 0.0249 2.86 1079244 
1 
solute carrier family 20 (phosphate transporter), member 2 29502 
0.00855 0.0555 2.86 1073289 
3 
cyclin J-like 303059 
0.002673 0.0313 2.85 1078017 
0 
NA NA 
0.004953 0.0421 2.85 1073014 
8 
oligodendrocytic myelin paranodal and inner loop protein 361757 
0.000693 0.018 2.84 1091493 
7 
NA NA 
0.000702 0.018 2.84 1086553 
1 
ubiquitin specific peptidase 5 (isopeptidase T) 297593 
0.001369 0.0233 2.83 1081628 
7 
ets variant 3 295297 
0.001525 0.0244 2.83 1072722 
8 
Fas (TNFRSF6)-associated via death domain 266610 
0.00259 0.0307 2.83 1071497 
3 
HECT domain containing 2 309514 
0.00706 0.0498 2.83 1072955 
0 
NA NA 
0.009842 0.059 2.83 1083240 
4 
minichromosome maintenance complex component 3 associated protein 294339 
0.000777 0.0185 2.82 1073939 
9 
NA NA 




   2   
0.000261 0.0115 2.81 1086466 
2 
transmembrane protein 111 312640 
0.000493 0.0159 2.81 1074961 
2 
actin, gamma 1 287876 
0.002697 0.0314 2.81 1089449 
8 
P55 362855 
0.006393 0.0481 2.8 1087480 
2 
ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast) 298689 
0.000381 0.0142 2.79 1088420 
5 
TWIST neighbor 362728 
0.000594 0.0172 2.79 1092334 
5 
heat shock protein 1 (chaperonin 10) 25462 
0.001088 0.0213 2.79 1085937 
1 
serine/threonine kinase receptor associated protein 297699 
0.001349 0.0232 2.79 1083181 
6 
BCL2-antagonist/killer 1 116502 
0.001661 0.0253 2.79 1087950 
2 
CAP, adenylate cyclase-associated protein 1 (yeast) 64185 
0.003042 0.0332 2.79 1081738 
3 
LAG1 homolog, ceramide synthase 2 310667 







CCHC-type zinc finger, nucleic acid binding protein 64530 
0.000978 0.0204 2.78 1087144 
4 
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 116509 
0.002122 0.0279 2.78 1088861 
0 
similar to limb-bud and heart 683626 
0.002325 0.0294 2.78 1092407 
6 
ribulose-5-phosphate-3-epimerase 501157 
0.004717 0.0414 2.78 1074519 
3 
protein interacting with cyclin A1 497959 
0.000413 0.0145 2.77 1088052 
4 
NA NA 
0.00424 0.0394 2.77 1092333 
8 
coenzyme Q10 homolog B (S. cerevisiae) 301416 
0.001599 0.0247 2.76 1090973 
3 
zinc finger protein 259 500989 
0.005982 0.0463 2.76 1091114 
5 
carbonic anyhydrase 12 363085 
0.008883 0.0565 2.76 1092822 
9 
CDC-like kinase 1 301434 
0.000624 0.0177 2.75 1075028 
2 
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 114507 
0.000489 0.0158 2.73 1085544 
9 
glycoprotein (transmembrane) nmb 113955 
0.006079 0.0468 2.73 1088946 
2 
NA NA 
0.006863 0.0492 2.73 1090810 
2 
NA NA 
0.001023 0.021 2.72 1086390 
4 
Sec61 alpha 1 subunit (S. cerevisiae) 80843 
0.002315 0.0293 2.72 1072804 
6 
D4, zinc and double PHD fingers family 2 361711 
0.003831 0.0381 2.72 1071900 
6 









0.006746 0.049 2.71 1079792 
9 
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme 306860 
0.00082 0.0187 2.7 1093692 
5 
NA NA 
0.001968 0.0271 2.7 1086462 
1 
jagunal homolog 1 (Drosophila) 502872 
0.003727 0.0374 2.7 1078662 
4 
5'-nucleotidase domain containing 2 290558 
0.00026 0.0115 2.69 1079422 
5 
nuclear factor, interleukin 3 regulated 114519 
0.002932 0.0325 2.69 1076516 
6 
similar to 2810422O20Rik protein 304928 
0.00403 0.0388 2.69 1078633 
8 
Rho guanine nucleotide exchange factor (GEF) 3 290541 
0.005954 0.0463 2.69 1081272 
2 
mitochondrial ribosomal protein S27 361883 
0.006922 0.0495 2.69 1089865 
4 
asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe) 245960 
0.000613 0.0175 2.68 1090716 
5 
Fas apoptotic inhibitory molecule 2 246274 
0.003125 0.0339 2.68 1083315 
2 
cysteine and glycine-rich protein 2 29317 
0.009779 0.059 2.68 1083381 
8 
NA NA 
0.005087 0.0427 2.67 1076260 
0 
GCN1 general control of amino-acid synthesis 1-like 1 (yeast) 690632 
0.005239 0.0434 2.67 1093207 
8 
NA NA 
0.002822 0.0319 2.65 1079345 
6 
splicing factor, arginine/serine-rich 3 361814 
0.002991 0.0329 2.65 1087803 
4 
NA NA 
0.006759 0.049 2.65 1084374 
9 
SEC16 homolog A (S. cerevisiae) 114089 
0.009209 0.0575 2.65 1092890 
2 
transmembrane BAX inhibitor motif containing 1 316516 
0.001024 0.021 2.64 1087229 
1 
tyrosyl-tRNA synthetase 313047 
0.002003 0.0273 2.63 1089514 
4 
dual specificity phosphatase 6 116663 
0.004679 0.0413 2.63 1080273 
4 
SMAD family member 7 81516 
0.000886 0.0194 2.62 1087445 
0 
leucine rich repeat containing 47 362672 
0.001637 0.0251 2.62 1088926 
3 
tribbles homolog 2 (Drosophila) 313974 
0.000647 0.0178 2.61 1089065 
0 
NA NA 
0.001237 0.0224 2.61 1093821 
7 
NA NA 
0.001299 0.0227 2.61 1085868 
6 
prohibitin 2 114766 
0.001969 0.0271 2.61 1088485 
3 
PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae) 314171 
0.003398 0.0355 2.61 1091208 
8 
5' nucleotidase, ecto 58813 
0.000761 0.0184 2.59 1079519 
4 
NA NA 




   8   
0.005138 0.0429 2.59 1092432 
6 
rcd1 (required for cell differentiation) homolog 1 (S. pombe) 301513 
0.000636 0.0177 2.58 1084682 
1 
thioredoxin-related transmembrane protein 2 295701 
0.001416 0.0236 2.58 1081187 
5 
TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor 307927 
0.000973 0.0203 2.57 1074769 
2 
dual specificity phosphatase 3 498003 
0.002212 0.0285 2.57 1079286 
3 
ATPase, class VI, type 11A 306600 
0.005119 0.0428 2.57 1079094 
8 
jun D proto-oncogene 24518 
0.00521 0.0433 2.57 1080360 
2 
LIM and senescent cell antigen like domains 2 361303 
0.000783 0.0185 2.56 1090416 
9 
N-myc downstream regulated 1 299923 
0.000809 0.0186 2.56 1080533 
5 
solute carrier family 14 (urea transporter), member 1 54301 
0.000934 0.0197 2.56 1076913 
1 
calcyclin binding protein 289144 
0.002887 0.0324 2.56 1083503 
7 
GLE1 RNA export mediator homolog (yeast) 362098 
0.008268 0.0543 2.56 1079531 
5 
NA NA 
0.000916 0.0196 2.55 1075275 
8 
BTG family, member 3 54230 
0.001275 0.0226 2.55 1078965 
3 
insulin receptor substrate 2 29376 
0.001392 0.0233 2.55 1076368 
5 
NA NA 
0.009211 0.0575 2.55 1090807 
2 
G protein-coupled receptor 83 140595 
0.000804 0.0186 2.54 1091588 
5 
NA NA 
0.001314 0.0228 2.54 1072737 
3 
NA NA 
0.005304 0.0436 2.54 1090940 
7 
Thy-1 cell surface antigen 24832 
0.000891 0.0194 2.53 1074413 
4 
eukaryotic translation initiation factor 4A, isoform 1 287436 
0.001363 0.0232 2.53 1081640 
5 
cellular retinoic acid binding protein 2 29563 
0.002122 0.0279 2.53 1093479 
4 
interferon stimulated exonuclease gene 20-like 2 361977 
0.006409 0.0481 2.53 1083096 
2 
NA NA 
0.006409 0.0481 2.53 1087598 
3 
NA NA 
0.007034 0.0498 2.53 1078751 
7 
growth differentiation factor 15 29455 
0.000557 0.0167 2.52 1094036 
4 
GDP dissociation inhibitor 1 25183 
0.001097 0.0213 2.52 1072764 
3 
NA NA 
0.006295 0.0476 2.52 1072780 
6 
NA NA 
0.008919 0.0567 2.52 1084251 
7 




0.000531 0.0165 2.51 1071794 
1 
t-complex 1 24818 
0.000596 0.0172 2.51 1079645 
5 
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 498798 
0.00188 0.0265 2.51 1092926 
3 
secretogranin II (chromogranin C) 24765 
0.004657 0.0413 2.51 1093199 
5 
A kinase (PRKA) anchor protein 14 60332 
0.001387 0.0233 2.5 1070536 
4 
SERTA domain containing 1 361526 
0.001908 0.0266 2.5 1085910 
8 
C-type lectin domain family 2, member g 362447 
0.001187 0.0221 2.49 1071316 
0 
synovial apoptosis inhibitor 1, synoviolin 361712 
0.002607 0.0308 2.49 1086538 
8 
vomeronasal 2 receptor, 51 502891 
0.00536 0.0437 2.49 1087247 
8 
small nuclear ribonucleoprotein 40 (U5) 313056 
0.009243 0.0575 2.49 1070192 
4 
interferon gamma receptor 1 116465 
0.000678 0.018 2.48 1076116 
2 
P450 (cytochrome) oxidoreductase 29441 
0.003568 0.0368 2.48 1075834 
4 
vacuolar protein sorting 37 homolog B (S. cerevisiae) 288659 
0.005763 0.0454 2.48 1079285 
9 
ATPase, class VI, type 11A 306600 
0.007715 0.0523 2.48 1082753 
1 
splicing factor, arginine/serine-rich 11 502603 
0.007725 0.0523 2.48 1079644 
5 
vimentin 81818 
0.002337 0.0294 2.47 1083639 
4 
membrane-associated ring finger (C3HC4) 7 311059 
0.000617 0.0176 2.46 1092827 
5 
family with sequence similarity 126, member B 316415 
0.002909 0.0324 2.46 1081789 
4 
NA NA 
0.006517 0.0484 2.46 1089207 
4 
NA NA 
0.000692 0.018 2.45 1078418 
1 
zinc finger, DHHC-type containing 20 305923 
0.000779 0.0185 2.45 1090256 
4 
Mdm2 p53 binding protein homolog (mouse) 314856 
0.001267 0.0225 2.45 1072192 
5 
glutamate-rich WD repeat containing 1 308592 
0.00131 0.0228 2.45 1075008 
0 
BTB and CNC homology 1, basic leucine zipper transcription factor 1 304127 
0.002726 0.0315 2.45 1070957 
5 
sphingomyelin phosphodiesterase 1, acid lysosomal 308909 
0.003074 0.0334 2.45 1080394 
7 
heparin-binding EGF-like growth factor 25433 
0.004957 0.0421 2.45 1086573 
2 
potassium voltage-gated channel, shaker-related subfamily, member 1 24520 
0.001299 0.0227 2.44 1075659 
7 
transmembrane protein 130 304280 
0.002054 0.0275 2.44 1093258 
4 
chloride channel 5 25749 
0.002159 0.0281 2.44 1071362 
6 
nuclear RNA export factor 1 59087 




   0   
0.003394 0.0355 2.44 1078099 
0 
cathepsin B 64529 
0.003406 0.0355 2.44 1086142 
9 
RNA binding motif protein 28 312182 
0.003768 0.0378 2.44 1082238 
6 
protein kinase (cAMP-dependent, catalytic) inhibitor alpha 114906 
0.001042 0.021 2.43 1072123 
2 
interferon stimulated exonuclease gene 20-like 2 361977 
0.001557 0.0245 2.43 1076763 
1 
neurofascin 116690 
0.003212 0.0344 2.43 1091943 
3 
NA NA 
0.006647 0.0486 2.43 1073783 
8 
NA NA 
0.000669 0.018 2.42 1070548 
5 
fibrillarin 292747 
0.008737 0.0563 2.42 1080668 
7 
coiled-coil domain containing 130 304656 
0.009646 0.0583 2.42 1093502 
1 
NA NA 
0.001346 0.0232 2.41 1091836 
4 
NA NA 
0.002117 0.0279 2.41 1088541 
7 
NA NA 
0.005593 0.0448 2.41 1081934 
7 
NA NA 
0.006942 0.0495 2.41 1074396 
4 
NA NA 
0.000451 0.0152 2.4 1088500 
6 
thioredoxin-related transmembrane protein 1 362751 
0.003327 0.0352 2.4 1084148 
7 
RNA-binding region containing protein 2-like 1E+08 
0.00693 0.0495 2.4 1088502 
9 
FERM domain containing 6 257646 
0.007187 0.0504 2.4 1077511 
3 
metal response element binding transcription factor 2 360905 
0.009543 0.0583 2.4 1081845 
2 
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 310791 
0.00055 0.0167 2.39 1077427 
4 
epidermal growth factor receptor 24329 
0.000745 0.0184 2.39 1082204 
3 
cadherin 6 25409 
0.001378 0.0233 2.39 1085848 
7 
mannose-6-phosphate receptor, cation dependent 312689 
0.002538 0.0304 2.39 1085195 
2 
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 362275 
0.006747 0.049 2.39 1088642 
9 
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 314396 
0.007716 0.0523 2.39 1079628 
0 
Sec61 alpha 2 subunit (S. cerevisiae) 361273 
0.007873 0.0528 2.39 1093867 
1 
zinc finger, MYM-type 3 317260 
0.008583 0.0556 2.39 1087944 
6 
defects in morphology 1 homolog (S. cerevisiae) 313563 
0.001096 0.0213 2.38 1080664 
0 
calreticulin 64202 
0.001239 0.0224 2.38 1089015 
6 




0.001435 0.0236 2.38 1072850 
7 
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 50567 
0.004111 0.0391 2.38 1087171 
1 
tRNA isopentenyltransferase 1 362586 
0.007052 0.0498 2.38 1087141 
7 
NA NA 
0.008775 0.0563 2.38 1081372 
1 
glyceraldehyde-3-phosphate dehydrogenase 24383 
0.001701 0.0254 2.37 1081153 
1 
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 50719 
0.002139 0.0279 2.37 1071270 
6 
choline kinase alpha 29194 
0.003541 0.0366 2.37 1093957 
0 
zinc finger, DHHC-type containing 9 302808 
0.005551 0.0446 2.37 1073589 
7 
NA NA 
0.000495 0.0159 2.36 1089768 
3 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 315133 
0.000661 0.0179 2.36 1082613 
7 
family with sequence similarity 102, member B 365903 
0.004612 0.0412 2.36 1082767 
3 
myelin oligodendrocyte glycoprotein 24558 
0.000859 0.0192 2.34 1090969 
1 
beta-site APP cleaving enzyme 1 29392 
0.000889 0.0194 2.34 1080589 
5 
gene trap locus 3 307642 
0.001294 0.0227 2.34 1090779 
3 
methyltransferase like 7A 315306 
0.002692 0.0314 2.34 1085793 
1 
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 79212 
0.002777 0.0317 2.34 1092356 
0 
basic leucine zipper and W2 domains 1 363232 
0.004521 0.0407 2.34 1077247 
8 
nuclear transcription factor, X-box binding-like 1 289595 
0.005486 0.0444 2.34 1079667 
3 
NA NA 
0.006813 0.0492 2.34 1090075 
3 
polypyrimidine tract binding protein 1 29497 
0.002241 0.0286 2.33 1071478 
8 
cleavage stimulation factor, 3' pre-RNA subunit 2, tau 309338 
0.002766 0.0316 2.33 1076039 
7 
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 304290 
0.002994 0.0329 2.33 1080323 
8 
NA NA 
0.007809 0.0526 2.33 1084530 
6 
calcium channel, voltage-dependent, beta 4 subunit 58942 
0.00463 0.0412 2.32 1072281 
8 
solute carrier organic anion transporter family, member 3a1 140915 
0.005483 0.0444 2.32 1078763 
0 
neurocan 58982 
0.005642 0.0449 2.32 1092327 
0 
oligonucleotide/oligosaccharide-binding fold containing 2A 363227 
0.00775 0.0523 2.32 1081775 
9 
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) 24450 
0.001024 0.021 2.31 1088977 
2 
NA NA 
0.008759 0.0563 2.31 1084027 
2 
glyceraldehyde-3-phosphate dehydrogenase 24383 




   7   
0.001575 0.0245 2.3 1076706 
7 
NA NA 
0.001805 0.026 2.3 1080836 
2 
ubiquitin specific peptidase 10 307905 
0.004146 0.0392 2.3 1080020 
0 
RIO kinase 3 (yeast) 361293 
0.006437 0.0482 2.3 1083056 
1 
sestrin 1 294518 
0.002181 0.0283 2.29 1073857 
6 
granulin 29143 
0.00238 0.0297 2.29 1082304 
9 
NA NA 
0.002909 0.0324 2.29 1075205 
0 
transformer 2 beta homolog (Drosophila) 117259 
0.003988 0.0388 2.29 1093191 
9 
lysosomal-associated membrane protein 2 24944 
0.004294 0.0397 2.29 1072057 
2 
amyloid beta (A4) precursor-like protein 1 502317 
0.004749 0.0414 2.29 1091736 
1 
hypothetical protein LOC100125362 1E+08 
0.004957 0.0421 2.29 1074714 
7 
NA NA 
0.004966 0.0421 2.29 1079913 
3 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 
5 
307766 
0.006854 0.0492 2.29 1070902 
0 
phosphoglucomutase 2-like 1 685076 
0.008205 0.0541 2.29 1084312 
5 
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 311726 
0.00088 0.0194 2.28 1070782 
4 
selenoprotein S 286900 
0.000902 0.0194 2.28 1089924 
8 
activating transcription factor 1 315305 
0.004157 0.0393 2.28 1092820 
7 
similar to hypothetical protein FLJ37953 301419 
0.000824 0.0188 2.27 1093983 
7 
membrane magnesium transporter 1 302864 
0.008293 0.0544 2.27 1076625 
3 
transmembrane protein 63a 289318 
0.009554 0.0583 2.27 1090632 
3 
choline kinase beta 29367 
0.00177 0.0258 2.26 1077696 
8 
transformer 2 beta homolog (Drosophila) 117259 
0.004013 0.0388 2.26 1079768 
1 
inositol 1,3,4,5,6-pentakisphosphate 2-kinase 306808 
0.00823 0.0541 2.26 1088875 
8 
brain and reproductive organ-expressed protein 362704 
0.00322 0.0344 2.25 1086748 
6 
NA NA 
0.003827 0.0381 2.25 1070712 
1 
general transcription factor IIH, polypeptide 1 361580 
0.004937 0.0421 2.25 1086095 
1 
asparagine synthetase 25612 
0.000924 0.0197 2.23 1091836 
8 
anterior pharynx defective 1 homolog B (C. elegans) 300802 
0.001154 0.0218 2.23 1091718 
3 
neural cell adhesion molecule 1 24586 
0.001208 0.0222 2.22 1072697 
9 




0.002021 0.0274 2.22 1087330 
3 
dolichyl-diphosphooligosaccharide-protein glycosyltransferase 313648 
0.00363 0.0371 2.22 1075759 
9 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 56010 
0.00478 0.0415 2.22 1078119 
1 
tripartite motif-containing 35 498538 
0.006344 0.0479 2.22 1073438 
2 
peripheral myelin protein 22 24660 
0.006685 0.0487 2.22 1088798 
1 
splicing factor, arginine/serine-rich 7, 35kDa 362687 
0.007457 0.0514 2.22 1089046 
3 
tripartite motif-containing 9 155812 
0.001519 0.0243 2.21 1091176 
5 
ELOVL family member 5, elongation of long chain fatty acids (yeast) 171400 
0.001684 0.0253 2.21 1092152 
7 
NA NA 
0.002198 0.0283 2.21 1093682 
7 
ATPase, H+ transporting, lysosomal accessory protein 2 302526 
0.002387 0.0297 2.21 1077909 
3 
ubiquitin specific peptidase 54 408223 
0.002469 0.03 2.21 1088420 
0 
EF-hand calcium binding domain 10 362727 
0.003356 0.0353 2.21 1085351 
5 
similar to RIKEN cDNA C030048B08 296840 
0.006051 0.0466 2.21 1089499 
9 
transmembrane and coiled-coil domain family 3 314751 
0.009593 0.0583 2.21 1088610 
9 
similar to FLJ20689 314325 
0.002387 0.0297 2.2 1070230 
9 
TATA box binding protein-like 1 689030 
0.006005 0.0465 2.2 1072271 
8 
NA NA 
0.002273 0.0289 2.19 1087226 
6 
ring finger protein 19B 313806 
0.00179 0.0259 2.18 1075669 
2 
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 288480 
0.002565 0.0305 2.18 1091386 
6 
NA NA 
0.0034 0.0355 2.18 1086487 
4 
Ras association (RalGDS/AF-6) domain family member 4 362423 
0.003975 0.0387 2.18 1082492 
6 
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha 365865 
0.005251 0.0434 2.18 1076076 
0 
similar to Leukosialin precursor (Leucocyte sialoglycoprotein) (Sialophorin) (CD43) (W3/13 
antigen) 
288521 
0.001801 0.026 2.17 1080357 
7 
synaptotagmin IV 64440 
0.001751 0.0258 2.16 1081452 
1 
arylacetamide deacetylase-like 1 294930 
0.003663 0.0372 2.16 1071972 
8 
ATPase, Na+/K+ transporting, alpha 3 polypeptide 24213 
0.003152 0.0339 2.15 1075639 
3 
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 25648 
0.005094 0.0427 2.15 1072043 
0 
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 292766 
0.005735 0.0454 2.15 1072452 
9 
tripeptidyl peptidase I 83534 
0.006139 0.0472 2.15 1093193 
0 
family with sequence similarity 70, member A 313453 




   4   
0.008344 0.0545 2.15 1075176 
9 
NA NA 
0.002474 0.03 2.14 1087486 
6 
nucleolar complex associated 2 homolog (S. cerevisiae) 313777 
0.003339 0.0353 2.14 1085444 
6 
caldesmon 1 25687 
0.004037 0.0388 2.14 1074601 
4 
NA NA 
0.005367 0.0437 2.14 1077437 
5 
pellino 1 305549 
0.001434 0.0236 2.13 1077669 
9 
transmembrane protein 33 59303 
0.00205 0.0275 2.13 1091903 
4 
NA NA 
0.003778 0.0378 2.13 1088681 
6 
similar to GTL2, imprinted maternally expressed untranslated 500717 
0.00441 0.0402 2.13 1072624 
4 
similar to RIKEN cDNA 2310057M21 309029 
0.005017 0.0425 2.12 1079885 
6 
cullin 2 361258 
0.005302 0.0436 2.12 1077361 
3 
macrophage erythroblast attacher 298982 
0.006169 0.0473 2.12 1086111 
7 
similar to CG3570-PA 500034 
0.004709 0.0414 2.1 1092905 
4 
hypothetical protein MGC:72616 316530 
0.00644 0.0482 2.1 1093699 
3 
pim-2 oncogene 317366 
0.008767 0.0563 2.1 1087757 
3 
deleted in bladder cancer 1 (human) 140610 
0.009061 0.0571 2.1 1088174 
0 
NA NA 
0.002897 0.0324 2.09 1081411 
9 
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain 
(TM) and short cytoplasmic domain, (semaphorin) 5A 
310207 
0.003513 0.0364 2.09 1080384 
3 
eukaryotic translation termination factor 1 307503 
0.003884 0.0382 2.09 1085150 
2 
serine incorporator 3 296350 
0.004029 0.0388 2.09 1084303 
9 
DnaJ (Hsp40) homolog, subfamily C, member 5 79130 
0.004537 0.0408 2.09 1078805 
3 
NA NA 
0.004683 0.0413 2.09 1070299 
6 
insulin-like growth factor 2 receptor 25151 
0.007203 0.0505 2.09 1079226 
8 
phosphatidic acid phosphatase type 2 domain containing 1B 680466 
0.001993 0.0273 2.08 1077606 
4 
UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) 305258 
0.004749 0.0414 2.08 1082603 
9 
seryl-tRNA synthetase 266975 
0.005667 0.045 2.08 1074935 
2 
jumonji domain containing 6 360665 
0.006276 0.0476 2.08 1075794 
0 
Williams-Beuren syndrome chromosome region 17 homolog (human) 288611 
0.007047 0.0498 2.08 1075872 
7 
protein tyrosine phosphatase, non-receptor type 11 25622 
0.008981 0.0568 2.08 1082346 
2 




0.00922 0.0575 2.08 1085729 
6 
transmembrane protein 43 362401 
0.001691 0.0253 2.07 1080439 
1 
transmembrane emp24 protein transport domain containing 7 252889 
0.002134 0.0279 2.07 1088906 
4 
selenoprotein I 362713 
0.00265 0.0312 2.07 1092822 
0 
potassium channel tetramerisation domain containing 18 301436 
0.005039 0.0425 2.07 1091492 
3 
centrosomal protein 57kDa 315423 
0.006676 0.0487 2.07 1082751 
7 
cystathionase (cystathionine gamma-lyase) 24962 
0.001775 0.0258 2.06 1081789 
8 
tetraspanin 2 64521 
0.003633 0.0371 2.06 1080257 
9 
mex-3 homolog C (C. elegans) 307271 
0.004878 0.0419 2.06 1071370 
6 
glucosidase, alpha; neutral AB 293721 
0.005057 0.0425 2.06 1074834 
7 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 287765 
0.005365 0.0437 2.06 1081295 
4 
polo-like kinase 2 (Drosophila) 83722 
0.007814 0.0526 2.06 1074527 
1 
proteasome (prosome, macropain) subunit, alpha type 3 29670 
0.002426 0.0299 2.05 1087159 
7 
forkhead box J3 313554 
0.005058 0.0425 2.05 1092758 
8 
NA NA 
0.006205 0.0475 2.05 1088372 
6 
Rho-associated coiled-coil containing protein kinase 2 25537 
0.006278 0.0476 2.05 1093593 
5 
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 50690 
0.006746 0.049 2.05 1087763 
0 
multiple EGF-like-domains 9 313270 
0.007461 0.0514 2.05 1076132 
9 
similar to 0610007L01Rik protein 288616 
0.003869 0.0382 2.04 1072730 
3 
immunoglobulin mu binding protein 2 29532 
0.006816 0.0492 2.04 1078228 
4 
NA NA 
0.008811 0.0564 2.04 1079203 
5 
dual specificity phosphatase 4 60587 
0.00409 0.039 2.03 1083229 
9 
pituitary tumor-transforming 1 interacting protein 365548 
0.004707 0.0414 2.03 1085605 
0 
NA NA 
0.008821 0.0564 2.03 1087206 
2 
proteasome (prosome, macropain) subunit, beta type 2 29675 
0.009631 0.0583 2.03 1091862 
0 
transcription factor 12 25720 
0.005803 0.0455 2.02 1083481 
2 
mitochondrial ribosomal protein S2 362094 
0.008451 0.0549 2.02 1086444 
1 
RING1 and YY1 binding protein 312603 
0.005082 0.0427 2.01 1071457 
6 
very low density lipoprotein receptor 25696 
0.005884 0.0459 2.01 1091200 
3 
trophoblast glycoprotein 83684 




   2   
0.006609 0.0484 2.01 1090059 
2 
NA NA 
0.008183 0.0541 2.01 1086167 
8 
plexin A4, A 312213 
0.009811 0.059 2.01 1070382 
0 
hippocampus abundant gene transcript 1 1E+08 
0.002466 0.03 2 1091800 
4 
leucine rich repeat containing 49 300763 
0.004969 0.0421 2 1088860 
8 
similar to limb-bud and heart 683626 
0.003838 0.0381 0.5 1072270 
6 
NA NA 
0.004362 0.0402 0.5 1077014 
0 
NA NA 
0.004616 0.0412 0.5 1092992 
9 
myeloma overexpressed 2 681389 
0.004805 0.0415 0.5 1090795 
8 
NA NA 
0.009841 0.059 0.5 1093512 
0 
NA NA 
0.001761 0.0258 0.49 1094002 
0 
NA NA 
0.00233 0.0294 0.49 1086734 
5 
NA NA 
0.003152 0.0339 0.49 1085616 
8 
NA NA 
0.003254 0.0348 0.49 1092328 
5 
NA NA 
0.003448 0.0358 0.49 1076360 
9 
NA NA 
0.007265 0.0506 0.49 1082174 
6 
NA NA 
0.007589 0.0517 0.49 1088342 
3 
hypothetical protein LOC500625 500625 
0.008866 0.0565 0.49 1086537 
2 
NA NA 
0.008926 0.0567 0.49 1075804 
8 
NA NA 
0.009538 0.0583 0.49 1073281 
9 
NA NA 
0.002069 0.0275 0.48 1092662 
7 
NA NA 
0.002831 0.0319 0.48 1093561 
1 
NA NA 
0.004724 0.0414 0.48 1092038 
8 
NA NA 
0.005399 0.0439 0.48 1089905 
3 
NA NA 
0.007249 0.0506 0.48 1092216 
9 
NA NA 
0.007348 0.051 0.48 1093575 
9 
NA NA 
0.007933 0.0531 0.48 1076675 
6 
NA NA 
0.009218 0.0575 0.48 1073119 
3 
NA NA 






0.001685 0.0253 0.47 1070846 
6 
NA NA 
0.001764 0.0258 0.47 1070833 
8 
SH3-domain GRB2-like 3 81921 
0.002702 0.0314 0.47 1091764 
5 
NA NA 
0.006021 0.0465 0.47 1090930 
7 
NA NA 
0.00629 0.0476 0.47 1072524 
5 
coenzyme Q7 homolog, ubiquinone (yeast) 25249 
0.007618 0.0518 0.47 1092557 
2 
NA NA 
0.008962 0.0568 0.47 1076497 
2 
hypothetical protein LOC100302372 1E+08 
0.001344 0.0232 0.46 1074050 
2 
NA NA 
0.00206 0.0275 0.46 1075196 
9 
NA NA 
0.002195 0.0283 0.46 1073141 
6 
NA NA 
0.002535 0.0304 0.46 1086080 
6 
NA NA 
0.002535 0.0304 0.46 1086080 
9 
NA NA 
0.002535 0.0304 0.46 1086081 
2 
NA NA 
0.002808 0.0318 0.46 1082479 
0 
NA NA 
0.003149 0.0339 0.46 1089846 
7 
pannexin 2 362979 
0.004129 0.0391 0.46 1093029 
9 
NA NA 
0.004213 0.0393 0.46 1082641 
6 
NA NA 
0.004591 0.0411 0.46 1072785 
4 
NA NA 
0.004762 0.0414 0.46 1091848 
0 
NA NA 
0.005504 0.0444 0.46 1075567 
0 
NA NA 
0.005809 0.0455 0.46 1076703 
2 
NA NA 
0.005965 0.0463 0.46 1072014 
4 
selenoprotein V 499113 
0.006865 0.0492 0.46 1087493 
6 
ribosomal protein S8-like 297756 
0.007338 0.051 0.46 1078754 
9 
similar to RIKEN cDNA 2810428I15 306348 
0.008981 0.0568 0.46 1083114 
8 
NA NA 
0.009058 0.0571 0.46 1086703 
3 
solute carrier organic anion transporter family, member 1a4 170698 
0.00126 0.0225 0.45 1083614 
5 
NA NA 
0.002907 0.0324 0.45 1082342 
5 
NA NA 
0.004859 0.0418 0.45 1081277 
9 
NA NA 




   9   
0.006034 0.0466 0.45 1071008 
9 
phosphodiesterase 3B, cGMP-inhibited 29516 
0.006583 0.0484 0.45 1083755 
4 
olfactory receptor 590 404858 
0.00677 0.049 0.45 1081283 
4 
ADAM metallopeptidase with thrombospondin type 1 motif, 6 361886 
0.009228 0.0575 0.45 1085371 
0 
glucocorticoid induced transcript 1 500026 
0.001993 0.0273 0.44 1088459 
9 
neuronal PAS domain protein 3 299016 
0.002278 0.0289 0.44 1086357 
0 
NA NA 
0.003046 0.0332 0.44 1085165 
0 
troponin C type 2 (fast) 296369 
0.003144 0.0339 0.44 1090318 
7 
NA NA 
0.00331 0.0352 0.44 1090938 
4 
tripartite motif-containing 29 300656 
0.003543 0.0366 0.44 1070163 
6 
NA NA 
0.004784 0.0415 0.44 1085607 
0 
NA NA 
0.006284 0.0476 0.44 1093918 
0 
NA NA 
0.00659 0.0484 0.44 1081383 
3 
NA NA 
0.00763 0.0518 0.44 1075120 
9 
NA NA 
0.007733 0.0523 0.44 1076436 
5 
NA NA 
0.008315 0.0545 0.44 1078854 
2 
NA NA 
0.008374 0.0546 0.44 1090919 
6 
olfactory receptor 1247 405093 
0.008778 0.0563 0.44 1076703 
9 
NA NA 
0.009278 0.0576 0.44 1090441 
4 
NA NA 
0.00136 0.0232 0.43 1082511 
1 
NA NA 
0.002135 0.0279 0.43 1088191 
7 
similar to KIAA0833 protein 362665 
0.004037 0.0388 0.43 1071569 
7 
deleted in primary ciliary dyskinesia 294004 
0.005027 0.0425 0.43 1088134 
1 
NA NA 
0.0059 0.0459 0.43 1078500 
5 
protein phosphatase 3, catalytic subunit, gamma isoform 171378 
0.006378 0.048 0.43 1091519 
0 
NA NA 
0.007511 0.0514 0.43 1075626 
8 
NA NA 
0.007511 0.0514 0.43 1075627 
0 
NA NA 
0.007511 0.0514 0.43 1075627 
2 
NA NA 






0.007511 0.0514 0.43 1075944 
5 
NA NA 
0.008004 0.0533 0.43 1091080 
5 
NA NA 
0.00918 0.0575 0.43 1091528 
7 
olfactory receptor 1155 300414 
0.009632 0.0583 0.43 1091886 
1 
similar to RIKEN cDNA 2900055D03 367117 
0.00079 0.0185 0.42 1077963 
6 
NA NA 
0.001034 0.021 0.42 1089628 
4 
regulating synaptic membrane exocytosis 2 116839 
0.001353 0.0232 0.42 1088379 
9 
NA NA 
0.002543 0.0304 0.42 1093411 
3 
NA NA 
0.002728 0.0315 0.42 1081187 
9 
cytochrome c oxidase subunit VIc-1 286962 
0.002985 0.0329 0.42 1078080 
1 
NA NA 
0.003404 0.0355 0.42 1081314 
6 
hypothetical protein LOC499530 499530 
0.00419 0.0393 0.42 1076603 
5 
NA NA 
0.004214 0.0393 0.42 1079855 
1 
olfactory receptor 1662 291361 
0.005048 0.0425 0.42 1088253 
2 
NA NA 
0.006568 0.0484 0.42 1076334 
2 
serpin peptidase inhibitor, clade B (ovalbumin), member 13 304690 
0.00079 0.0185 0.41 1086245 
7 
NA NA 
0.001247 0.0224 0.41 1070342 
4 
NA NA 
0.001566 0.0245 0.41 1086779 
5 
NA NA 
0.001906 0.0266 0.41 1093357 
4 
NA NA 
0.002088 0.0277 0.41 1088922 
3 
NA NA 
0.002418 0.0298 0.41 1074600 
0 
glycerophosphodiester phosphodiesterase domain containing 1 303407 
0.00371 0.0374 0.41 1075464 
2 
NA NA 
0.004246 0.0394 0.41 1084796 
3 
NA NA 
0.004378 0.0402 0.41 1082401 
0 
NA NA 
0.006247 0.0476 0.41 1086328 
5 
NA NA 
0.006847 0.0492 0.41 1071401 
7 
NA NA 
0.009221 0.0575 0.41 1086442 
5 
eukaryotic translation initiation factor 4E family member 3 297481 
0.009424 0.0581 0.41 1077675 
1 
NOL1/NOP2/Sun domain family, member 7 305339 
0.009588 0.0583 0.41 1070259 
2 
NA NA 




   8   
0.000561 0.0167 0.4 1088923 
2 
NA NA 
0.001071 0.0212 0.4 1080440 
2 
NA NA 
0.001144 0.0217 0.4 1087530 
9 
NA NA 
0.001231 0.0224 0.4 1080494 
7 
NA NA 
0.002865 0.0322 0.4 1077304 
7 
NA NA 
0.002934 0.0325 0.4 1090518 
8 
NA NA 
0.003268 0.0348 0.4 1077446 
6 
NA NA 
0.004181 0.0393 0.4 1088396 
9 
NA NA 
0.00483 0.0416 0.4 1078308 
0 
RNA component of mitochondrial RNA processing endoribonuclease 29536 
0.005764 0.0454 0.4 1080819 
4 
NA NA 
0.005881 0.0459 0.4 1080319 
4 
establishment of cohesion 1 homolog 1 (S. cerevisiae) 680014 
0.006236 0.0476 0.4 1072365 
6 
ankyrin repeat domain 42 293117 
0.006267 0.0476 0.4 1080985 
2 
NA NA 
0.006533 0.0484 0.4 1081302 
7 
NA NA 
0.006593 0.0484 0.4 1080032 
3 
NA NA 
0.006955 0.0495 0.4 1083232 
6 
NA NA 
0.008192 0.0541 0.4 1083641 
4 
NA NA 
0.008192 0.0541 0.4 1084562 
6 
NA NA 
0.008877 0.0565 0.4 1087979 
7 
NA NA 
0.009382 0.058 0.4 1083374 
4 
NA NA 
0.000489 0.0158 0.39 1093616 
1 
NA NA 
0.000662 0.0179 0.39 1082982 
8 
NA NA 
0.000701 0.018 0.39 1088686 
8 
NA NA 
0.000896 0.0194 0.39 1079692 
5 
NA NA 
0.000933 0.0197 0.39 1079998 
3 
NA NA 
0.001268 0.0225 0.39 1073447 
5 
NA NA 
0.001433 0.0236 0.39 1086714 
2 
NA NA 
0.001913 0.0267 0.39 1092300 
0 
KDEL (Lys-Asp-Glu-Leu) containing 1 316370 






0.002797 0.0318 0.39 1083382 
3 
sine oculis-binding protein homolog-like (Drosophila) 309860 
0.002811 0.0318 0.39 1090321 
2 
NA NA 
0.003938 0.0385 0.39 1093060 
6 
NA NA 
0.003939 0.0385 0.39 1090199 
9 
mitochondrial ribosomal protein L42 299743 
0.004022 0.0388 0.39 1082728 
9 
NA NA 
0.004322 0.0399 0.39 1079150 
9 
NA NA 
0.006768 0.049 0.39 1093233 
9 
NA NA 
0.009853 0.059 0.39 1093831 
9 
NA NA 
0.00041 0.0145 0.38 1072362 
3 
NA NA 
0.000523 0.0165 0.38 1074503 
9 
NA NA 
0.000699 0.018 0.38 1079349 
3 
NA NA 
0.000894 0.0194 0.38 1076901 
6 
Ral GEF with PH domain and SH3 binding motif 2 304887 
0.00107 0.0212 0.38 1088842 
2 
NA NA 
0.001135 0.0217 0.38 1079305 
2 
NA NA 
0.001174 0.0221 0.38 1081704 
0 
NA NA 
0.001238 0.0224 0.38 1081246 
4 
NA NA 
0.001542 0.0244 0.38 1087001 
0 
NA NA 
0.003297 0.0351 0.38 1085617 
5 
NA NA 
0.003508 0.0364 0.38 1082381 
9 
relaxin/insulin-like family peptide receptor 1 295144 
0.003848 0.0381 0.38 1094001 
3 
NA NA 
0.005541 0.0446 0.38 1088937 
0 
NA NA 
0.005781 0.0454 0.38 1079398 
8 
family with sequence similarity 193, member B 498703 
0.007144 0.0502 0.38 1082242 
0 
NA NA 
0.007263 0.0506 0.38 1083213 
7 
NA NA 
0.007486 0.0514 0.38 1081302 
9 
solute carrier family 38, member 9 310091 
0.000405 0.0144 0.37 1088688 
8 
NA NA 
0.001507 0.0242 0.37 1083917 
4 
NA NA 
0.002124 0.0279 0.37 1086961 
4 
NA NA 
0.002672 0.0313 0.37 1088740 
0 
NA NA 




   4   
0.005865 0.0459 0.37 1086496 
8 
NA NA 
0.007829 0.0526 0.37 1083598 
5 
NA NA 
0.008085 0.0538 0.37 1075318 
5 
crystallin, zeta (quinone reductase)-like 1 288256 
0.008321 0.0545 0.37 1085993 
5 
chaperonin containing TCP1, subunit 8 (theta)-like 1 499967 








0.000273 0.0118 0.36 1075325 
7 
phosphatidylinositol glycan anchor biosynthesis, class P 288238 
0.00045 0.0152 0.36 1092569 
2 
NA NA 
0.000726 0.0184 0.36 1083565 
2 
NA NA 
0.001106 0.0215 0.36 1071088 
6 
NA NA 
0.001127 0.0217 0.36 1073329 
8 
olfactory receptor 1406 405064 
0.001145 0.0217 0.36 1079034 
6 
NA NA 
0.001212 0.0222 0.36 1083996 
8 
NA NA 
0.001327 0.023 0.36 1071490 
3 
interferon-induced protein with tetratricopeptide repeats 3 309526 
0.001687 0.0253 0.36 1076130 
9 
NA NA 
0.001896 0.0266 0.36 1089358 
6 
mitochondrial ribosomal protein L54 299628 
0.001938 0.0268 0.36 1089789 
1 
NA NA 
0.002409 0.0298 0.36 1072323 
1 
NA NA 
0.002978 0.0329 0.36 1079846 
7 
NA NA 
0.004243 0.0394 0.36 1084594 
7 
serine/threonine kinase 39, STE20/SPS1 homolog (yeast) 54348 
0.004427 0.0402 0.36 1071434 
6 
NA NA 
0.004427 0.0402 0.36 1081385 
4 
NA NA 
0.004427 0.0402 0.36 1081580 
4 
NA NA 
0.004427 0.0402 0.36 1090566 
8 
NA NA 
0.004427 0.0402 0.36 1092128 
6 
NA NA 
0.004902 0.042 0.36 1076437 
6 
NA NA 
0.005295 0.0436 0.36 1092766 
8 
NA NA 
0.006054 0.0466 0.36 1077626 
2 
NA NA 






0.007878 0.0528 0.36 1087010 
8 
NA NA 
0.008205 0.0541 0.36 1085509 
0 
olfactory receptor 808 405140 
0.008982 0.0568 0.36 1093550 
6 
NA NA 
0.009077 0.0571 0.36 1090396 
5 
NA NA 
0.009616 0.0583 0.36 1088826 
9 
NA NA 
0.000215 0.01 0.35 1078259 
9 
similar to HT021 289928 
0.000288 0.0119 0.35 1072430 
7 
olfactory receptor 127 405911 
0.000549 0.0167 0.35 1079758 
4 
NA NA 
0.000686 0.018 0.35 1086510 
5 
ELKS/RAB6-interacting/CAST family member 1 266806 
0.000898 0.0194 0.35 1085827 
5 
NA NA 
0.001046 0.021 0.35 1091549 
2 
ferredoxin 1-like 313786 
0.00108 0.0213 0.35 1086084 
8 
microRNA mir-653 1E+08 
0.001919 0.0267 0.35 1078216 
6 
propionyl-coenzyme A carboxylase, alpha polypeptide 687008 
0.001931 0.0267 0.35 1083827 
8 
NA NA 
0.002146 0.028 0.35 1087620 
6 
NA NA 
0.002738 0.0316 0.35 1076703 
4 
NA NA 
0.00388 0.0382 0.35 1091258 
1 
anaphase promoting complex subunit 13 685029 
0.004668 0.0413 0.35 1091072 
2 
NA NA 
0.005367 0.0437 0.35 1077972 
4 
NA NA 







RAN binding protein 17 303029 
0.00086 0.0192 0.34 1084171 
8 
NA NA 
0.001181 0.0221 0.34 1089694 
1 
NA NA 
0.001383 0.0233 0.34 1080973 
0 
NA NA 
0.00167 0.0253 0.34 1076555 
7 
prefoldin subunit 2 685607 
0.002089 0.0277 0.34 1073330 
0 
olfactory receptor 1407 287262 
0.003157 0.0339 0.34 1074032 
5 
NA NA 
0.004004 0.0388 0.34 1088733 
6 
NA NA 
0.006444 0.0482 0.34 1072849 
4 
solute carrier family 22, member 25 192273 




   1   
0.006951 0.0495 0.34 1093884 
7 
NA NA 
0.007317 0.0509 0.34 1093922 
3 
NA NA 
0.000399 0.0143 0.33 1075721 
1 
COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis) 304343 
0.00059 0.0172 0.33 1080528 
5 
NA NA 
0.000678 0.018 0.33 1077279 
9 
NA NA 
0.000683 0.018 0.33 1073922 
3 
NA NA 
0.00107 0.0212 0.33 1084581 
4 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc- 
T3) 
366061 
0.001867 0.0265 0.33 1087873 
2 
NA NA 
0.002223 0.0285 0.33 1078839 
9 
myotubularin related protein 7 306490 
0.002354 0.0295 0.33 1080059 
2 
similar to AW554918 protein 498832 
0.003167 0.034 0.33 1077774 
4 
NA NA 
0.003613 0.037 0.33 1079854 
7 
NA NA 
0.004175 0.0393 0.33 1075291 
9 
glutamate receptor, ionotropic, kainate 1 29559 
0.004687 0.0413 0.33 1080350 
5 
similar to 4930429A08Rik protein 500551 
0.004772 0.0415 0.33 1070360 
3 
vomeronasal 2 receptor, 17 690716 
0.005731 0.0454 0.33 1081227 
0 
NA NA 
0.007025 0.0498 0.33 1092869 
8 
NA NA 
0.008659 0.056 0.33 1084042 
9 
similar to RIKEN cDNA 1700010M22 311491 
0.000395 0.0143 0.32 1092938 
1 
NA NA 
0.000419 0.0146 0.32 1090118 
2 
olfactory receptor 1096 302027 
0.000526 0.0165 0.32 1079953 
2 
UPF2 regulator of nonsense transcripts homolog (yeast) 361271 
0.000732 0.0184 0.32 1093816 
9 
NA NA 
0.000733 0.0184 0.32 1073913 
5 
proteasome (prosome, macropain) 26S subunit, ATPase, 5 81827 
0.000753 0.0184 0.32 1079592 
1 
NA NA 
0.00093 0.0197 0.32 1072831 
2 
FK506 binding protein 2 293702 
0.002378 0.0297 0.32 1071121 
9 
syntaxin 4 81803 
0.002788 0.0318 0.32 1077141 
2 
lin-54 homolog (C. elegans) 305171 
0.003328 0.0352 0.32 1093392 
2 
NA NA 
0.003834 0.0381 0.32 1074081 
0 




0.004423 0.0402 0.32 1075065 
1 
olfactory receptor 1561 288186 
0.00563 0.0449 0.32 1077189 
1 
NA NA 
0.007103 0.05 0.32 1093057 
6 
NA NA 
0.007108 0.05 0.32 1079304 
6 
NA NA 
0.007565 0.0516 0.32 1070940 
5 






0.000661 0.0179 0.31 1086027 
2 
membrane associated guanylate kinase, WW and PDZ domain containing 2 113970 
0.000766 0.0184 0.31 1092605 
4 
NA NA 
0.000906 0.0195 0.31 1076431 
4 
mitochondrial ribosomal protein L42 299743 
0.001045 0.021 0.31 1093040 
9 
NA NA 
0.001143 0.0217 0.31 1081467 
8 
NA NA 
0.001312 0.0228 0.31 1070220 
1 
A kinase (PRKA) anchor protein 7 361458 
0.001396 0.0233 0.31 1090117 
6 
NA NA 
0.001397 0.0233 0.31 1076707 
5 
NA NA 
0.001487 0.024 0.31 1075589 
0 
similar to RIKEN cDNA 2310008H04 498119 
0.001761 0.0258 0.31 1087787 
6 
NA NA 
0.001784 0.0259 0.31 1073768 
0 
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) 287645 
0.00181 0.026 0.31 1072241 
9 
NA NA 
0.00245 0.03 0.31 1086069 
1 
KRIT1, ankyrin repeat containing 362317 
0.002513 0.0304 0.31 1076004 
7 
NA NA 
0.00276 0.0316 0.31 1074219 
2 
NA NA 
0.005523 0.0445 0.31 1084570 
8 
interferon induced with helicase C domain 1 499801 
0.009765 0.059 0.31 1080856 
3 
cadherin 15 361432 
0.000842 0.0191 0.3 1092576 
1 
fer (fms/fps related) protein kinase, testis specific 2 301737 
0.00094 0.0198 0.3 1087508 
7 
NA NA 
0.00113 0.0217 0.3 1085887 
1 
sodium channel, nonvoltage-gated 1 alpha 25122 
0.003067 0.0334 0.3 1088687 
4 
NA NA 
0.003388 0.0355 0.3 1079453 
4 
ataxin 1 25049 
0.003587 0.0369 0.3 1077763 
9 
G protein-coupled receptor kinase 4 59077 




   6   
0.005147 0.0429 0.3 1089480 
8 
NA NA 
0.000894 0.0194 0.29 1092129 
0 
TBC1 domain family, member 5 501088 
0.000989 0.0205 0.29 1088207 
1 
similar to RIKEN cDNA 2810405K02 362676 
0.003718 0.0374 0.29 1080302 
5 
F-box protein 15 361354 
0.006846 0.0492 0.29 1077614 
4 
odontogenic, ameloblast asssociated 641555 
0.008713 0.0562 0.29 1070735 
2 
NA NA 
0.009317 0.0577 0.29 1077216 
0 
NA NA 
0.000335 0.013 0.28 1087509 
1 
NA NA 
0.000394 0.0143 0.28 1079131 
8 
transmembrane protein 192 361137 
0.00046 0.0153 0.28 1079146 
1 
similar to 2700029M09Rik protein 290706 
0.000634 0.0177 0.28 1076076 
2 
NA NA 
0.001109 0.0215 0.28 1089502 
4 
NA NA 
0.001193 0.0221 0.28 1090012 
2 
NA NA 
0.001571 0.0245 0.28 1088689 
4 
NA NA 
0.001594 0.0247 0.28 1070356 
8 
NA NA 
0.001684 0.0253 0.28 1086620 
5 
NA NA 
0.001689 0.0253 0.28 1081515 
0 
La ribonucleoprotein domain family, member 1B 310348 
0.001872 0.0265 0.28 1074183 
1 
NA NA 
0.003936 0.0385 0.28 1087565 
6 
NA NA 
0.004078 0.039 0.28 1072248 
3 
NA NA 
0.004789 0.0415 0.28 1087112 
7 
MOB1, Mps One Binder kinase activator-like 2C (yeast) 313511 
0.005223 0.0433 0.28 1070164 
8 
vomeronasal 2 receptor, 5 679691 
0.006897 0.0494 0.28 1076829 
4 
NA NA 
0.006939 0.0495 0.28 1082195 
5 
NA NA 
0.008355 0.0545 0.28 1075513 
5 











0.000285 0.0119 0.27 1087548 
3 
epithelial splicing regulatory protein 1 500409 






0.000749 0.0184 0.27 1073059 
1 
ADP-ribosylation factor-like 3 64664 
0.000795 0.0185 0.27 1090008 
5 
olfactory receptor 1059 288831 
0.00081 0.0186 0.27 1077489 
2 
NA NA 
0.001074 0.0212 0.27 1093759 
9 
NA NA 
0.00185 0.0265 0.27 1087996 
9 
similar to 4930429A08Rik protein 500551 
0.001874 0.0265 0.27 1079617 
0 
NA NA 
0.003691 0.0374 0.27 1070975 
9 
NA NA 
0.003869 0.0382 0.27 1077019 
7 
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 29414 
0.00396 0.0386 0.27 1081868 
4 
NA NA 
0.00653 0.0484 0.27 1071463 
2 
NA NA 
0.000778 0.0185 0.26 1077585 
7 
NA NA 
0.001582 0.0245 0.26 1073986 
4 
NA NA 
0.001776 0.0258 0.26 1085433 
8 
muskelin 1, intracellular mediator containing kelch motifs 83536 
0.002466 0.03 0.26 1088038 
1 
eyes absent homolog 3 (Drosophila) 313027 
0.002618 0.0309 0.26 1080788 
1 
NA NA 
0.004286 0.0397 0.26 1088685 
8 
NA NA 
0.005335 0.0437 0.26 1087831 
4 
NA NA 
0.006614 0.0484 0.26 1080382 
4 
cell division cycle 25 homolog C (S. pombe) 307511 
0.008862 0.0565 0.26 1072426 
0 
olfactory receptor 92 293233 
0.000398 0.0143 0.25 1079534 
6 
glutathione peroxidase 5 113919 
0.001608 0.0248 0.25 1086966 
4 
NA NA 
0.001703 0.0254 0.25 1072962 
9 
NA NA 
0.004217 0.0393 0.25 1071487 
9 
NA NA 
0.004384 0.0402 0.25 1072507 
8 
pleckstrin homology domain containing, family A member 7 499249 
0.007482 0.0514 0.25 1079989 
6 
NA NA 












Rh-associated glycoprotein 65207 
0.003407 0.0355 0.24 1084314 
2 
GTPase activating protein testicular GAP1 294892 




   7   
0.004068 0.0389 0.24 1090861 
7 
NA NA 
0.004693 0.0413 0.24 1088700 
8 
NA NA 
0.009161 0.0574 0.24 1079254 
7 
defensin NP-4 precursor 286958 
0.000242 0.0111 0.23 1077847 
2 
zona pellucida binding protein 498415 
0.000646 0.0178 0.23 1087508 
9 
NA NA 
0.000788 0.0185 0.23 1083566 
6 
mitogen-activated protein kinase associated protein 1 296648 
0.001544 0.0244 0.23 1088686 
2 
NA NA 
0.002745 0.0316 0.23 1079152 
0 
NA NA 
0.002761 0.0316 0.23 1083404 
6 
NA NA 
0.003845 0.0381 0.23 1082766 
9 
olfactory receptor 1749 294203 
0.004115 0.0391 0.23 1081577 
8 
similar to Restin 361953 
0.006298 0.0476 0.23 1092202 
7 
cysteine-rich secretory protein 2 360445 













0.000286 0.0119 0.22 1079984 
8 
NA NA 
0.001538 0.0244 0.22 1085348 
1 
ankyrin repeat and IBR domain containing 1 368062 
0.001985 0.0273 0.22 1088932 
8 
NA NA 
0.002591 0.0307 0.22 1088689 
6 
NA NA 
0.00276 0.0316 0.22 1080257 
4 
NA NA 
0.002804 0.0318 0.22 1076200 
9 
anaphase promoting complex subunit 7 304490 
0.005746 0.0454 0.22 1076002 
4 





tetratricopeptide repeat domain 3 360702 
0.000496 0.0159 0.21 1090814 
5 
NA NA 
0.001572 0.0245 0.21 1080032 
8 
NA NA 
0.003348 0.0353 0.21 1077732 
8 



















0.000879 0.0194 0.2 1093684 
7 
NA NA 
0.001034 0.021 0.2 1076738 
0 
NA NA 
0.001127 0.0217 0.2 1075633 
4 
NA NA 
0.001454 0.0237 0.2 1075030 
8 
NA NA 
0.001687 0.0253 0.2 1088686 
6 
NA NA 
0.001873 0.0265 0.2 1085263 
6 
sulfide quinone reductase-like (yeast) 691966 
0.004522 0.0407 0.2 1085976 
2 
NA NA 
0.004797 0.0415 0.2 1074292 
7 











0.000373 0.014 0.19 1085044 
0 
NA NA 
0.001453 0.0237 0.19 1093979 
5 
NA NA 
0.004483 0.0405 0.19 1084468 
1 





arginine-glutamic acid dipeptide (RE) repeats 116665 
0.000253 0.0114 0.18 1093055 
5 
NA NA 
0.001506 0.0242 0.18 1091907 
4 
NA NA 
0.001686 0.0253 0.18 1075653 
0 
NA NA 
0.002057 0.0275 0.18 1071067 
4 
NA NA 
0.002558 0.0305 0.18 1093397 
4 
NA NA 
0.002988 0.0329 0.18 1083624 
1 
NA NA 
0.007145 0.0502 0.18 1075651 
9 
NA NA 
0.000446 0.0152 0.17 1089481 
4 
NA NA 
0.001203 0.0222 0.17 1083853 
8 
NA NA 
0.004341 0.04 0.17 1077482 
5 
similar to hypothetical protein FLJ40298 498431 
0.009157 0.0574 0.17 1083064 
0 
NA NA 
0.000253 0.0114 0.16 1089481 
2 
NA NA 
0.001056 0.0212 0.16 1088701 
0 
NA NA 












   8   








0.002182 0.0283 0.11 1091179 
7 
glutathione S-transferase alpha 4 300850 



















APPENDIX B: TRANSCRIPTS DIFFERENTIALLY 







ProbeSet Name EntrezID 
0.001923 0.197 46.41 10828154 heat shock 70kD protein 1B (mapped) 294254 
0.001064 0.197 43.13 10770710 activating transcription factor 3 25389 
0.000316 0.173 38.24 10761128 heat shock protein 1 24471 
0.003758 0.211 28.93 10764551 prostaglandin-endoperoxide synthase 2 29527 
0.001802 0.197 19.34 10785461 protocadherin 8 64865 
0.001452 0.197 18.84 10831298 heat shock 70kD protein 1B (mapped) 294254 
0.004214 0.212 17.54 10757082 zinc finger, AN1-type domain 2A 360772 
0.003745 0.211 17.06 10806122 heme oxygenase (decycling) 1 24451 
0.007367 0.234 16.89 10828827 cyclin-dependent kinase inhibitor 1A 114851 
0.0096 0.243 16.69 10909892 crystallin, alpha B 25420 
0.001245 0.197 15.88 10756343 heat shock 105kDa/110kDa protein 1 288444 
0.002119 0.197 15.41 10797566 NA NA 
0.003376 0.202 14.25 10798702 inhibin beta-A 29200 
0.002923 0.199 12.66 10711401 Bcl2-associated athanogene 3 293524 
0.00119 0.197 11.22 10810295 DnaJ (Hsp40) homolog, subfamily B, member 1 361384 
0.000675 0.185 11 10758344 vacuolar protein sorting 37 homolog B (S. cerevisiae) 288659 
0.000981 0.197 10.44 10857314 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 29464 
0.007906 0.238 10.19 10768332 regulator of G-protein signaling 2 84583 
0.000235 0.15 9.05 10767001 methionine adenosyltransferase II, alpha 171347 
0.002147 0.197 9.04 10928154 heat shock protein 1 (chaperonin) 63868 
0.007808 0.238 8.6 10925291 chemokine (C-X-C motif) receptor 7 84348 
0.007796 0.238 8.44 10711053 NA NA 
0.009041 0.241 8.02 10803947 heparin-binding EGF-like growth factor 25433 
0.008613 0.241 7.94 10837279 integrin, alpha V 296456 
0.004553 0.212 7.86 10842500 similar to Docking protein 5 (Downstream of tyrosine kinase 5) (Protein dok-5) 502694 
0.005689 0.213 7.83 10799291 Kruppel-like factor 6 58954 
0.002146 0.197 7.76 10901367 NA NA 
0.003304 0.202 7.63 10802734 SMAD family member 7 81516 
0.006426 0.221 7.6 10906608 solute carrier family 38, member 2 29642 
0.005114 0.212 7.54 10890354 cyclin-dependent kinase-like 1 (CDC2-related kinase) 314198 
0.004777 0.212 7.49 10834022 arrestin domain containing 3 309945 
0.006866 0.221 7.42 10845725 potassium voltage-gated channel, subfamily H (eag-related), member 7 170739 
0.00574 0.213 7.2 10903210 NA NA 




0.009195 0.241 6.89 10860900 pyruvate dehydrogenase kinase, isozyme 4 89813 
0.00123 0.197 6.85 10931308 prolyl 4-hydroxylase, alpha polypeptide I 64475 
0.00057 0.177 6.77 10855701 aquaporin 1 25240 
0.000535 0.177 6.76 10708672 prolylcarboxypeptidase (angiotensinase C) 293118 
0.005812 0.214 6.71 10869772 NA NA 
0.001372 0.197 6.7 10863221 methionine adenosyltransferase II, alpha 171347 
0.000792 0.197 6.64 10785773 sprouty homolog 2 (Drosophila) 306141 
0.000358 0.177 6.62 10787005 NA NA 
0.003777 0.211 6.6 10865349 solute carrier family 2 (facilitated glucose transporter), member 3 25551 
0.000202 0.148 6.48 10862461 NA NA 
0.002298 0.197 6.43 10847761 Cd44 molecule 25406 
0.002167 0.197 6.39 10806981 SMAD family member 1 25671 
0.002964 0.199 6.3 10936753 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked 317335 
0.006058 0.215 6.27 10874866 nucleolar complex associated 2 homolog (S. cerevisiae) 313777 
0.005408 0.212 6.24 10880095 serine incorporator 2 313057 
0.00216 0.197 6.13 10827686 RT1 class I, locus M6, gene 1 414785 
0.006813 0.221 6.11 10772580 NA NA 
0.005599 0.212 6.08 10836394 membrane-associated ring finger (C3HC4) 7 311059 
0.008056 0.239 6.04 10821900 DnaJ (Hsp40) homolog, subfamily C, member 21 192210 
0.001789 0.197 5.84 10845095 origin recognition complex, subunit 4-like (yeast) 295596 
0.00645 0.221 5.83 10935131 ring finger protein 128 315911 
0.009705 0.244 5.83 10742464 zinc finger protein 2 497897 
0.000454 0.177 5.73 10749983 coxsackie virus and adenovirus receptor 89843 
0.002841 0.199 5.67 10772330 NA NA 
0.007999 0.238 5.65 10928229 CDC-like kinase 1 301434 
0.003723 0.211 5.61 10922962 NA NA 
0.00325 0.202 5.59 10713102 mitogen-activated protein kinase kinase kinase 11 309168 
0.003883 0.211 5.56 10853202 putative homeodomain transcription factor 2 296762 
0.002112 0.197 5.54 10867163 recombination signal binding protein for immunoglobulin kappa J region 679028 
0.006698 0.221 5.52 10884205 TWIST neighbor 362728 
0.009411 0.243 5.48 10799158 DIP2 disco-interacting protein 2 homolog C (Drosophila) 307067 
1.05E-05 0.0414 5.45 10933345 toll-like receptor 7 317468 
0.00498 0.212 5.43 10868289 DnaJ (Hsp40) homolog, subfamily A, member 1 65028 
0.002099 0.197 5.37 10809328 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 85430 
0.00118 0.197 5.24 10752754 nuclear receptor interacting protein 1 304157 
0.006869 0.221 5.1 10864481 contactin 3 (plasmacytoma associated) 54279 
0.004942 0.212 5.08 10854446 caldesmon 1 25687 
0.005529 0.212 5.05 10927055 family with sequence similarity 135, member A 367235 
0.00166 0.197 4.95 10776667 NA NA 
0.001137 0.197 4.94 10924230 NA NA 




0.000251 0.15 4.85 10796507 solute carrier family 39 (zinc transporter), member 12 291328 
0.004938 0.212 4.8 10729999 nucleolar complex associated 3 homolog (S. cerevisiae) 361753 
0.007583 0.234 4.79 10721232 interferon stimulated exonuclease gene 20-like 2 361977 
0.003831 0.211 4.78 10871133 MAP kinase-interacting serine/threonine kinase 1 500526 
0.00865 0.241 4.78 10810951 NA NA 
0.007569 0.234 4.73 10702792 claudin 20 680178 
0.003756 0.211 4.68 10924076 ribulose-5-phosphate-3-epimerase 501157 
0.002779 0.199 4.56 10895152 KIT ligand 60427 
0.000476 0.177 4.54 10701717 katanin p60 (ATPase-containing) subunit A1 292464 
0.004681 0.212 4.54 10701663 similar to hypothetical protein 292449 
0.001584 0.197 4.51 10730884 survival motor neuron domain containing 1 287768 
0.000554 0.177 4.48 10789709 NA NA 
0.009907 0.247 4.48 10880404 platelet-activating factor receptor 58949 
0.004091 0.212 4.47 10867731 calbindin 1 83839 
0.005509 0.212 4.47 10872867 NA NA 
0.006653 0.221 4.43 10739204 survival motor neuron domain containing 1 287768 
0.002266 0.197 4.4 10862473 NA NA 
0.002847 0.199 4.35 10732113 NA NA 
0.00084 0.197 4.3 10805100 similar to chromosome 18 open reading frame 54 361346 
0.003715 0.211 4.29 10931717 complement component 3 24232 
0.000078 0.0855 4.26 10884853 PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae) 314171 
0.007931 0.238 4.26 10844801 zinc finger and BTB domain containing 6 366029 
0.001537 0.197 4.21 10875939 zinc finger protein 292 50552 
0.003356 0.202 4.17 10787212 myosin IXb 25486 
0.007579 0.234 4.17 10938101 protein kinase, X-linked 501563 
0.00912 0.241 4.17 10872291 tyrosyl-tRNA synthetase 313047 
0.002103 0.197 4.11 10875936 zinc finger protein 292 50552 
0.002328 0.197 4.09 10763913 retinoblastoma binding protein 5 304794 
0.001405 0.197 4.07 10903482 solute carrier family 25, member 32 315023 
0.001143 0.197 4.06 10781197 stathmin-like 4 79423 
0.003168 0.201 4.06 10864874 Ras association (RalGDS/AF-6) domain family member 4 362423 
0.008933 0.241 4.06 10733321 CDC like kinase 4 287269 
0.007991 0.238 4.01 10935229 NA NA 
0.002398 0.197 3.99 10832478 pre-B lymphocyte 3 365550 
0.003175 0.201 3.99 10854558 tripartite motif-containing 24 500084 
0.00701 0.225 3.97 10890626 glycoprotein hormone beta 5 366668 
0.001371 0.197 3.95 10751769 NA NA 
0.004692 0.212 3.95 10899964 methyltransferase like 7B 366792 
0.002268 0.197 3.91 10884921 hypothetical protein LOC502894 502894 
0.004128 0.212 3.91 10712340 CD151 molecule (Raph blood group) 64315 




0.009065 0.241 3.87 10752771 protease, serine, 7 (enterokinase) 288291 
6.54E-05 0.0855 3.78 10772795 NA NA 
0.005039 0.212 3.76 10934631 lysophosphatidic acid receptor 4 302378 
0.004954 0.212 3.74 10811531 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 50719 
0.001208 0.197 3.73 10703508 NA NA 
0.002793 0.199 3.71 10774274 epidermal growth factor receptor 24329 
0.005124 0.212 3.66 10844033 general transcription factor IIIC, polypeptide 5 362095 
0.008903 0.241 3.66 10833337 golgi associated PDZ and coiled-coil motif containing 309774 
0.009227 0.241 3.66 10886928 NA NA 
0.009227 0.241 3.66 10886960 NA NA 
0.000647 0.185 3.64 10778834 NA NA 
0.002373 0.197 3.61 10923345 heat shock protein 1 (chaperonin 10) 25462 
0.006794 0.221 3.61 10918848 solute carrier family 17 (anion/sugar transporter), member 5 363103 
0.000436 0.177 3.6 10907913 matrix metallopeptidase 8 63849 
0.002017 0.197 3.59 10762115 N(alpha)-acetyltransferase 25, NatB auxiliary subunit 360811 
0.009542 0.243 3.59 10827989 metallothionein 2A 689415 
0.001701 0.197 3.57 10824051 dual endothelin 1, angiotensin II receptor 446170 
3.91E-05 0.0855 3.55 10840396 Sec23 homolog B (S. cerevisiae) 362226 
0.00409 0.212 3.44 10877431 haloacid dehalogenase-like hydrolase domain containing 3 688746 
0.006029 0.215 3.43 10822099 sertolin 64038 
0.009166 0.241 3.41 10934794 interferon stimulated exonuclease gene 20-like 2 361977 
0.009219 0.241 3.41 10746014 NA NA 
0.004603 0.212 3.37 10767763 proline/arginine-rich end leucine-rich repeat protein 84400 
0.008401 0.241 3.37 10903736 ectonucleotide pyrophosphatase/phosphodiesterase 2 84050 
0.002121 0.197 3.31 10727493 NA NA 
0.00598 0.215 3.28 10765335 cellular repressor of E1A-stimulated genes 1 289185 
0.002362 0.197 3.24 10883785 ornithine decarboxylase 1 24609 
0.003032 0.199 3.22 10901783 apoptotic peptidase activating factor 1 78963 
7.43E-05 0.0855 3.21 10856673 solute carrier family 4, sodium bicarbonate cotransporter, member 5 297386 
0.002621 0.199 3.21 10705485 fibrillarin 292747 
0.005184 0.212 3.15 10827531 splicing factor, arginine/serine-rich 11 502603 
0.000168 0.138 3.14 10886280 spermatogenesis associated 7 192225 
0.003544 0.208 3.09 10820213 NA NA 
0.008239 0.241 3.08 10886868 NA NA 
0.0086 0.241 3.06 10889657 NA NA 
0.001 0.197 3.03 10811875 TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor 307927 
0.004773 0.212 2.99 10757175 cytochrome P450, family 3, subfamily a, polypeptide 9 171352 
0.007494 0.234 2.99 10762704 splicing factor, arginine/serine-rich 9 288701 
0.007241 0.231 2.95 10885417 NA NA 
0.002891 0.199 2.92 10763477 Mki67 (FHA domain) interacting nucleolar phosphoprotein 246042 




0.006437 0.221 2.9 10833366 NA NA 
0.006865 0.221 2.87 10885006 thioredoxin-related transmembrane protein 1 362751 
0.00109 0.197 2.86 10727373 NA NA 
0.004217 0.212 2.84 10789246 NA NA 
0.001522 0.197 2.81 10818687 NA NA 
0.005184 0.212 2.8 10736914 NA NA 
0.009134 0.241 2.8 10747564 family with sequence similarity 134, member C 360632 
0.008617 0.241 2.74 10788374 mitochondrial tumor suppressor 1 306487 
0.005375 0.212 2.73 10839579 dual specificity phosphatase 2 311406 
0.001907 0.197 2.67 10763685 NA NA 
0.002194 0.197 2.65 10890210 MAM domain containing glycosylphosphatidylinositol anchor 2 314180 
0.006677 0.221 2.59 10859774 NA NA 
0.003331 0.202 2.58 10934118 androgen receptor 24208 
0.009515 0.243 2.57 10713089 v-rel reticuloendotheliosis viral oncogene homolog A (avian) 309165 
0.005511 0.212 2.55 10897203 NA NA 
0.002463 0.199 2.54 10798471 TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor 307927 
0.002768 0.199 2.48 10909646 FXYD domain-containing ion transport regulator 2 29639 
0.003884 0.211 2.45 10937688 NA NA 
0.006289 0.221 2.4 10766565 similar to probable ATP-dependent RNA helicase - mouse 364073 
0.000847 0.197 2.38 10826137 family with sequence similarity 102, member B 365903 
0.00543 0.212 2.34 10937558 TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) 317418 
0.006825 0.221 2.34 10853916 NA NA 
0.003177 0.201 2.31 10794721 signal sequence receptor, alpha 361233 
0.003989 0.212 2.31 10917361 hypothetical protein LOC100125362 1E+08 
0.000938 0.197 2.26 10739558 solute carrier family 16, member 5 (monocarboxylic acid transporter 6) 690212 
0.009148 0.241 2.2 10770252 transcription factor B2, mitochondrial 289307 
0.004338 0.212 2.15 10889522 dihydrolipoamide dehydrogenase 298942 
0.002859 0.199 2.13 10802579 mex-3 homolog C (C. elegans) 307271 
0.003938 0.211 2.11 10824091 doublecortin-like kinase 2 310698 
0.004174 0.212 0.47 10837528 olfactory receptor 566 404867 
0.005454 0.212 0.45 10918485 NA NA 
0.001171 0.197 0.43 10915988 NA NA 
0.003008 0.199 0.41 10908175 olfactory receptor 1148 405173 
0.005869 0.214 0.41 10710886 NA NA 
0.005969 0.215 0.41 10859838 NA NA 
0.007391 0.234 0.41 10846948 olfactory receptor 480 404890 
0.004592 0.212 0.4 10805285 NA NA 
0.005541 0.212 0.4 10756225 NA NA 
0.005613 0.212 0.4 10716498 NA NA 
0.005159 0.212 0.39 10909105 olfactory receptor 1197 406021 




0.002221 0.197 0.38 10836352 NA NA 
0.000494 0.177 0.37 10708466 NA NA 
0.002389 0.197 0.37 10853137 F-box and leucine-rich repeat protein 13 1E+08 
0.002555 0.199 0.37 10866120 immunoreceptor Ly49si1 494206 
0.007982 0.238 0.37 10932617 NA NA 
0.00467 0.212 0.36 10871038 NA NA 
0.006763 0.221 0.35 10939186 NA NA 
0.0084 0.241 0.34 10779766 NA NA 
0.003208 0.201 0.33 10856168 NA NA 
0.008892 0.241 0.33 10894810 NA NA 
0.008945 0.241 0.33 10791964 NA NA 
0.004723 0.212 0.32 10763351 serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 11 304689 
0.005441 0.212 0.32 10742866 NA NA 
0.000591 0.177 0.31 10775134 NA NA 
0.004816 0.212 0.31 10901713 NA NA 
0.006715 0.221 0.31 10889328 NA NA 
0.009367 0.243 0.31 10798284 Prolactin family 3, subfamily b, member 1 24283 
0.002696 0.199 0.3 10721315 tonin 24841 
0.003073 0.2 0.3 10860226 leucine rich repeat containing 17 502715 
0.005556 0.212 0.3 10933559 protein phosphatase, EF-hand calcium binding domain 1 317498 
0.00752 0.234 0.3 10836065 NA NA 
0.009138 0.241 0.3 10722483 NA NA 
0.009353 0.243 0.3 10756749 zinc finger protein 316 304293 
0.001484 0.197 0.29 10909196 olfactory receptor 1247 405093 
0.00811 0.239 0.29 10839970 NA NA 
0.00949 0.243 0.29 10927264 NA NA 
0.00518 0.212 0.28 10714610 NA NA 
0.009929 0.247 0.28 10939202 NA NA 
0.001637 0.197 0.27 10710089 phosphodiesterase 3B, cGMP-inhibited 29516 
0.001949 0.197 0.27 10752253 NA NA 
0.004765 0.212 0.27 10862947 NA NA 
0.005437 0.212 0.27 10813253 complement component 6 24237 
0.009573 0.243 0.27 10834600 NA NA 
0.009993 0.248 0.27 10847229 olfactory receptor 720 405955 
0.004335 0.212 0.25 10814176 NA NA 
0.008403 0.241 0.25 10765169 NA NA 
0.005076 0.212 0.24 10750655 olfactory receptor 1563 288184 
0.006799 0.221 0.24 10771206 hypothetical protein LOC100188984 1E+08 
0.006799 0.221 0.23 10920741 NA NA 
0.002365 0.197 0.22 10781525 NA NA 




0.009026 0.241 0.21 10873885 NA NA 
0.001304 0.197 0.2 10732439 guanine nucleotide binding protein (G protein), gamma 13 685451 
0.001262 0.197 0.19 10724047 NA NA 
0.005518 0.212 0.19 10932269 NA NA 
0.008487 0.241 0.18 10760760 similar to Leukosialin precursor (Leucocyte sialoglycoprotein) (Sialophorin) (CD43) (W3/13 
antigen) 
288521 
0.002766 0.199 0.17 10704376 NA NA 
0.003945 0.211 0.16 10900041 NA NA 
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motile sperm domain containing 1 317312 
































































































































































































































































































































































































































































































































heat shock 70kD protein 1B (mapped) 294254 
0.000255 0.011 4.7 1086828 
9 
DnaJ (Hsp40) homolog, subfamily A, member 1 65028 
0.000257 0.011 6.27 1093231 
0 
NA NA 




























































































splicing factor, arginine/serine-rich 18 297942 












































































































































































































































































































ADP-ribosylation-like factor 6 interacting protein 5 66028 
0.000492 0.014 3.99 1084682 
1 
thioredoxin-related transmembrane protein 2 295701 




   8   
0.000498 0.014 0.15 1078114 
6 
PDZ binding kinase 290326 
0.0005 0.014 4.16 1072668 
7 
NA NA 
0.000502 0.014 6.68 1092615 
3 
NA NA 
0.000502 0.014 5.7 1086250 
5 
similar to RIKEN cDNA 4921507P07 500124 
0.000504 0.014 6.88 1086953 
3 
NA NA 
0.000504 0.014 0.18 1088962 
2 
NA NA 
0.00051 0.014 9.42 1070293 
6 
Wilms tumor 1 associated protein 499020 
0.000513 0.014 4.58 1083005 
0 
SAR1 homolog A (S. cerevisiae) 361842 
0.000514 0.014 5.14 1084849 
9 
coiled-coil domain containing 32 296081 
0.000514 0.014 6.85 1084776 
1 
Cd44 molecule 25406 
0.000517 0.014 0.2 1093226 
9 
NA NA 
0.00052 0.014 4.12 1092407 
6 
ribulose-5-phosphate-3-epimerase 501157 
0.000521 0.014 4.04 1075501 
3 















































































































































































































































































































































0.000753 0.016 0.19 1084066 
3 
NA NA 






























































































































































































DnaJ (Hsp40) homolog, subfamily B, member 5 313811 













































































































































































































































































aldehyde dehydrogenase family 1, subfamily A7 29651 
0.001097 0.018 0.23 1072243 
5 
NA NA 






















calcium/calmodulin-dependent protein kinase II alpha 25400 











































































































































































































































































zinc finger protein 509 305428 
0.001403 0.02 4.41 1081679 
1 
SHC (Src homology 2 domain containing) transforming protein 1 85385 
0.001405 0.02 5.37 1082916 
3 
NA NA 
0.001406 0.02 3.64 1084106 
6 
microtubule-associated protein, RP/EB family, member 1 114764 












mitochondrial tumor suppressor 1 306487 






























































































































































































































































































trafficking protein particle complex 3 362599 
0.001673 0.021 3.21 1081409 
8 










vomeronasal 2 receptor, 70 364086 


























































































































































































































0.001917 0.022 5.23 1088429 
2 
transmembrane protein 195 362732 
0.00192 0.022 5.4 1087904 
7 
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 298451 
0.001925 0.022 6.27 1088378 
5 
ornithine decarboxylase 1 24609 
0.001929 0.022 3.71 1089815 
8 
NA NA 
0.001929 0.022 3.71 1091075 
2 
NA NA 
0.00193 0.022 0.32 1071279 
1 
phosphatidylinositol transfer protein, membrane-associated 1 361694 
0.001936 0.022 4.54 1076706 
7 
NA NA 
0.001937 0.022 3.63 1088129 
3 
podoplanin 54320 
0.001942 0.022 0.31 1071944 
5 
NA NA 
0.001943 0.022 0.2 1089704 
8 
NA NA 
0.001943 0.022 4.4 1088239 
7 
NA NA 
0.001944 0.022 0.19 1079254 
7 






























































































































































































































































































































protein tyrosine phosphatase type IVA, member 3 362930 















































































coenzyme Q5 homolog, methyltransferase (S. cerevisiae) 304542 
0.002315 0.023 0.25 1087001 
2 
NA NA 
0.002316 0.023 0.21 1078227 
1 
















































































































































































































similar to Robo-1 691277 









































































































































































































































































































olfactory receptor 707 405953 



























































chromobox homolog 3-like 1E+08 
0.002936 0.025 4.72 1090348 
2 
































































































































































0.003183 0.026 6.38 1082753 
1 











































































RWD domain containing 4A 502084 











































































































































































































































































































D4, zinc and double PHD fingers family 2 361711 


































glycoprotein (transmembrane) nmb 113955 
0.003772 0.028 0.31 1083709 
7 
NA NA 
0.003774 0.028 0.33 1070420 
0 
vomeronasal 1 receptor 51 494281 
0.003778 0.028 3.43 1077519 
3 
epoxide hydrolase 4 289440 
0.003791 0.028 3.17 1091759 
7 










































































































































theobromine induced protein 689604 
0.004041 0.029 0.28 1090614 
2 
mitogen-activated protein kinase 12 60352 
0.004058 0.029 2.81 1090989 
2 



































































































VGF nerve growth factor inducible 29461 


































































































































































transmembrane protein 88B 680723 
0.004432 0.03 3.05 1084576 
7 
Cobl-like 1 311088 
0.004445 0.03 3.04 1070712 
1 
general transcription factor IIH, polypeptide 1 361580 
0.004452 0.03 0.21 1091401 
9 
NA NA 
0.004459 0.03 0.24 1091633 
8 
olfactory receptor 1294 367064 
0.004469 0.03 0.21 1070624 
0 
NA NA 
0.004474 0.03 3.46 1082238 
6 
protein kinase (cAMP-dependent, catalytic) inhibitor alpha 114906 
0.004474 0.03 4.65 1077666 
7 
NA NA 
0.004488 0.03 0.16 1075577 
5 
NA NA 
0.00449 0.03 2.98 1079738 
8 
NA NA 
0.004506 0.03 6.06 1075742 
0 
hypothetical protein LOC684993 684993 
0.004509 0.03 4.21 1090810 
0 
NA NA 
0.00451 0.03 5.3 1075834 
4 
vacuolar protein sorting 37 homolog B (S. cerevisiae) 288659 
0.004519 0.03 5.06 1075717 
5 
cytochrome P450, family 3, subfamily a, polypeptide 9 171352 
0.004533 0.03 0.27 1089652 
4 
NA NA 
0.004534 0.03 3.44 1074141 
6 
tryptase alpha/beta 1 54271 


















































0.004535 0.03 5.87 1086931 
0 
solute carrier family 31 (copper transporters), member 1 171135 
0.004544 0.03 2.56 1075634 
3 
heat shock 105kDa/110kDa protein 1 288444 




   2   
0.004559 0.03 0.28 1084696 
8 
olfactory receptor 491 405252 
0.004565 0.03 0.25 1086955 
7 
NA NA 
0.004565 0.03 0.25 1090108 
7 
NA NA 
0.004581 0.03 0.32 1076545 
2 
hydroxysteroid (17-beta) dehydrogenase 7 29540 
0.004591 0.03 0.25 1089427 
0 
NA NA 
0.004592 0.03 0.35 1076473 
6 
nicotinamide nucleotide adenylyltransferase 2 289095 
0.004599 0.03 4.3 1079667 
3 
NA NA 
0.0046 0.03 5.43 1088952 
2 
dihydrolipoamide dehydrogenase 298942 
0.004604 0.03 4.25 1087097 
4 
ATP/GTP binding protein-like 4 362562 
0.004604 0.03 0.23 1084250 
7 
melanocortin 3 receptor 29310 
0.004607 0.03 4.89 1082330 
9 
stress-associated endoplasmic reticulum protein 1 80881 
0.004608 0.03 2.7 1074567 
7 
chemokine (C-C motif) ligand 3 25542 
0.004617 0.03 0.36 1093060 
6 
NA NA 
0.004623 0.03 3.71 1087564 
2 
NA NA 
0.004627 0.03 0.29 1079595 
2 
NA NA 
0.004628 0.03 3.46 1082462 
4 
NA NA 








































































































olfactory receptor 720 405955 
0.004876 0.031 3.04 1087158 
2 
NA NA 
0.004889 0.031 0.34 1076965 
7 






































































































similar to hypothetical protein 287554 














macrophage erythroblast attacher 298982 
0.005169 0.032 0.12 1086618 
2 
NA NA 
0.005174 0.032 0.38 1089332 
5 
olfactory receptor 905 288797 
0.005178 0.032 3.24 1090140 
9 
carbohydrate (chondroitin 4) sulfotransferase 11 314694 










































































replication factor C (activator 1) 4 288003 
0.005403 0.033 3.69 1076313 
7 
NA NA 






























































































































0.005714 0.034 4.64 1080836 
2 
































































































0.005972 0.035 0.27 1086496 
8 
NA NA 
0.005987 0.035 2.6 1075194 
5 
somatostatin 24797 
0.005994 0.035 0.33 1077573 
7 
NA NA 
0.005996 0.035 6.07 1073402 
5 
COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis) 287367 





0.006014 0.035 0.34 1070362 
6 






































































































































































































































thymocyte selection-associated high mobility group box 362481 



































































































leucine zipper protein 1 79428 
0.006727 0.037 0.31 1085914 
9 
killer cell lectin-like receptor, family E, member 1 297645 
0.006733 0.037 3.95 1093807 
7 











































































































































0.007064 0.038 0.27 1089337 
3 
olfactory receptor 995 405265 
0.007075 0.038 0.33 1093112 
3 








































pleckstrin homology-like domain, family A, member 1 29380 





























































































































































sphingomyelin synthase 1 353229 
0.007493 0.039 0.28 1076825 
4 







































































































































cyclin T1 315291 








































































































































































































































dolichyl-phosphate mannosyltransferase polypeptide 3 502017 
0.008345 0.041 0.4 1081751 
2 
synaptic vesicle glycoprotein 2a 117559 
0.008349 0.041 4.31 1075958 
5 
NA NA 
0.008371 0.041 3.1 1076391 
3 
retinoblastoma binding protein 5 304794 
0.008372 0.041 0.43 1074845 
9 
calcium channel, voltage-dependent, gamma subunit 4 140725 
0.00838 0.041 3.61 1079691 
2 
































































































































































































0.009234 0.044 2.85 1078202 
8 
DnaJ (Hsp40) homolog, subfamily C, member 3 63880 
0.009246 0.044 0.35 1078204 
1 
NA NA 
0.009264 0.044 0.33 1084496 
0 
low density lipoprotein-related protein 1B (deleted in tumors) 311926 
0.009277 0.044 5.05 1078156 
8 
nuclear fragile X mental retardation protein interacting protein 1 364430 
0.009278 0.044 2.49 1076374 
0 









































































































tubulin polymerization-promoting protein family member 3 291966 
0.009627 0.045 0.34 1090938 
4 
tripartite motif-containing 29 300656 
0.009629 0.045 3.34 1081475 
2 
mitofusin 1 192647 
0.009642 0.045 3.51 1076646 
3 
dual specificity phosphatase 10 63995 




   5   






































































0.009968 0.046 0.28 1093272 
1 
lipoma HMGIC fusion partner-like 1 300286 
0.009976 0.046 0.37 1093692 
5 
NA NA 
0.009983 0.046 0.33 1083843 
9 
olfactory receptor 773 296026 










APPENDIX D: TRANCRIPTS DIFFERENTIALLY EXPRESSED IN 
UNBOUND CA1 8HR AND NIC GROUPS 
 
Parametricp-value FDR Fold-change ProbeSet Name EntrezID 
2E-07 0.00132 42.06 10719977 melanoma inhibitory activity 81510 
9E-07 0.00296 22.48 10756606 NA NA 
1.9E-06 0.00408 15.53 10871413 NA NA 
0.000004 0.00408 11.29 10898158 NA NA 
0.000004 0.00408 11.29 10910752 NA NA 
4.4E-06 0.00408 15.77 10761128 heat shock protein 1 24471 
4.4E-06 0.00408 12.86 10828827 cyclin-dependent kinase inhibitor 1A 114851 
5.7E-06 0.00408 11.13 10840791 sulfiredoxin 1 homolog (S. cerevisiae) 296271 
6.1E-06 0.00408 14.83 10757082 zinc finger, AN1-type domain 2A 360772 
6.2E-06 0.00408 11.67 10770710 activating transcription factor 3 25389 
7.3E-06 0.00437 9.8 10736697 chemokine (C-C motif) ligand 2 24770 
9.6E-06 0.00526 12.37 10844268 NA NA 
1.43E-05 0.00649 11.67 10835845 olfactory receptor 400 296661 
1.46E-05 0.00649 9.19 10764551 prostaglandin-endoperoxide synthase 2 29527 
1.48E-05 0.00649 8.73 10795280 NA NA 
1.68E-05 0.00691 7.99 10790966 inositol-3-phosphate synthase 1 290651 
1.95E-05 0.00755 8.46 10795297 histone cluster 1, H4b 64627 
2.21E-05 0.00755 8.7 10798490 histone cluster 1, H4b 64627 
2.23E-05 0.00755 8.62 10798461 histone cluster 1, H4b 64627 
2.32E-05 0.00755 11.57 10703104 Park2 co-regulated 499021 
2.41E-05 0.00755 8.02 10798499 histone cluster 1, H4b 64627 
3.11E-05 0.00886 9.54 10928522 NA NA 
0.000032 0.00886 7.38 10933947 NA NA 
3.36E-05 0.00886 8.43 10809392 metallothionein 1a 24567 
0.000034 0.00886 16.52 10727717 neuronal PAS domain protein 4 266734 
0.000035 0.00886 7.67 10796411 metallothionein 1a 24567 
3.95E-05 0.00956 6.93 10736914 NA NA 
4.07E-05 0.00956 7.14 10839579 dual specificity phosphatase 2 311406 
4.22E-05 0.00957 8.33 10761394 phosphoserine phosphatase 304429 
184  
5.63E-05 0.0117 12.17 10797527 growth arrest and DNA-damage-inducible, gamma 291005 
6.09E-05 0.0117 6.31 10825151 histone cluster 2, H4 295277 
6.16E-05 0.0117 8.67 10702428 ADP-ribosylation factor 1 64310 
0.000062 0.0117 5.99 10795335 zinc finger with KRAB and SCAN domains 3 306977 
6.42E-05 0.0117 19.1 10862867 growth arrest and DNA-damage-inducible, alpha 25112 
6.45E-05 0.0117 17.07 10732652 dual specificity phosphatase 1 114856 
6.49E-05 0.0117 8.4 10891026 zinc finger, FYVE domain containing 1 299188 
6.66E-05 0.0117 6.02 10878009 NA NA 
6.76E-05 0.0117 9.22 10931010 similar to lymphocyte antigen 6 complex, locus E ligand 501282 
7.53E-05 0.0127 5.53 10872062 proteasome (prosome, macropain) subunit, beta type 2 29675 
8.34E-05 0.0133 9.65 10937867 NA NA 
8.37E-05 0.0133 10.39 10746789 NA NA 
8.67E-05 0.0133 8.04 10820151 NA NA 
9.11E-05 0.0133 6.3 10720215 zinc finger protein 36 79426 
9.31E-05 0.0133 14.3 10923338 coenzyme Q10 homolog B (S. cerevisiae) 301416 
9.37E-05 0.0133 5.57 10869533 NA NA 
9.41E-05 0.0133 5.03 10910666 NA NA 
9.48E-05 0.0133 9.29 10703139 ribonuclease T2 292306 
9.81E-05 0.0134 0.14 10798547 NA NA 
9.98E-05 0.0134 5.27 10875420 pro-histogranin 502940 
0.000105 0.0138 5.4 10795200 pro-histogranin 502940 
0.000107 0.0138 0.2 10938312 NA NA 
0.000119 0.0149 4.66 10913174 NA NA 
0.00012 0.0149 0.19 10722483 NA NA 
0.000125 0.015 5.34 10851484 NA NA 
0.000125 0.015 6.37 10934772 mannose-6-phosphate receptor, cation dependent 312689 
0.000132 0.0156 4.38 10923345 heat shock protein 1 (chaperonin 10) 25462 
0.000138 0.016 5.33 10707824 selenoprotein S 286900 
0.000144 0.0164 5.6 10768332 regulator of G-protein signaling 2 84583 
0.000154 0.0166 12.18 10792268 phosphatidic acid phosphatase type 2 domain containing 1B 680466 
0.000156 0.0166 5.15 10709875 adrenomedullin 25026 
0.000156 0.0166 5.59 10758930 heat shock protein B8 113906 
0.000157 0.0166 0.21 10703420 NA NA 
0.000159 0.0166 4.77 10873336 phospholipase A2, group IID 298579 
185  
0.000162 0.0167 12.77 10733047 NA NA 
0.000168 0.0169 11.76 10733045 NA NA 
0.00017 0.0169 5.7 10872654 protein phosphatase 1, regulatory (inhibitor) subunit 8 313030 
0.000177 0.0173 5.26 10909733 zinc finger protein 259 500989 
0.000181 0.0175 8.1 10897045 mesenchymal stem cell protein DSCD75 300015 
0.000184 0.0175 6.13 10711401 Bcl2-associated athanogene 3 293524 
0.000186 0.0175 4.36 10719464 NA NA 
0.00019 0.0176 4.47 10897543 H1 histone family, member 0 24437 
0.000204 0.0186 4.93 10773235 zinc finger protein 509 305428 
0.000206 0.0186 8.56 10900358 growth arrest and DNA-damage-inducible, beta 299626 
0.000213 0.0189 0.14 10723064 mannosidase 2, alpha 2 308757 
0.000219 0.0189 4.78 10832287 ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) 294331 
0.000222 0.0189 0.22 10703640 vomeronasal 2 receptor, 25 502286 
0.000224 0.0189 0.17 10932699 NA NA 
0.000224 0.0189 9.93 10769672 regulator of G-protein signaling 4 29480 
0.000227 0.0189 4.25 10799914 NA NA 
0.000234 0.0193 5.28 10778375 NA NA 
0.00024 0.0194 6.25 10757636 chemokine (C-C motif) ligand 26 685958 
0.000254 0.0204 0.17 10852437 potassium voltage-gated channel, KQT-like subfamily, member 2 170848 
0.000266 0.0208 5.8 10846740 frizzled-related protein 295691 
0.000269 0.0208 0.19 10866134 immunoreceptor Ly49si2 494207 
0.00027 0.0208 7.6 10759585 NA NA 
0.000272 0.0208 7.76 10831077 immediate early response 3 294235 
0.000277 0.0208 4.34 10909892 crystallin, alpha B 25420 
0.000279 0.0208 4.57 10868289 DnaJ (Hsp40) homolog, subfamily A, member 1 65028 
0.000286 0.0212 3.95 10899378 GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein 192254 
0.000297 0.0215 9.27 10878034 NA NA 
0.000298 0.0215 5.38 10720430 proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 292766 
0.0003 0.0215 0.25 10772799 NA NA 
0.000305 0.0216 5.03 10853916 NA NA 
0.000314 0.022 0.21 10938176 NA NA 
0.000324 0.0222 0.23 10722435 NA NA 
0.000331 0.0222 0.23 10728494 solute carrier family 22, member 25 192273 
0.000333 0.0222 0.25 10803438 NA NA 
186  
0.000335 0.0222 4.39 10838823 ChaC, cation transport regulator homolog 1 (E. coli) 362196 
0.000336 0.0222 4.94 10769131 calcyclin binding protein 289144 
0.000338 0.0222 5.62 10740869 tumor necrosis factor receptor superfamily, member 12a 302965 
0.00034 0.0222 3.74 10890271 NA NA 
0.000345 0.0222 4.27 10805895 gene trap locus 3 307642 
0.000351 0.0223 7.51 10750371 NA NA 
0.000352 0.0223 0.21 10887336 NA NA 
0.000364 0.0226 4.24 10820504 betaine-homocysteine methyltransferase 2 365972 
0.000366 0.0226 0.2 10934209 diacylglycerol O-acyltransferase 2-like 6 678749 
0.00037 0.0226 7.28 10871417 NA NA 
0.000375 0.0226 3.97 10772795 NA NA 
0.000377 0.0226 0.21 10823425 NA NA 
0.000379 0.0226 0.26 10907676 NA NA 
0.000382 0.0226 7.7 10765411 NA NA 
0.000385 0.0226 5.45 10922182 NA NA 
0.000388 0.0226 9.29 10845624 NA NA 
0.000393 0.0227 4.7 10811452 coactosin-like 1 (Dictyostelium) 361422 
0.000422 0.0238 5.23 10776667 NA NA 
0.000423 0.0238 6.24 10766760 lysophosphatidylglycerol acyltransferase 1 679692 
0.000423 0.0238 4.08 10912076 similar to Selenoprotein H 502642 
0.000428 0.0239 0.27 10774420 NA NA 
0.000437 0.0239 0.27 10724047 NA NA 
0.000437 0.0239 5.02 10924230 NA NA 
0.000441 0.0239 0.24 10910872 immunoglobulin superfamily, DCC subclass, member 4 363081 
0.000446 0.024 7.9 10893242 DnaJ (Hsp40) homolog, subfamily C, member 14 114481 
0.000448 0.024 4.39 10801584 COMM domain containing 10 361323 
0.000469 0.0249 4.9 10711657 NA NA 
0.000482 0.0252 4.48 10737770 NA NA 
0.000486 0.0252 4.25 10866672 RecQ protein-like (DNA helicase Q1-like) 312824 
0.000487 0.0252 5.27 10868428 DnaJ (Hsp40) homolog, subfamily B, member 5 313811 
0.0005 0.0254 0.2 10918867 NA NA 
0.000501 0.0254 7.49 10858497 NA NA 
0.000503 0.0254 0.15 10846980 olfactory receptor 500 404884 
0.000506 0.0254 5.69 10918820 NA NA 
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0.000522 0.026 4.17 10829703 transcription factor A, mitochondrial 83474 
0.000528 0.0261 5.52 10858487 mannose-6-phosphate receptor, cation dependent 312689 
0.000536 0.0261 0.24 10751086 NA NA 
0.000536 0.0261 4.77 10936063 solute carrier family 10 (sodium/bile acid cotransporter family), member 3 501665 
0.000543 0.0261 0.23 10799370 tubulin, alpha-like 3 291287 
0.000544 0.0261 0.25 10866306 taste receptor, type 2, member 106 1E+08 
0.000552 0.0262 6.82 10934700 apolipoprotein O-like 317191 
0.000555 0.0262 0.21 10701630 NA NA 
0.000559 0.0262 7.43 10896992 protein tyrosine phosphatase type IVA, member 3 362930 
0.000562 0.0262 4.4 10734873 NA NA 
0.000575 0.0264 3.41 10928154 heat shock protein 1 (chaperonin) 63868 
0.000577 0.0264 4.32 10774964 NA NA 
0.000578 0.0264 4.6 10901231 TIMP metallopeptidase inhibitor 3 25358 
0.000583 0.0265 5.45 10917106 RNA binding motif protein 7 315634 
0.0006 0.027 3.97 10780003 NA NA 
0.00061 0.0272 7.26 10919960 testis expressed 264 300988 
0.000613 0.0272 6.13 10896628 NA NA 
0.000621 0.0273 5.39 10906323 choline kinase beta 29367 
0.000623 0.0273 4.82 10802336 NA NA 
0.000647 0.0277 0.24 10811248 NA NA 
0.00065 0.0277 0.17 10761287 GATS protein-like 2 304410 
0.00065 0.0277 0.3 10909251 olfactory receptor 1266 405088 
0.000652 0.0277 7.09 10909639 FXYD domain-containing ion transport regulator 6 63847 
0.000657 0.0277 4.25 10892962 prostaglandin E synthase 3 (cytosolic) 362809 
0.000657 0.0277 0.29 10755035 tumor protein p63 246334 
0.000664 0.0278 4.46 10770045 NA NA 
0.000669 0.0279 3.79 10869541 NA NA 
0.000675 0.0279 0.27 10908229 NA NA 
0.000685 0.0281 0.27 10838416 olfactory receptor 757 404802 
0.00069 0.0281 0.29 10770109 NA NA 
0.000693 0.0281 4.11 10879963 hippocalcin 29177 
0.000711 0.0287 0.3 10874116 NA NA 
0.000748 0.0298 4.75 10860580 NA NA 
0.000751 0.0298 4.54 10865855 NA NA 
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0.000758 0.0298 0.19 10731291 limkain b1 170946 
0.000759 0.0298 0.25 10893325 olfactory receptor 905 288797 
0.000762 0.0298 0.26 10765820 NA NA 
0.000772 0.0299 4.01 10910490 hexosaminidase A 300757 
0.000774 0.0299 0.23 10765904 olfactory receptor 1598 405221 
0.00078 0.0299 3.43 10900112 NA NA 
0.000787 0.0299 4.4 10782901 cornichon homolog (Drosophila) 289994 
0.000791 0.0299 0.27 10812061 coiled-coil domain containing 7 497041 
0.000795 0.0299 4.14 10925373 ubiquitin-conjugating enzyme E2F (putative) 363284 
0.000796 0.0299 0.26 10916867 transmembrane protein 25 689172 
0.000817 0.0303 0.28 10837554 olfactory receptor 590 404858 
0.000818 0.0303 4.46 10844229 dystonia 1 266606 
0.000825 0.0303 0.22 10933753 NA NA 
0.000827 0.0303 4.32 10846982 NA NA 
0.000828 0.0303 6.97 10859655 mediator complex subunit 21 312849 
0.000859 0.0312 7.32 10896748 ring finger protein 139 315000 
0.000899 0.0322 3.23 10809399 metallothionein 2A 689415 
0.000911 0.0322 0.31 10902129 NA NA 
0.000912 0.0322 5.79 10855462 similar to chromosome 7 open reading frame 30 297082 
0.000913 0.0322 5.69 10918272 U5 small nuclear RNA 113834 
0.000916 0.0322 0.3 10884614 NA NA 
0.000916 0.0322 0.17 10837504 olfactory receptor 554 295797 
0.000921 0.0322 0.28 10908660 neuropeptide S receptor 1 300458 
0.000927 0.0322 3.92 10812580 NA NA 
0.000931 0.0322 3.17 10823309 stress-associated endoplasmic reticulum protein 1 80881 
0.000947 0.0326 0.23 10719159 NA NA 
0.000954 0.0327 0.25 10888617 similar to 14-3-3 protein sigma 298795 
0.000966 0.0329 4.89 10810831 CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae) 364996 
0.000971 0.0329 4.59 10774171 uridine phosphorylase 1 289801 
0.000981 0.033 5.12 10776064 UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae) 305258 
0.000984 0.033 0.26 10768754 NA NA 
0.000999 0.0333 0.23 10884820 NA NA 
0.001014 0.0336 5.23 10763477 Mki67 (FHA domain) interacting nucleolar phosphoprotein 246042 
0.001016 0.0336 0.25 10877307 major urinary protein 5 298107 
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0.001022 0.0336 3.29 10795194 NA NA 
0.001035 0.0337 0.24 10878314 NA NA 
0.001037 0.0337 0.21 10703216 NA NA 
0.001039 0.0337 4.51 10897203 NA NA 
0.001046 0.0337 0.3 10855090 olfactory receptor 808 405140 
0.00106 0.034 4.64 10829759 NA NA 
0.001069 0.0341 0.33 10791964 NA NA 
0.00109 0.0343 0.3 10711087 NA NA 
0.001093 0.0343 0.22 10718152 NA NA 
0.001098 0.0343 7 10911309 general transcription factor IIA, 2 83828 
0.001106 0.0343 0.21 10811999 NA NA 
0.001109 0.0343 0.32 10909196 olfactory receptor 1247 405093 
0.001113 0.0343 0.25 10714610 NA NA 
0.001116 0.0343 5.71 10838873 inositol 1,4,5-trisphosphate 3-kinase A 81677 
0.001118 0.0343 0.3 10820221 NA NA 
0.00112 0.0343 3.03 10742975 olfactory receptor 1457 363608 
0.001126 0.0343 6.6 10738140 insulin-like growth factor binding protein 4 360622 
0.001136 0.0343 8.93 10748336 NA NA 
0.001139 0.0343 0.22 10765818 olfactory receptor 1583 289241 
0.001145 0.0343 0.25 10837489 olfactory receptor 527 404878 
0.001146 0.0343 3.38 10865420 calsyntenin 3 171393 
0.001151 0.0343 0.24 10759459 NA NA 
0.001157 0.0343 0.26 10934197 NA NA 
0.001168 0.0343 0.22 10865681 tubulin, alpha 3A 500319 
0.001168 0.0343 3.04 10827989 metallothionein 2A 689415 
0.001196 0.0347 0.3 10902970 kinesin family member 5A 314906 
0.001202 0.0347 0.26 10932339 NA NA 
0.001203 0.0347 3.8 10818317 proteasome (prosome, macropain) subunit, alpha type 5 29672 
0.001205 0.0347 0.23 10745782 phosphatidylinositol glycan anchor biosynthesis, class W 378774 
0.00121 0.0347 0.25 10936923 histone variant H2al2-like 1E+08 
0.001219 0.0347 3.48 10879047 ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b 298451 
0.001222 0.0347 3.26 10884853 PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae) 314171 
0.001225 0.0347 0.24 10863430 hexokinase 2 25059 
0.001229 0.0347 4.28 10811126 fatty acid 2-hydroxylase 307855 
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0.001233 0.0347 0.26 10900010 olfactory receptor 921 366798 
0.001248 0.0347 0.25 10814392 NA NA 
0.001257 0.0347 3.75 10796455 signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 498798 
0.001264 0.0347 4.09 10936302 ubiquitin-conjugating enzyme E2A (RAD6 homolog) 298317 
0.001265 0.0347 0.26 10797541 SECIS binding protein 2 79049 
0.001266 0.0347 5.33 10779825 NA NA 
0.001274 0.0347 4.37 10796134 RNA binding motif protein 17 291295 
0.001282 0.0347 5.17 10804856 thioredoxin-like 1 140922 
0.001282 0.0347 5.2 10799558 phytanoyl-CoA 2-hydroxylase 114209 
0.001283 0.0347 6.84 10725387 cerebellar degeneration-related 2 308958 
0.001292 0.0348 0.22 10858612 vomeronasal 2 receptor, 49 688392 
0.001298 0.0348 4.73 10827686 RT1 class I, locus M6, gene 1 414785 
0.001303 0.0348 0.3 10781982 NA NA 
0.00131 0.0348 3.41 10938209 NA NA 
0.001322 0.0348 4.78 10774625 NA NA 
0.001327 0.0348 0.33 10725078 pleckstrin homology domain containing, family A member 7 499249 
0.001329 0.0348 0.31 10776185 theobromine induced protein 689604 
0.001334 0.0348 3.97 10876213 rCG55084-like 1E+08 
0.001338 0.0348 4.94 10907913 matrix metallopeptidase 8 63849 
0.001342 0.0348 3.68 10890024 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 25493 
0.001345 0.0348 0.23 10723553 NA NA 
0.001374 0.0349 0.24 10894295 vomeronasal 1 receptor 107 494260 
0.001377 0.0349 4.81 10834035 endosulfine alpha 60334 
0.001379 0.0349 4.52 10883094 protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform 259229 
0.001381 0.0349 12.24 10738703 reprimo-like 685826 
0.001389 0.0349 8.31 10820843 CART prepropeptide 29131 
0.001391 0.0349 0.33 10805285 NA NA 
0.0014 0.0349 0.25 10800744 excision repair cross-complementing rodent repair deficiency, complementation group 3 291703 
0.001409 0.0349 7.32 10805882 casein kinase 2, alpha prime polypeptide 307641 
0.00141 0.0349 0.25 10807889 NA NA 
0.001411 0.0349 3.05 10747075 keratin 28 360623 
0.001411 0.0349 5.38 10835618 torsin family 2, member A 362112 
0.001413 0.0349 0.34 10916365 olfactory receptor 1301 300602 
0.001423 0.0351 3.87 10876011 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 297990 
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0.00143 0.0351 5.07 10762709 coenzyme Q5 homolog, methyltransferase (S. cerevisiae) 304542 
0.001448 0.0354 0.3 10845708 interferon induced with helicase C domain 1 499801 
0.001461 0.0356 4.08 10832224 NA NA 
0.001468 0.0356 3.49 10917483 RAB39, member RAS oncogene family 315668 
0.001512 0.0365 4.31 10863722 NA NA 
0.001515 0.0365 0.21 10939533 NA NA 
0.00156 0.0372 0.33 10813253 complement component 6 24237 
0.00156 0.0372 0.25 10729019 NA NA 
0.001563 0.0372 0.25 10891991 serine (or cysteine) peptidase inhibitor, clade A, member 3K 24794 
0.001568 0.0372 7.01 10919034 NA NA 
0.001586 0.0374 0.29 10889723 NA NA 
0.001609 0.0374 4.03 10749789 hypothetical protein LOC619574 619574 
0.001613 0.0374 3.95 10934794 interferon stimulated exonuclease gene 20-like 2 361977 
0.001616 0.0374 0.33 10902418 NA NA 
0.001629 0.0374 3.26 10713583 WD repeat domain 74 690229 
0.001631 0.0374 3.9 10924326 rcd1 (required for cell differentiation) homolog 1 (S. pombe) 301513 
0.001633 0.0374 0.32 10939779 NA NA 
0.00164 0.0374 0.28 10815913 NA NA 
0.001643 0.0374 0.27 10885482 NA NA 
0.001647 0.0374 0.32 10826451 solute carrier family 44, member 3 295417 
0.001674 0.0374 0.28 10908167 olfactory receptor 1128 405345 
0.001679 0.0374 0.26 10934683 NA NA 
0.00169 0.0374 0.2 10756105 NA NA 
0.001691 0.0374 10.09 10887016 NA NA 
0.001691 0.0374 10.09 10887020 NA NA 
0.001691 0.0374 10.09 10887024 NA NA 
0.001691 0.0374 10.09 10887028 NA NA 
0.001691 0.0374 10.09 10887032 NA NA 
0.001691 0.0374 10.09 10887036 NA NA 
0.001691 0.0374 10.09 10887040 NA NA 
0.001693 0.0374 0.27 10826616 NA NA 
0.001713 0.0377 5.73 10927840 NA NA 
0.001728 0.0379 0.16 10814286 fatty acid binding protein 4, adipocyte 79451 
0.001738 0.0379 3.59 10874450 leucine rich repeat containing 47 362672 
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0.00174 0.0379 3.37 10745266 transmembrane protein 97 303330 
0.001751 0.038 3.61 10807722 thioredoxin-like 4B 292008 
0.001764 0.0382 3.04 10910252 snurportin 1 316108 
0.001774 0.0383 3.85 10787209 CCR4-NOT transcription complex, subunit 7 306492 
0.001779 0.0383 3.38 10829639 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 361825 
0.001811 0.0386 0.2 10706240 NA NA 
0.001811 0.0386 0.15 10837881 low density lipoprotein receptor-related protein 4 83469 
0.001815 0.0386 0.27 10791227 NA NA 
0.001829 0.0388 5.4 10928207 similar to hypothetical protein FLJ37953 301419 
0.001836 0.0388 3.08 10758344 vacuolar protein sorting 37 homolog B (S. cerevisiae) 288659 
0.001842 0.0388 0.28 10776260 NA NA 
0.001856 0.0388 0.3 10867318 NA NA 
0.001858 0.0388 0.3 10796679 NA NA 
0.001864 0.0388 3.05 10879516 major facilitator superfamily domain containing 2 298504 
0.001864 0.0388 0.27 10774892 NA NA 
0.001877 0.0389 0.21 10866205 NA NA 
0.001886 0.039 0.32 10767503 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 304775 
0.001896 0.0391 0.22 10848118 olfactory receptor 775 296028 
0.001902 0.0391 0.29 10729762 NA NA 
0.001926 0.0395 0.28 10938671 zinc finger, MYM-type 3 317260 
0.001945 0.0397 0.25 10887050 NA NA 
0.001966 0.04 4.08 10912439 retinol binding protein 1, cellular 25056 
0.001985 0.0402 0.26 10795719 NA NA 
0.001986 0.0402 0.19 10884912 NA NA 
0.002007 0.0405 3.65 10780237 similar to 1700123O20Rik protein 361038 
0.002027 0.0408 2.78 10889657 NA NA 
0.002044 0.041 0.28 10881685 kinesin family member 1B 117548 
0.002081 0.0414 0.27 10738097 Rap guanine nucleotide exchange factor (GEF)-like 1 303515 
0.002088 0.0414 0.24 10837097 NA NA 
0.002089 0.0414 6.4 10775260 similar to RIKEN cDNA 1700081O22 363337 
0.002098 0.0414 3 10827238 NA NA 
0.002098 0.0414 4.27 10797918 PAK1 interacting protein 1 361232 
0.002105 0.0415 3.84 10702485 programmed cell death 6 308061 
0.002118 0.0415 0.28 10828046 HLA-B associated transcript 2 294250 
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0.002122 0.0415 0.29 10715255 NA NA 
0.002129 0.0415 0.29 10863035 NA NA 
0.002134 0.0415 0.12 10864300 NA NA 
0.002143 0.0416 4.03 10729120 NA NA 
0.00215 0.0416 3.17 10860801 similar to OEF2 500011 
0.002158 0.0416 3.45 10791250 lipoprotein lipase 24539 
0.002166 0.0417 3.47 10850666 NA NA 
0.002175 0.0417 0.28 10858142 olfactory receptor 824 405215 
0.00219 0.0418 0.28 10934517 LRRGT00193 680227 
0.002197 0.0418 4.14 10773722 NA NA 
0.002198 0.0418 0.25 10881350 NA NA 
0.002216 0.042 3.43 10935131 ring finger protein 128 315911 
0.002225 0.0421 0.29 10730750 NA NA 
0.002259 0.0425 0.19 10877943 protein tyrosine phosphatase-like A domain containing 2 362540 
0.002261 0.0425 3.87 10891850 NA NA 
0.002266 0.0425 2.87 10761463 RAN, member RAS oncogene family 84509 
0.002287 0.0426 5.54 10828154 heat shock 70kD protein 1B (mapped) 294254 
0.002294 0.0426 4.27 10914935 LOC363015 363015 
0.002295 0.0426 0.32 10893338 NA NA 
0.002312 0.0428 3.21 10890354 cyclin-dependent kinase-like 1 (CDC2-related kinase) 314198 
0.002315 0.0428 0.25 10854998 seminal vesicle antigen-like 1 680174 
0.002325 0.0428 0.31 10764491 NA NA 
0.002344 0.0431 3.02 10909407 Thy-1 cell surface antigen 24832 
0.002361 0.0432 0.25 10848111 olfactory receptor 768 405234 
0.002366 0.0432 0.3 10812495 NA NA 
0.002386 0.0434 0.29 10901043 NA NA 
0.00239 0.0434 2.99 10809899 NA NA 
0.002394 0.0434 0.23 10922247 NA NA 
0.002404 0.0434 0.24 10833906 NA NA 
0.002419 0.0435 0.31 10707887 NA NA 
0.002434 0.0435 2.77 10743117 ADP-ribosylation factor 1 64310 
0.002437 0.0435 3.38 10867165 lactamase, beta 2 297768 
0.002438 0.0435 4.27 10866265 NA NA 
0.002441 0.0435 3.04 10824300 solute carrier family 25, member 44 365841 
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0.002463 0.0438 0.2 10881301 NA NA 
0.002471 0.0438 0.33 10913722 myosin, light chain 3, alkali; ventricular, skeletal, slow 24585 
0.002501 0.0439 3.18 10751945 somatostatin 24797 
0.002505 0.0439 0.2 10716056 NA NA 
0.002507 0.0439 0.28 10846944 NA NA 
0.00253 0.0439 3.05 10827517 cystathionase (cystathionine gamma-lyase) 24962 
0.00253 0.0439 0.27 10903182 retinol dehydrogenase 7 360420 
0.002531 0.0439 0.34 10925572 NA NA 
0.002536 0.0439 3.6 10798465 NA NA 
0.00254 0.0439 3.27 10752050 transformer 2 beta homolog (Drosophila) 117259 
0.002547 0.0439 3.64 10843169 NA NA 
0.00255 0.0439 0.31 10857265 NA NA 
0.002559 0.0439 2.82 10867731 calbindin 1 83839 
0.002567 0.0439 2.78 10822902 NA NA 
0.00257 0.0439 0.24 10714175 NA NA 
0.002579 0.0439 0.35 10715541 carboxypeptidase N, polypeptide 1 365466 
0.002579 0.0439 3.49 10884205 TWIST neighbor 362728 
0.00259 0.044 4.03 10889728 ADP-ribosylation factor-like 4A 29308 
0.002596 0.044 0.35 10737838 NA NA 
0.002601 0.044 5.67 10794016 PDZ and LIM domain 7 286908 
0.002609 0.044 0.32 10923877 ADAM metallopeptidase domain 23 301460 
0.00263 0.0441 4.67 10729970 retinol binding protein 4, plasma 25703 
0.00263 0.0441 0.27 10733843 similar to Robo-1 691277 
0.002659 0.0444 3.13 10846286 nuclear factor, erythroid derived 2, like 2 83619 
0.002661 0.0444 0.13 10729065 NA NA 
0.002677 0.0446 0.36 10774782 spectrin, beta, non-erythrocytic 1 305614 
0.002691 0.0447 5 10832927 NA NA 
0.002702 0.0447 0.32 10833744 NA NA 
0.002704 0.0447 0.31 10774825 similar to hypothetical protein FLJ40298 498431 
0.002708 0.0447 0.27 10908214 olfactory receptor 1174 405390 
0.002722 0.0447 0.28 10795346 glutathione peroxidase 5 113919 
0.002732 0.0447 3.3 10845110 NS5A (hepatitis C virus) transactivated protein 4 311934 
0.002734 0.0447 3 10704652 NA NA 
0.002753 0.0449 0.24 10703461 NA NA 
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0.002774 0.0452 4.76 10837053 NA NA 
0.002783 0.0452 0.27 10724575 NA NA 
0.002801 0.0454 3.28 10895128 NA NA 
0.002831 0.0457 5.71 10752650 similar to 4930453N24Rik protein 304176 
0.002836 0.0457 0.27 10856166 NA NA 
0.002858 0.0458 3.61 10794225 nuclear factor, interleukin 3 regulated 114519 
0.002859 0.0458 4.56 10923155 asparagine synthetase domain containing 1 299507 
0.002862 0.0458 3.92 10746532 NA NA 
0.002866 0.0458 0.34 10891780 fibulin 5 29158 
0.002882 0.0459 3.6 10822433 NA NA 
0.002918 0.0463 0.24 10724819 DENN/MADD domain containing 5A 308942 
0.002923 0.0463 3.48 10702792 claudin 20 680178 
0.002959 0.0468 0.32 10915299 olfactory receptor 1177 405160 
0.002971 0.0469 4.64 10903061 serine hydroxymethyltransferase 2 (mitochondrial) 299857 
0.002986 0.0469 0.18 10759497 NA NA 
0.002988 0.0469 4.5 10890484 NA NA 
0.003001 0.047 5.38 10883865 NA NA 
0.003009 0.047 3.38 10851739 solute carrier family 35, member C2 311637 
0.003017 0.047 3.06 10934777 NA NA 
0.003026 0.0471 3.5 10871415 NA NA 
0.003042 0.0472 5.62 10739455 G protein-coupled receptor, family C, group 5, member C 287805 
0.003063 0.0473 0.23 10760762 NA NA 
0.003067 0.0473 6.1 10849863 small nuclear ribonucleoprotein polypeptides B and B1 171365 
0.003079 0.0473 3.11 10931308 prolyl 4-hydroxylase, alpha polypeptide I 64475 
0.00308 0.0473 3.56 10725289 glycoprotein 2 (zymogen granule membrane) 171459 
0.003107 0.0475 0.3 10706974 NA NA 
0.003119 0.0475 0.25 10845890 sodium channel, voltage-gated, type IX, alpha 78956 
0.003128 0.0475 3.2 10726682 interferon induced transmembrane protein 3 361673 
0.003134 0.0475 0.27 10750898 NA NA 
0.003135 0.0475 0.31 10867380 NA NA 
0.00314 0.0475 0.33 10738469 RAD52 motif 1 287726 
0.003143 0.0475 2.87 10869666 small nuclear RNA activating complex, polypeptide 3 362537 
0.00316 0.0477 3.17 10915885 NA NA 
0.003172 0.0477 0.28 10702306 transcription factor 21 252856 
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0.003174 0.0477 0.3 10846962 NA NA 
0.003181 0.0477 3.25 10834225 neural proliferation, differentiation and control, 1 296562 
0.003221 0.048 0.35 10776109 NA NA 
0.003227 0.048 0.38 10922577 NA NA 
0.003233 0.048 2.98 10890626 glycoprotein hormone beta 5 366668 
0.003233 0.048 3.06 10863866 CCHC-type zinc finger, nucleic acid binding protein 64530 
0.003244 0.048 2.69 10871711 tRNA isopentenyltransferase 1 362586 
0.003249 0.048 0.33 10871127 MOB1, Mps One Binder kinase activator-like 2C (yeast) 313511 
0.003282 0.0483 2.94 10795384 ependymin related protein 1 (zebrafish) 291180 
0.003287 0.0483 2.82 10714973 HECT domain containing 2 309514 
0.00329 0.0483 0.25 10862921 NA NA 
0.003325 0.0486 3 10937558 TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) 317418 
0.003333 0.0486 0.36 10869137 fukutin 362520 
0.003337 0.0486 5.97 10795174 histone cluster 1, H2ba 24829 
0.003346 0.0486 2.64 10721050 CCAAT/enhancer binding protein (C/EBP), gamma 25301 
0.003349 0.0486 6.24 10910089 cellular retinoic acid binding protein 1 25061 
0.003353 0.0486 0.29 10810236 latrophilin 1 65096 
0.003362 0.0486 5.76 10769509 TIP41, TOR signaling pathway regulator-like (S. cerevisiae) 360869 
0.003369 0.0486 4.22 10912567 kyphoscoliosis peptidase 315962 
0.00338 0.0487 0.19 10856086 NA NA 
0.003402 0.0489 3.06 10749656 family with sequence similarity 195, member B 360677 
0.003425 0.049 7.89 10879697 NA NA 
0.003435 0.049 3.21 10704413 N-ethylmaleimide-sensitive factor attachment protein, alpha 140673 
0.003442 0.049 0.37 10892832 NA NA 
0.003448 0.049 6.12 10899756 coenzyme Q10 homolog A (S. cerevisiae) 362810 
0.003448 0.049 4.85 10933015 similar to 4930453N24Rik protein 304176 
0.00347 0.0492 0.3 10857408 NA NA 
0.003495 0.0493 0.29 10783048 olfactory receptor 1629 405389 
0.003504 0.0493 0.3 10707113 potassium voltage gated channel, Shaw-related subfamily, member 1 25327 
0.003508 0.0493 0.38 10729055 olfactory receptor 378 405366 
0.003511 0.0493 3.12 10721315 tonin 24841 
0.003523 0.0493 4.5 10726924 HCCA2 protein 499288 
0.003531 0.0493 0.32 10906666 NA NA 
0.003534 0.0493 3.65 10824695 S100 calcium binding protein A9 94195 
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0.003535 0.0493 0.24 10798255 NA NA 
0.003573 0.0495 2.68 10781197 stathmin-like 4 79423 
0.003573 0.0495 0.4 10762142 NA NA 
0.003579 0.0495 2.82 10796768 NA NA 
0.003585 0.0495 0.37 10884574 NA NA 
0.003587 0.0495 0.16 10801135 NA NA 
0.003612 0.0496 2.65 10765115 vesicle-associated membrane protein 4 364033 
0.003615 0.0496 3.14 10906470 zinc finger CCHC-type and RNA binding motif 1 362990 
0.00364 0.0499 0.36 10844681 ABO-family member 5 652927 
0.003686 0.0502 0.22 10894260 vomeronasal 2 receptor, 55 691442 
0.003697 0.0502 0.31 10763342 serpin peptidase inhibitor, clade B (ovalbumin), member 13 304690 
0.003701 0.0502 0.26 10914019 NA NA 
0.003717 0.0502 3.47 10874193 ERBB receptor feedback inhibitor 1 313729 
0.003719 0.0502 0.34 10815915 NA NA 
0.003721 0.0502 0.35 10756225 NA NA 
0.003724 0.0502 0.23 10852195 NA NA 
0.003728 0.0502 0.32 10737647 NA NA 
0.003733 0.0502 4.48 10888398 protein serine-threonine phosphatase catalytic subunit PP-1c 316717 
0.003755 0.0503 3.77 10745285 family with sequence similarity 58, member B 303321 
0.003761 0.0503 3.26 10747292 keratin 16 303530 
0.003772 0.0503 3.36 10791902 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 64554 
0.003773 0.0503 3.03 10724507 ADP-ribosylation factor interacting protein 2 293344 
0.003779 0.0503 4.36 10768814 immediate early response 5 498256 
0.0038 0.0504 0.31 10813856 NA NA 
0.003821 0.0504 0.27 10837638 olfactory receptor 727 404811 
0.003824 0.0504 0.31 10858645 NA NA 
0.003836 0.0504 0.32 10739211 NA NA 
0.003837 0.0504 0.31 10739994 NA NA 
0.003844 0.0504 0.34 10806016 Bardet-Biedl syndrome 2 113948 
0.003844 0.0504 2.64 10802405 chromatin modifying protein 1B 689364 
0.003855 0.0504 3.04 10809893 NA NA 
0.003857 0.0504 3.36 10745323 WD repeat and SOCS box-containing 1 303336 
0.003859 0.0504 0.39 10704376 NA NA 
0.003871 0.0504 0.31 10803824 cell division cycle 25 homolog C (S. pombe) 307511 
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0.003894 0.0506 3.9 10756671 similar to CG14980-PB 360768 
0.003905 0.0507 0.36 10801580 NA NA 
0.003923 0.0507 3.45 10859371 serine/threonine kinase receptor associated protein 297699 
0.003927 0.0507 3.4 10818090 solute carrier family 16, member 1 (monocarboxylic acid transporter 1) 25027 
0.003945 0.0509 0.21 10736606 NA NA 
0.00396 0.051 2.86 10756343 heat shock 105kDa/110kDa protein 1 288444 
0.003979 0.0511 0.27 10748440 NA NA 
0.003995 0.0512 0.28 10803721 NA NA 
0.004006 0.0513 2.96 10722897 hyaluronan and proteoglycan link protein 3 308773 
0.004019 0.0513 0.24 10778438 NA NA 
0.004024 0.0513 0.24 10830957 RT1 class I, locus M1, gene 2 414786 
0.004042 0.0513 0.37 10822390 NA NA 
0.004048 0.0513 0.32 10919788 NA NA 
0.004057 0.0513 0.27 10864684 ATPase, Ca++ transporting, plasma membrane 2 24215 
0.004058 0.0513 3.19 10766463 dual specificity phosphatase 10 63995 
0.004072 0.0514 0.33 10703102 NA NA 
0.004081 0.0514 0.34 10764942 NA NA 
0.0041 0.0515 0.25 10934115 NA NA 
0.004102 0.0515 4.08 10729604 similar to RIKEN cDNA 5033414D02 293888 
0.004113 0.0515 0.36 10839238 tripartite motif-containing 69 311373 
0.004129 0.0516 2.71 10701797 splicing factor 3b, subunit 5 680891 
0.004135 0.0516 3.08 10809909 NA NA 
0.004167 0.0519 0.39 10917984 NA NA 
0.004187 0.0519 2.56 10756040 ubiquitin fusion degradation 1 like (yeast) 84478 
0.004189 0.0519 0.36 10782271 plasminogen activator, urokinase 25619 
0.004192 0.0519 3.53 10823733 programmed cell death 10 494345 
0.004212 0.0521 0.29 10793071 NA NA 
0.004219 0.0521 4.77 10794257 NA NA 
0.004227 0.0521 3.42 10792187 proline synthetase co-transcribed homolog (bacterial) 306544 
0.00424 0.0521 4.94 10757175 cytochrome P450, family 3, subfamily a, polypeptide 9 171352 
0.004259 0.0523 3.12 10794206 serine palmitoyltransferase, long chain base subunit 1 361213 
0.004273 0.0523 0.29 10867497 family with sequence similarity 110, member B 500400 
0.004274 0.0523 0.35 10886840 NA NA 
0.0043 0.0525 3.89 10855599 NA NA 
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0.004329 0.0527 4.52 10736863 chemokine (C-C motif) ligand 4 116637 
0.004346 0.0528 0.37 10832715 ankyrin 3, node of Ranvier 361833 
0.004395 0.0528 0.31 10742254 cytoplasmic FMR1 interacting protein 2 303073 
0.004408 0.0528 0.4 10940025 NA NA 
0.004409 0.0528 3.47 10801996 RNA binding motif protein 22 307410 
0.00441 0.0528 0.25 10856189 NA NA 
0.004416 0.0528 2.44 10804508 heat shock protein A8 24468 
0.004418 0.0528 0.31 10771951 UDP glycosyltransferase 2 family, polypeptide B 24862 
0.004429 0.0528 0.36 10930132 solute carrier organic anion transporter family, member 6c1 287006 
0.004445 0.0528 0.31 10820000 NA NA 
0.004455 0.0528 0.24 10873887 NA NA 
0.004455 0.0528 0.23 10756519 NA NA 
0.004459 0.0528 0.35 10782080 FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) 306183 
0.004459 0.0528 0.39 10808563 cadherin 15 361432 
0.004462 0.0528 0.31 10922487 NA NA 
0.004471 0.0528 0.33 10881624 NA NA 
0.004475 0.0528 0.28 10887088 NA NA 
0.004486 0.0528 0.37 10810556 TNFRSF1A-associated via death domain 246756 
0.004488 0.0528 3.24 10847693 apoptosis inhibitor 5 362170 
0.004491 0.0528 0.34 10865531 ubiquitin specific peptidase 5 (isopeptidase T) 297593 
0.004544 0.0534 0.27 10749931 NA NA 
0.004578 0.0535 3.09 10924076 ribulose-5-phosphate-3-epimerase 501157 
0.004584 0.0535 0.33 10780281 NA NA 
0.0046 0.0535 4.67 10791921 vacuolar protein sorting 37 homolog A (S. cerevisiae) 290775 
0.004601 0.0535 0.32 10848956 NA NA 
0.004602 0.0535 3.34 10754201 G protein-coupled receptor 156 260430 
0.004622 0.0535 0.32 10733884 olfactory receptor 1443 287331 
0.004639 0.0535 0.24 10899997 olfactory receptor 906 404951 
0.004639 0.0535 0.41 10718377 vomeronasal 1 receptor 12 494306 
0.004644 0.0535 0.3 10935402 NA NA 
0.004645 0.0535 2.84 10907749 glycosylation dependent cell adhesion molecule 1 25258 
0.004645 0.0535 0.37 10846912 olfactory receptor 441 295712 
0.004649 0.0535 2.76 10823049 NA NA 
0.004675 0.0536 0.38 10837506 olfactory receptor 555 295798 
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0.004684 0.0536 0.28 10878741 forkhead box E3 171302 
0.004688 0.0536 3.83 10891910 interferon, alpha-inducible protein 27 like 2B 299269 
0.004691 0.0536 0.28 10728644 flap structure-specific endonuclease 1 84490 
0.00471 0.0537 3.46 10821914 brix domain containing 2 294799 
0.004737 0.0539 0.37 10792547 defensin NP-4 precursor 286958 
0.004765 0.0539 3.3 10937660 trafficking protein particle complex 2 501550 
0.004768 0.0539 0.33 10709405 olfactory receptor 78 293221 
0.004773 0.0539 0.28 10922105 NA NA 
0.004776 0.0539 4.51 10873258 similar to RIKEN cDNA 1110008F13 296315 
0.004779 0.0539 0.27 10873327 phospholipase A2, group IIC 29387 
0.004793 0.054 0.35 10924044 NA NA 
0.004802 0.054 0.38 10783445 NA NA 
0.00484 0.0542 2.65 10939480 MORC family CW-type zinc finger 4 315914 
0.004856 0.0542 3.07 10741841 ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 94170 
0.004865 0.0542 0.37 10733195 TBC1 domain family, member 9B 360520 
0.004873 0.0542 0.36 10724268 NA NA 
0.004875 0.0542 2.43 10937827 heat shock protein A8 24468 
0.004879 0.0542 7.73 10819442 tetraspanin 5 362048 
0.004883 0.0542 0.28 10787117 mediator complex subunit 26 306328 
0.004887 0.0542 0.23 10729771 NA NA 
0.004893 0.0542 0.33 10901713 NA NA 
0.004926 0.0545 0.35 10730765 NA NA 
0.004938 0.0545 3.3 10704655 NA NA 
0.004953 0.0545 0.38 10702076 NA NA 
0.004954 0.0545 0.34 10847187 olfactory receptor 696 405951 
0.004963 0.0545 3.23 10885417 NA NA 
0.005022 0.0551 0.33 10938203 NA NA 
0.005042 0.0552 0.31 10860765 NA NA 
0.005072 0.0552 0.4 10760307 lemur tyrosine kinase 2 304286 
0.005074 0.0552 0.24 10858618 vomeronasal 2 receptor, 50 500312 
0.005075 0.0552 0.27 10722862 NA NA 
0.005078 0.0552 6.5 10731941 NA NA 
0.005093 0.0552 0.38 10803767 NA NA 
0.005097 0.0552 0.37 10901607 Spi-C transcription factor (Spi-1/PU.1 related) 314711 
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0.005101 0.0552 0.39 10870269 DnaJ (Hsp40) homolog, subfamily C, member 6 313409 
0.005127 0.0552 3.39 10887966 NA NA 
0.005132 0.0552 0.31 10722479 NA NA 
0.005141 0.0552 6.31 10852144 prostate transmembrane protein, androgen induced 1 311676 
0.005142 0.0552 0.27 10837247 NA NA 
0.005143 0.0552 2.94 10880233 YTH domain family, member 2 313053 
0.005162 0.0553 0.4 10859201 NA NA 
0.005178 0.0554 0.28 10718725 NLR family, pyrin domain containing 5 308325 
0.005191 0.0554 3.52 10773180 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 84406 
0.0052 0.0554 0.32 10735492 ankyrin repeat and FYVE domain containing 1 303292 
0.005205 0.0554 5.27 10879402 CTP synthase 313560 
0.005224 0.0555 3.37 10821900 DnaJ (Hsp40) homolog, subfamily C, member 21 192210 
0.00525 0.0557 2.65 10716303 NA NA 
0.00528 0.0558 3.15 10852600 regulator of G-protein signaling 19 59293 
0.005285 0.0558 0.39 10719935 NA NA 
0.005291 0.0558 3.43 10777034 similar to 1810013D10Rik protein 501923 
0.005297 0.0558 2.79 10756253 NA NA 
0.005297 0.0558 2.79 10756255 NA NA 
0.005318 0.0558 0.41 10869076 NA NA 
0.005319 0.0558 0.36 10715117 G protein-coupled receptor 120 294075 
0.005329 0.0558 3.49 10902564 Mdm2 p53 binding protein homolog (mouse) 314856 
0.005343 0.0558 0.21 10894244 NA NA 
0.005346 0.0558 0.35 10883971 NA NA 
0.005375 0.056 2.93 10782028 DnaJ (Hsp40) homolog, subfamily C, member 3 63880 
0.005389 0.056 4.2 10924669 NA NA 
0.005392 0.056 0.39 10849125 elongation factor RNA polymerase II-like 3 296102 
0.005398 0.056 0.33 10935622 melanoma antigen family A, 11 302845 
0.005441 0.0563 0.31 10886880 NA NA 
0.005457 0.0563 0.38 10751868 similar to hypothetical protein A430031N04 498100 
0.005458 0.0563 0.27 10857177 NA NA 
0.005467 0.0563 3.47 10748861 NA NA 
0.005472 0.0563 0.29 10900041 NA NA 
0.005492 0.0564 0.24 10848105 olfactory receptor 760 405957 
0.00552 0.0565 3.27 10708167 NA NA 
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0.005522 0.0565 0.38 10863028 NA NA 
0.005526 0.0565 3.26 10883785 ornithine decarboxylase 1 24609 
0.005578 0.0569 0.22 10807883 NA NA 
0.005587 0.0569 0.42 10935023 NA NA 
0.00559 0.0569 3.4 10888341 NA NA 
0.005607 0.057 0.24 10845382 NA NA 
0.005617 0.057 0.28 10829713 bicaudal C homolog 1 (Drosophila) 361832 
0.005631 0.057 0.37 10769436 NA NA 
0.005645 0.057 0.25 10722425 NA NA 
0.005648 0.057 6.48 10922415 IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) 316317 
0.005655 0.057 0.37 10891977 serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 299274 
0.005664 0.057 0.39 10890166 NA NA 
0.005666 0.057 0.3 10814528 tumor necrosis factor (ligand) superfamily, member 10 246775 
0.005693 0.057 0.37 10829751 NA NA 
0.005705 0.057 2.67 10928626 LanC lantibiotic synthetase component C-like 1 (bacterial) 114515 
0.005715 0.057 2.68 10718486 NA NA 
0.00573 0.057 4.18 10794464 thiopurine S-methyltransferase 690050 
0.00574 0.057 0.29 10823498 NA NA 
0.005754 0.057 3.83 10938094 NA NA 
0.005757 0.057 0.38 10916876 tetratricopeptide repeat domain 36 300676 
0.005765 0.057 0.28 10890570 NA NA 
0.005777 0.057 4.12 10728723 transmembrane protein 216 361727 
0.005777 0.057 0.38 10709464 hypothetical protein LOC499219 499219 
0.005796 0.057 0.37 10840429 similar to RIKEN cDNA 1700010M22 311491 
0.005801 0.057 0.36 10820280 NA NA 
0.005802 0.057 0.29 10813005 NA NA 
0.005839 0.057 3.59 10821546 mitochondrial ribosomal protein S30 294767 
0.005865 0.057 0.17 10915287 olfactory receptor 1155 300414 
0.005874 0.057 5.51 10815205 NA NA 
0.005875 0.057 2.85 10903459 Kruppel-like factor 10 81813 
0.005878 0.057 0.18 10775303 NA NA 
0.005891 0.057 3.54 10723253 adaptor-related protein complex 3, beta 2 subunit 308777 
0.005948 0.057 0.34 10922743 NA NA 
0.005957 0.057 5.98 10923606 STE20-related kinase adaptor beta 501146 
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0.005957 0.057 0.17 10933168 NA NA 
0.005962 0.057 0.33 10857341 similar to chromosome 3 open reading frame 20 500258 
0.005963 0.057 0.3 10882702 NA NA 
0.005964 0.057 0.34 10863363 NA NA 
0.005967 0.057 0.35 10750325 NA NA 
0.005968 0.057 0.36 10734475 NA NA 
0.005971 0.057 3.13 10701697 NA NA 
0.005992 0.057 0.19 10882892 NA NA 
0.005997 0.057 0.41 10918485 NA NA 
0.005998 0.057 0.32 10814096 NA NA 
0.005999 0.057 2.83 10836244 ADP-ribosylation-like factor 6 interacting protein 6 499798 
0.006002 0.057 0.4 10729282 NA NA 
0.006005 0.057 2.58 10811289 NA NA 
0.006007 0.057 0.29 10763421 NA NA 
0.006015 0.057 0.32 10793493 NA NA 
0.006016 0.057 0.32 10890645 WD repeat domain 89 314243 
0.006046 0.057 0.4 10864968 NA NA 
0.00606 0.057 2.96 10923270 oligonucleotide/oligosaccharide-binding fold containing 2A 363227 
0.006062 0.057 0.29 10932721 lipoma HMGIC fusion partner-like 1 300286 
0.006068 0.057 0.39 10753348 high-mobility group nucleosome binding domain 1 360704 
0.006083 0.057 0.33 10840502 NA NA 
0.006084 0.057 6.75 10891864 hypothetical protein LOC100233176 1E+08 
0.006098 0.057 4.93 10865956 C-type lectin domain family 2 member D2 362445 
0.006103 0.057 0.27 10911797 glutathione S-transferase alpha 4 300850 
0.006105 0.057 4.25 10842500 similar to Docking protein 5 (Downstream of tyrosine kinase 5) (Protein dok-5) 502694 
0.006109 0.057 0.34 10863000 rCG64263-like 502812 
0.006121 0.057 5.35 10760605 carbohydrate (chondroitin 4) sulfotransferase 12 304322 
0.006128 0.057 3.15 10870837 thioredoxin domain containing 12 (endoplasmic reticulum) 298370 
0.006143 0.057 6.25 10746916 ORM1-like 3 (S. cerevisiae) 360618 
0.006144 0.057 3.44 10804164 NA NA 
0.006154 0.057 0.19 10766277 NA NA 
0.006168 0.057 0.27 10764365 NA NA 
0.00617 0.057 0.36 10712606 LRRG00136-like 1E+08 
0.006171 0.057 0.3 10865397 LOC362433 362433 
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0.006173 0.057 0.29 10704299 vomeronasal 1 receptor 58 494226 
0.006178 0.057 3.87 10859108 C-type lectin domain family 2, member g 362447 
0.006181 0.057 0.29 10873885 NA NA 
0.006183 0.057 0.19 10705225 cytochrome P450, family 2, subfamily b, polypeptide 1 24300 
0.006197 0.0571 0.36 10716498 NA NA 
0.006231 0.0573 0.32 10756749 zinc finger protein 316 304293 
0.006247 0.0573 0.22 10779529 NA NA 
0.00625 0.0573 0.22 10755135 kininogen 1-like 1 288001 
0.006259 0.0573 0.4 10869551 NA NA 
0.006265 0.0573 0.38 10755670 NA NA 
0.006271 0.0573 3.56 10805577 NA NA 
0.006277 0.0573 3.13 10740191 neuropeptide B 259222 
0.006288 0.0573 2.82 10900753 polypyrimidine tract binding protein 1 29497 
0.006311 0.0574 3.59 10888610 similar to limb-bud and heart 683626 
0.006318 0.0574 6.76 10940413 emerin 25437 
0.006343 0.0575 3.47 10788766 farnesyltransferase, CAAX box, alpha 25318 
0.006355 0.0576 2.54 10731493 lipopolysaccharide-induced TNF factor 65161 
0.006364 0.0576 0.26 10837613 olfactory receptor 659 295865 
0.006412 0.0579 2.35 10749854 heat shock protein A8 24468 
0.006415 0.0579 0.31 10703706 paired-Ig-like receptor A2 361492 
0.006422 0.0579 0.23 10832083 MAM domain containing glycosylphosphatidylinositol anchor 1 309659 
0.006473 0.0582 0.24 10706750 TEA domain family member 2 308582 
0.00648 0.0582 0.27 10871588 zinc finger, MYND-type containing 12 313552 
0.006497 0.0582 2.66 10927413 ARP1 actin-related protein 1 homolog B (yeast) 316333 
0.006498 0.0582 0.33 10890622 NA NA 
0.006504 0.0582 4.32 10887981 splicing factor, arginine/serine-rich 7, 35kDa 362687 
0.006524 0.0583 0.29 10936701 NA NA 
0.006544 0.0584 0.29 10766880 microRNA mir-29b-2 1E+08 
0.006559 0.0585 0.4 10759479 NA NA 
0.006587 0.0586 4.12 10807625 nuclear import 7 homolog (S. cerevisiae) 192180 
0.006589 0.0586 3.7 10845124 Rho family GTPase 3 295588 
0.006619 0.0588 3.58 10806640 calreticulin 64202 
0.006642 0.0589 0.37 10731247 myosin, heavy chain 11, smooth muscle 24582 
0.006665 0.059 2.97 10863710 NA NA 
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0.006696 0.0592 0.39 10900767 hypothetical LOC500797 500797 
0.006748 0.0596 6.44 10827691 RT1 class I, locus M6, gene 2 365527 
0.00676 0.0596 0.29 10750606 olfactory receptor 1528 405995 
0.006772 0.0596 0.35 10939186 NA NA 
0.006773 0.0596 3.52 10719659 similar to RIKEN cDNA 1700008P20 292706 
0.00679 0.0596 0.41 10815222 NA NA 
0.006798 0.0596 0.31 10850555 cystatin 11 245916 
0.006801 0.0596 2.61 10855449 glycoprotein (transmembrane) nmb 113955 
0.006827 0.0597 3.75 10926577 mitochondrial ribosomal protein L14 301250 
0.006843 0.0597 3.27 10760290 neuronal pentraxin 2 288475 
0.006848 0.0597 3.06 10723032 calcium and integrin binding 1 (calmyrin) 81823 
0.006859 0.0598 0.36 10730272 cyclin M1 309387 
0.006886 0.0598 0.36 10883452 NA NA 
0.006887 0.0598 0.39 10877675 NA NA 
0.006938 0.0602 0.34 10830828 NA NA 
0.00696 0.0602 7.06 10914517 NA NA 
0.006961 0.0602 0.28 10800328 NA NA 
0.007025 0.0607 0.27 10789727 zinc finger, CCHC domain containing 24 361104 
0.00703 0.0607 2.32 10889219 heat shock protein A8 24468 
0.007068 0.0609 3 10826300 coiled-coil domain containing 76 499697 
0.0071 0.0611 9.9 10772330 NA NA 
0.007128 0.0612 0.26 10722373 NA NA 
0.007128 0.0612 0.36 10847105 olfactory receptor 621 404849 
0.007179 0.0616 2.32 10909347 heat shock protein A8 24468 
0.007257 0.0622 0.36 10859772 NA NA 
0.007268 0.0622 0.093 10857641 NA NA 
0.007281 0.0622 0.27 10828340 butyrophilin-like 4 294268 
0.007329 0.0625 2.76 10758212 Rab interacting lysosomal protein-like 2 288652 
0.00737 0.0627 0.41 10857546 inositol 1,4,5-triphosphate receptor, type 1 25262 
0.007376 0.0627 0.32 10792894 NA NA 
0.007378 0.0627 0.36 10894417 NA NA 
0.007388 0.0627 2.53 10810295 DnaJ (Hsp40) homolog, subfamily B, member 1 361384 
0.007401 0.0627 3.49 10904511 activity-regulated cytoskeleton-associated protein 54323 
0.007403 0.0627 0.35 10939206 NA NA 
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0.007425 0.0627 0.42 10835624 peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) 362113 
0.007425 0.0627 0.35 10829378 collagen, type XVIII, alpha 1 85251 
0.007475 0.0629 0.42 10745470 transmembrane and immunoglobulin domain containing 1 363654 
0.007482 0.0629 0.39 10742921 olfactory receptor 1415 405059 
0.007492 0.0629 4.49 10834159 transmembrane protein 203 311800 
0.007519 0.0629 0.43 10846850 NA NA 
0.00752 0.0629 0.36 10774752 similar to hypothetical protein FLJ31438 289865 
0.007523 0.0629 0.18 10753561 olfactory receptor 1553 288192 
0.007524 0.0629 2.28 10800590 heat shock protein A8 24468 
0.007531 0.0629 4.23 10834999 ubiquitin related modifier 1 homolog (S. cerevisiae) 311840 
0.007557 0.0631 2.64 10822356 NA NA 
0.007572 0.0631 0.33 10830640 NA NA 
0.007627 0.0633 2.3 10881303 heat shock protein A8 24468 
0.007636 0.0633 3.85 10720126 NA NA 
0.007637 0.0633 0.32 10932693 NA NA 
0.007643 0.0633 0.3 10807965 NA NA 
0.007643 0.0633 2.29 10752769 heat shock protein A8 24468 
0.007661 0.0633 0.27 10899693 NA NA 
0.007667 0.0633 0.33 10866056 killer cell lectin-like receptor subfamily C, member 2 29684 
0.007676 0.0633 2.7 10813752 myotubularin related protein 12 310155 
0.007686 0.0633 3.95 10719967 RAB4B, member RAS oncogene family 50866 
0.007687 0.0633 0.37 10725045 cytochrome P450, family 2, subfamily r, polypeptide 1 361631 
0.007704 0.0633 3.75 10850958 peroxisomal membrane protein 4 282634 
0.007727 0.0635 3.03 10797657 osteomodulin 83717 
0.007744 0.0635 0.2 10768294 NA NA 
0.007811 0.0639 3.66 10937347 asparagine-linked glycosylation 13 homolog (S. cerevisiae) 300284 
0.007824 0.0639 3.01 10860749 NA NA 
0.007825 0.0639 0.29 10863285 NA NA 
0.00783 0.0639 3.85 10894919 NA NA 
0.007838 0.0639 0.25 10796436 NA NA 
0.007868 0.0641 2.71 10935798 NA NA 
0.007902 0.0641 0.36 10878617 NA NA 
0.007906 0.0641 0.31 10752586 NA NA 
0.007911 0.0641 0.29 10863615 exocyst complex component 6B 500233 
207  
0.007917 0.0641 0.31 10930201 NA NA 
0.007918 0.0641 0.41 10775737 NA NA 
0.007939 0.0641 4.08 10875532 pyruvate dehyrogenase phosphatase catalytic subunit 1 54705 
0.007947 0.0641 0.38 10877689 NA NA 
0.007961 0.0642 0.38 10852191 NA NA 
0.008007 0.0645 4.27 10785895 NA NA 
0.008028 0.0645 0.26 10938584 NA NA 
0.008032 0.0645 0.37 10929937 NA NA 
0.00805 0.0645 0.43 10811980 NA NA 
0.008054 0.0645 0.35 10935662 NA NA 
0.00807 0.0646 8.5 10817183 S100 calcium binding protein A11 (calizzarin) 445415 
0.008094 0.0647 3.46 10874802 ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast) 298689 
0.008107 0.0647 0.33 10894140 NA NA 
0.008111 0.0647 3.83 10717793 regulator of G-protein signaling 17 308118 
0.008119 0.0647 0.32 10886896 NA NA 
0.008149 0.0648 2.66 10872018 trafficking protein particle complex 3 362599 
0.008159 0.0648 3.28 10861196 NA NA 
0.008173 0.0648 0.3 10909237 NA NA 
0.008184 0.0649 0.22 10767034 NA NA 
0.008221 0.0651 2.45 10829678 similar to RIKEN cDNA 1700049L16 502418 
0.008231 0.0651 0.31 10853467 NA NA 
0.008245 0.0651 3.33 10789246 NA NA 
0.008275 0.0652 0.37 10838439 olfactory receptor 773 296026 
0.008279 0.0652 0.33 10851380 NA NA 
0.008286 0.0652 2.75 10730884 survival motor neuron domain containing 1 287768 
0.008291 0.0652 4.42 10724228 Bcl2-like 1 24888 
0.008317 0.0653 2.61 10737636 solute carrier family 35, member B1 287642 
0.008347 0.0653 2.79 10762600 GCN1 general control of amino-acid synthesis 1-like 1 (yeast) 690632 
0.008356 0.0653 0.39 10739160 NA NA 
0.008361 0.0653 0.29 10896524 NA NA 
0.008363 0.0653 0.31 10933974 NA NA 
0.008381 0.0654 4.82 10850125 similar to chromosome 20 open reading frame 30; HSPC274 protein 681315 
0.008401 0.0655 0.17 10847221 olfactory receptor 715 404815 
0.008429 0.0655 3.22 10830908 ring finger protein 39 171387 
208  
0.008446 0.0655 3.68 10884738 NA NA 
0.008447 0.0655 4.47 10901920 small nuclear ribonucleoprotein polypeptide F 680737 
0.008452 0.0655 0.43 10909616 sodium channel, voltage-gated, type II, beta 25349 
0.008452 0.0655 0.23 10707254 NA NA 
0.008467 0.0655 0.32 10737736 NA NA 
0.008484 0.0655 2.98 10863502 WD repeat domain 54 500226 
0.008492 0.0655 0.34 10747371 ATP citrate lyase 24159 
0.00851 0.0655 0.36 10862281 olfactory receptor 801 405372 
0.008516 0.0655 0.32 10736792 NA NA 
0.00853 0.0655 4.08 10864662 transmembrane protein 111 312640 
0.008532 0.0655 0.32 10887108 NA NA 
0.008546 0.0655 0.44 10909590 myelin protein zero-like 2 300679 
0.008553 0.0655 0.44 10886773 NA NA 
0.008569 0.0655 2.8 10721232 interferon stimulated exonuclease gene 20-like 2 361977 
0.008603 0.0655 0.33 10927175 NA NA 
0.008603 0.0655 2.97 10841637 neuronatin 94270 
0.008605 0.0655 0.36 10795313 NA NA 
0.008609 0.0655 3.09 10832905 sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae) 309757 
0.008612 0.0655 0.38 10737587 protein phosphatase 1, regulatory subunit 9B 84686 
0.00862 0.0655 0.35 10703459 NA NA 
0.008627 0.0655 0.29 10764493 NA NA 
0.008649 0.0656 3.29 10704452 Meis homeobox 3 361514 
0.008652 0.0656 0.36 10869301 NA NA 
0.008678 0.0657 5.11 10809007 carbonic anhydrase 7 291819 
0.008703 0.0657 4.15 10927692 four and a half LIM domains 2 63839 
0.008706 0.0657 0.36 10752974 NA NA 
0.008734 0.0659 4.47 10929600 phosphodiesterase 6D, cGMP-specific, rod, delta 363272 
0.008759 0.066 0.31 10903965 NA NA 
0.00881 0.0663 0.4 10720510 NA NA 
0.008818 0.0663 3.32 10909338 adipocyte-specific adhesion molecule 286939 
0.008824 0.0663 0.42 10836019 kynureninase (L-kynurenine hydrolase) 116682 
0.008833 0.0663 5.2 10938077 acyl-CoA thioesterase 9 302640 
0.008855 0.0663 3.5 10910167 NA NA 
0.008908 0.0666 0.36 10719824 cornifelin 365217 
209  
0.008914 0.0666 2.34 10937523 NA NA 
0.00895 0.0668 3.21 10899387 nuclear receptor subfamily 4, group A, member 1 79240 
0.008998 0.067 3.49 10934548 similar to RIKEN cDNA 2610029G23 363485 
0.009014 0.067 3.43 10729331 similar to RIKEN cDNA 1110059E24 361740 
0.00902 0.067 3.65 10876520 exosome component 3 313243 
0.00902 0.067 3.39 10790002 guanine nucleotide binding protein-like 3 (nucleolar) 290556 
0.009054 0.0671 3.48 10760514 NA NA 
0.00906 0.0671 0.4 10872361 brain-specific angiogenesis inhibitor 2 313058 
0.009062 0.0671 3.46 10894268 NA NA 
0.009062 0.0671 3.46 10918270 NA NA 
0.009079 0.0671 0.35 10746602 nuclear factor, erythroid derived 2,-like 1 360610 
0.009102 0.0671 0.37 10887078 NA NA 
0.009105 0.0671 3.37 10701846 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 114490 
0.009106 0.0671 3.42 10767001 methionine adenosyltransferase II, alpha 171347 
0.009142 0.0672 0.3 10917568 acyl-CoA synthetase bubblegum family member 1 171410 
0.009148 0.0672 0.42 10891436 general transcription factor IIA, 1 83830 
0.009165 0.0673 2.86 10799657 N-myristoyltransferase 2 291318 
0.009226 0.0677 3.29 10902547 lysozyme 2 25211 
0.009261 0.0678 0.45 10734368 NA NA 
0.009302 0.068 0.36 10720945 NA NA 
0.009304 0.068 0.38 10791563 NA NA 
0.009314 0.068 3.23 10730297 zinc finger, FYVE domain containing 27 309376 
0.009325 0.068 2.26 10737125 peptidyl-tRNA hydrolase 2 287593 
0.009341 0.068 0.31 10754176 Cd80 molecule 25408 
0.009345 0.068 2.53 10811589 ring finger protein 166 365022 
0.009385 0.0682 3.53 10864893 NA NA 
0.009442 0.0685 2.44 10908414 queuine tRNA-ribosyltransferase 1 64016 
0.009473 0.0686 0.2 10772013 transmembrane protease, serine 11b 365265 
0.009479 0.0686 4.09 10927680 transforming growth factor, beta receptor associated protein 1 301373 
0.009488 0.0686 0.31 10788707 adrenergic, beta-3-, receptor 25645 
0.0095 0.0686 3.4 10809882 NA NA 
0.009507 0.0686 3.79 10707121 general transcription factor IIH, polypeptide 1 361580 
0.009526 0.0687 0.41 10861563 NA NA 
0.00954 0.0687 0.29 10785867 NA NA 
210  
0.009556 0.0687 0.28 10724280 NA NA 
0.00957 0.0687 0.27 10848138 olfactory receptor 785 404792 
0.00957 0.0687 0.23 10871773 NA NA 
0.009591 0.0688 2.78 10916456 NA NA 
0.00967 0.0693 0.35 10927264 NA NA 
0.009691 0.0694 0.32 10889328 NA NA 
0.009702 0.0694 2.73 10796991 aminopeptidase O 290963 
0.009814 0.0701 0.3 10898849 NA NA 
0.00983 0.0701 3.44 10895406 pleckstrin homology-like domain, family A, member 1 29380 
0.009862 0.0703 0.33 10915283 olfactory receptor 1151 300411 
0.00988 0.0703 0.44 10772160 NA NA 
0.009956 0.0708 2.27 10806884 NA NA 
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The final cause of death in most patients revived after cardiac arrest is ischemia and 
reperfusion (I/R) injury in the brain. Survival after brain I/R injury depends on the expression of 
new stress response proteins such as heat shock protein 70 (HSP70). Little is known about why 
recovering neurons are able to express new stress response proteins while neurons that will die can 
transcribe RNA but do not translated protein in early reperfusion. Previous studies suggested that 
the mRNA-binding protein HuR may regulate hsp70 mRNA in reperfused neurons through a novel 
cytoplasmic structure, the mRNA granule. To determine the roles of HuR and the mRNA granule 
in reperfused neurons and to characterize global translation regulation, we 1) prevented mRNA 
granule formation in reperfused neurons or induced mRNA granules in uninjured neurons by 
pharmacological manipulation polysomes, 2. studied potential HuR posttranscriptional regulation 
mechanisms of facilitated nuclear export and polysome association, and 3. performed translation 
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